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Microorganisms, including bacteria, viruses, fungi, or parasites, give rise to 
infectious diseases, which can spread between people, and can even transfer from animals 
or insects to humans.  Infectious diseases are common, sometimes fatal, health issues.  To 
date, the treatment of infectious diseases has largely relied on antibiotics.  However, the 
therapeutic outcomes of current treatments need to be enhanced due to the emergence of 
drug-resistant microorganisms and the decline in the development of new antibiotics.  
Nanotechnology could help improve the efficacy of currently available antibiotics via 
changing the pharmacokinetics and biodistribution of drugs, which could enhance 
bioavailability, reduce side effects, help overcome physical and biological barriers for the 
efficient delivery to the site of infection, and so on.  This dissertation aims to explore a 
novel treatment method to treat infectious diseases using degradable polymer-based 
nanoparticles.   
In a first project, bacterial adhesin, FimHA-targeted polymeric nanoparticles were 
developed for the delivery of antimicrobials to bacteria hiding inside the cells by 
mimicking the bacterial mode of cell invasion in order to treat and eradicate recurrent 
urinary tract infections.  Amidation between carboxylic acids located in the shell of the 
poly(acrylic acid)-block-polystyrene-based polymeric nanoparticles and primary amine 
groups of lysine residues on FimHA was employed as the conjugation method.  We 




the surface without free and/or physically-associated proteins under the improved 
coupling conditions. 
In a second direction involving a series of projects, functional polycarbonates were 
developed in order to expand the pool of degradable polymers and their self-assembled 
nanostructures, which can be utilized as drug-delivery vehicles.  Degradable 
polycarbonates were synthesized by metal-free organocatalytic ring-opening 
polymerization of cyclic carbonate monomers.  Postpolymerization modifications were 
also employed to introduce new functionalities onto the same degradable polymer 
backbone.  Water-soluble polycarbonate formed a hydrophilic shell domain of polymeric 
nanostructures, and reactive aldehyde- and vinyl ether-functionalized polycarbonates were 
synthesized and their potential for drug delivery systems were demonstrated. 
In a third direction, advanced mechanistic understanding of organocatalytic ring-
opening polymerization (ROP), which is widely used for syntheses of degradable 
polymers, was gained by specialized NMR spectroscopy studies.  The collection of 13C 
NMR data in real time during polymerization was enhanced via hyperpolarization of 
nuclear spins.  The “living” characteristics of ring-opening polymerization enabled the 
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Proper medical diagnosis and therapy are essential for providing patients with 
proper care, but improper detection of the diseases, unsatisfactory therapeutic outcomes, 
and/or serious adverse reactions often result from inefficient diagnoses and conventional 
therapy.  Advances in the design of various diagnostic and therapeutic agents and the 
recent trend of utilizing molecules for both therapeutic and diagnostic applications (i.e., 
theranostics) still have not achieved complete control of the navigation and biodistribution 
of these molecules within the biological system during therapy. From small molecules to 
macromolecular drugs (e.g., natural product-, protein-, and nucleic acid-based drugs, or 
synthetic, polymer-based conjugates, carriers, or other systems), the key challenges 
toward the use of existing therapeutic agents are typically the loss of activity via rapid 
clearance or degradation, inefficient delivery to the target sites, and/or inappropriate 
probing of the disease states.   
The concept of nanotechnology was initiated early in 1959 by Richard Feynman 
during his legendary talk at Caltech, “There’s Plenty of Room at the Bottom,” where he 
introduced the possibility of manipulating materials at the atomic and molecular levels.1  
Nearly twenty years later, Norio Taniguchi at Tokyo University, coined the term 
*Adapted with permission from “Polymeric Nanostructures for Imaging and Therapy” by
Mahmoud Elsabahy, Gyu Seong Heo, Soon-Mi Lim, Guorong Sun, and Karen L. Wooley, 
Chem. Rev. 2015, 115 (19), 10967-11011.  Copyright © 2015 American Chemical Society. 
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“nanotechnology” in 1974, referring to the design of materials on the nanoscale.2  Since 
the early 1990s, the use of nanomaterials of different compositions (organic and inorganic) 
and for various applications (from medical, to electronic, to manufacturing) has been 
greatly expanded, in particular over the last couple of decades.3,4  In the medical field, 
nanotechnology now includes noninvasive systems for probing of disease, capable of 
carrying cargo for localized high-concentration delivery with reduction of off-target 
effects.  The use of nanomaterials, in particular polymeric nanostructures, in nanomedicine 
has demonstrated both improved efficiency in delivery of diagnostic and therapeutic 
agents to the target sites, as well as the ability to fine-tune control of their navigation to 
target sites by incorporating several therapeutic/diagnostic/targeting moieties within 
specific compartments in the nanoparticles.  Recent understanding of the nature of 
microenvironments within biological systems (e.g., different pH, temperature, 
permeability, drainage, or overexpression of proteins, enzymes, or receptors) and the 
barriers toward the delivery of various moieties to their intra- or extracellular destinations 
has aided the design of nanomaterials that deftly evade various physiological barriers. 
Selective delivery to the site of the disease increases the therapeutic efficacy, imaging 
contrast, and accuracy, while reducing adverse reactions and the dose and cost of 
medications. 
The remarkable advantage of polymeric nanostructures over other types of 
nanomaterials is the flexibility with which their structures can be modified to yield 
materials of various compositions, morphologies, sizes, and surface properties, with the 
possibility of hierarchical assembly of several nanomaterials of various components into 
3 
one construct that can be accommodated with a variety of therapeutic, diagnostic, and/or 
targeting moieties, within selective compartments of the nanodevices.  Efficiency in 
diagnosis and treatment of diseases and patient quality-of-life and compliance can be 
vastly improved by grasping the molecular events associated with various diseases and 
combining advances in the design of therapeutic and diagnostic agents and nanomaterials 
together with innovative instruments utilized for monitoring these agents.   
1.1. Capabilities and Challenges for Medical Therapy 
Medical therapy, in particular the systems that target special events related to a 
disease, promises effective treatment of several diseases on the molecular level, for 
instance, via correcting genetic mutations or protein misfolding or via interfering with one 
or more of the pathway cascades involved in disease progression.  Diseased tissues 
typically differ from healthy ones in several aspects, such as having different 
microenvironment (pH or temperature), permeability, or drainage, or overexpressing 
specific proteins, enzymes, or receptors.  Exploitation of these differences allows selective 
delivery once the therapeutic molecules overcome biological barriers and reach the 
diseased tissues and molecular targets.  The same principles apply to therapy as to 
imaging, where selective binding or release of the diagnostic agents to the diseased tissues 
can improve the imaging contrast and provide more efficient diagnosis and information 
on the disease status and progression.  Theranostic agents are being developed currently 
via either utilizing a particular probe or drug that has therapeutic and diagnostic 
capabilities or labeling therapeutic agents with imaging probes, for both therapy and 
imaging.  The use of a theranostic approach, in addition to providing simultaneous therapy 
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and imaging, reducing the frequency of administration, enhancing patient compliance, and 
decreasing the burden on patients and caregivers, can also provide useful information on 
the drug biodistribution and clearance. 
Selective delivery to the site of the disease can increase the therapeutic and 
imaging efficacy, reduce adverse reactions, and reduce the cost.  However, there are 
several challenges toward this efficient delivery (Figure 1.1). Several of these drugs have 
poor aqueous solubilities and, thus, cannot be solubilized, dispersed, or diluted in saline 
prior to injection, or solubilized in other aqueous solutions for administration via other 
routes of administration.  Rapid degradation, enzymatic or hydrolytic, of some drugs, both 
in vitro during storage and in vivo after administration (extra- or intracellularly), hinders 
drugs from reaching their target sites in an intact form.  Interaction between drugs and 
various biological environments (depending on the administration route and target site) 
may destabilize the drug, prevent their penetration to the target site, or redirect their 
distribution in the body.  The detailed biological barriers (external, en route, internal) have 
been reviewed previously by our group (Figure 1.1) and others.5-8 
The main barriers toward the delivery of therapeutic and diagnostic agents to their 
target sites are the external barriers (skin and mucosa that cover body surface) that prevent 
them from entering the body, blood, blood components, and extracellular matrices that 
hinder them from reaching the targeted cells or sites in the various organs, and cellular 
barriers (limited uptake, degradation in the endosomes/lysosomes or the cytoplasm, and 
low nuclear uptake, if the nucleus is the target site).  These barriers also destabilize the 
therapeutic and diagnostic agents before they reach their target sites.  The tightly packed 
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layers of the stratum corneum of the skin usually hinder penetration of various drugs, 
whereas the viscoelastic hydrogel of the mucus that covers various body surface areas 
hinders delivery to the underlying tissues via several mechanisms.9,10  The mucus has 
various compositions (cells, bacteria, lipids, salts, proteins, macromolecules, and cellular 
debris), thicknesses, and pH’s, depending on the physiological region and disease status; 
thus, mucus work to inhibit drug delivery via adhesiveness, steric hindrance, and 
mucociliary clearance.  Additionally, drugs that reach the bloodstream are subjected to 
opsonization, degradation, immune response, nonspecific biodistribution, and renal, 
hepatic, and/or splenic clearance.11  Even upon reaching the cellular surface, drugs are 
usually not at their final destination yet, and may not have the capability of entering cells, 
especially if they are hydrophilic macromolecules; after uptake, they may degrade within 
the endosomal/lysosomal compartments.  When the target site is a subcellular organelle, 
such as mitochondria or the nucleus, yet another barrier is incorporated into the journey, 
as these organelles do not allow nonspecific uptake of various moieties. 
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Figure 1.1.  The main challenges towards the use of various therapeutics, diagnostics and theranostics, 
during formulation, administration and the resulting biodistribution, with no control over their 
characteristics and navigation within the biological system.   
1.2. Infectious Diseases as Targets for Medical Therapy 
Infectious diseases are usually caused by bacteria, viruses, parasites, or fungi. 
They typically spread from one organism to another and may become serious, difficult to 
treat, and life-threatening.  More recently, the outbreaks of Ebola, influenza, salmonella, 
HIV, etc. have brought worldwide attention to zoonotic diseases that can be transmitted 
to humans by infected animals.  Since the expansion of the global transport network, 
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infectious diseases have become more broadly transmissible,12 increasing the urgency to 
develop efficient treatment methods.  Although there are several therapeutics and 
diagnostics for management of infectious diseases have been tested with varying degrees 
of success, the poor bioavailability (due to rapid metabolism and excretion from the body 
or inactivation of drugs) and serious side effects of some of these agents, development of 
resistant microorganisms, and biological barriers that hinder the efficient delivery of 
therapeutic and diagnostic agents to the infection sites compromise the expected 
therapeutic outcomes.13-15 
We have a keen interest in the treatment of urinary tract infections (UTIs) and 
pulmonary infectious diseases due to their prevalence, limited treatment strategies, and 
promise for direct routes of administration, which may avoid complications from systemic 
delivery and damage to the human microbiome, among other beneficial microflora. 
UTIs include infections in the urethra, bladder, ureters, and kidneys, which 
constitute the urinary system.  Although several uropathogens including bacteria, viruses
and fungi can also cause UTIs, bacteria, especially uropathogenic Escherichia coli 
(UPEC), are the primary source of infections.16  A high tendency of recurrence makes 
treatments of UTIs more challenging.
Examples of infectious diseases that affect the lung are pneumonia, tuberculosis, 
and chronic obstructive pulmonary diseases.  Barriers toward the delivery of 
antimicrobials for the treatment of infectious diseases depend upon the type and site of 
infections and could include, but are not limited to, multidrug-resistant bacteria and need 
for high doses, which often results in toxicity, mucociliary clearance, steric hindrance of 
8 
drug uptake, presence of enzymes and macrophages in the mucus gel and tissues, and high 
viscosity of sputum, especially in the case of cystic fibrosis.9,36,46-54  Mucus is a 
viscoelastic hydrogel secreted by the mucosal glands to protect regions that are not 
covered by the skin, with varying composition, thickness, and permeability depending on 
the region and disease status.10  The use of physical or chemical methods to hydrolyze 
mucin and mucolytic agents enhances penetration of the drug in patients with lung disease 
by reducing the viscosity of mucus.17-19 
1.3. Design of Polymer Nanostructures to Address Challenges in Medical 
Therapy 
Polymeric nanostructures have the potential to improve the medical outcomes of 
various therapeutics and diagnostics by enhancing the accumulation of the embedded 
active species into the target sites of diseased tissues via passive and/or active targeting 
(Figure 1.2).  They can also be utilized for combinational therapy/diagnosis.  In passive 
targeting, nanoparticles accumulate in pathological sites with leaky vasculature (e.g., 
tumor and inflammation sites) due to the "enhanced permeability and retention"  (EPR) 
effect,20 whereas active targeting is achieved by decorating the surface of nanoparticles 





Active targeting features can also be incorporated into the nanostructures via incorporating 
stimuli-responsive components into the nanomaterials.  Ideally, both targeting 
mechanisms aim to concentrate the nanomaterials, while containing the embedded drugs 
and/or diagnostic probes, at the diseased tissues and avoid accumulation or drug release 
at healthy tissues.  No matter which targeting strategy is employed, a common 
characteristic of nanoparticulate materials is that loading drugs into nanoparticles redirects 
biodistribution by preventing small molecule drugs from passing through normal blood 
vasculature, renal tubules, and other pores <10 nm, thus eliminating rapid biological 
clearance and alleviating severe side effects systemically.  Instead, nanomaterials 
selectively permeate and accumulate in pathological areas with leaky vasculature (pores 
>100 nm).  Local routes of administration offer opportunities to further narrow the 
selective region of access of nanomaterials, for instance, exclusively to diseased skin, 












Figure 1.2.  Compositional versatility of multifunctional nanoparticles for biomedical delivery applications, 
illustrated generically for a solid core–shell polymer nanoparticle scaffold.  (a) Targeting: Clusters of 
targeting moieties are important for multivalent binding to receptors for enhanced cellular uptake; the use 
of various ligands (antibody, antibody fragment, peptide, etc.) depends on the therapeutic application and 
disease type.  (b) Shell: The length, spacing, and cross-linking of the shell polymers are critical parameters 
that dictate the blood circulation time and stability of nanoparticles with ∼1 nm spacing found to be efficient 
in preventing protein adsorption.  (c) Core: The nature of the core dictates the type of drug to be 
encapsulated.  Cross-linking and conjugation of drugs to the core-forming polymer are common strategies 
for enhancing the stability of nanoparticles and drug-encapsulation efficiency, respectively.  (d) Cargo: A 
wide range of imaging agents and/or therapeutics can be packaged, ranging from small molecules to 
macromolecular cargoes.  Reprinted with permission from refs 5,21.  Copyright 2012 and 2013 Royal Society 
of Chemistry. 
Typically, nanoparticle-based carrier materials possess a core–shell morphology, 
for which the nature of the core-forming polymer dictates the type of 
therapeutics/diagnostics that can be incorporated into the nanomaterials, whereas the 
composition and structure of the shell-forming polymer components (e.g., the polymer 
chain length, spacing, and incorporation of cross-linking moieties) control the stability of 





toward the development of effective therapeutics, the ability to control their characteristics 
via chemical modifications of the building blocks is an exciting strategy to improve the 
utility of nanomaterials for biomedical applications.  The building blocks can be modified 
to encapsulate hydrophobic drugs, nucleic acids, enzymes, hormones, small peptides, and 
other macromolecules.  They can also be modified to respond to external or internal 
stimuli. 
Multifunctional polymeric nanoparticles with precisely-controlled architecture of 
the individual polymer components and overall nanoparticle composition can be 
engineered via bottom-up control of the polymer chemistry and supramolecular assembly.  
The chemistry of polymer precursors can be modified for efficient encapsulation of 
various therapeutic molecules.  For example, chemical modification with hydrophobic 
side chains or cationic functional groups can be utilized for incorporation of hydrophobic 
drugs and nucleic acids, respectively.  These drugs also can be attached covalently onto 
polymers to afford drug–polymer conjugates, which consequently eliminate the diffusion-
dominated premature release and provide further tunability of either hydrolytically- or 
enzymatically-induced controlled release.  Diagnostic probes can also be included in these 
materials through orthogonal chemical modifications. 
Hydrophilic polymer components/segments should be carefully selected to mask 
the hydrophobic domains of the nanoparticles and the embedded cargoes, as well as to 
allow for prolonged blood circulation time and low interaction with extracellular matrices 
and with the immune system components.  Poly(ethylene glycol) (PEG), also known as 
poly(ethylene oxide) (PEO) or polyoxyethylene (POE), is the most commonly used 
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polymer to coat various types of nanomaterials and to impart stealth properties.  Other 
polymers have also been investigated to form the corona of nanoparticles, such as poly(N-
(2-hydroxypropyl)methacrylamide) (PHPMA), poly(acrylic acid) (PAA), poly(N-
vinylpyrrolidone), poly(N-isopropylacrylamide), and poly(carboxybetaine) (PCB).22-27 
Although still controversial, it was reported that PCB can impart an antibiofouling effect 
better than PEG, possibly due to better hydration of the corona via the tighter electrostatic 
binding of water molecules than hydrogen bonding in the case of PEG, thus minimizing 
protein adsorption on the surface of nanoparticles.25-27  Antibiofouling means lower 
competences for adsorbing proteins or other opsonins in the surrounding environment.  As 
potential toxicities and immunogenicities of PEGylated therapeutics were previously 
reported,28-30  alternative degradable PEG analogues are currently under investigation to 
improve the safety profiles of PEG-based therapeutics.31  However, it is worth mentioning 
that safety, biocompatibility, and performance of nanomaterials depend on the overall 
nanoparticle composition and not only that of the shell. 
The recently-developed controlled polymerization methodologies not only provide 
a powerful toolbox for incorporation of diverse functionalities into polymers but also 
enable precise rationalization of drug/targeting ligand/probes-to-polymer or unimer-to-
unimer ratio, thus providing the possibility of predefined control over the size and shape 
of the formed nanoparticles.  The size and morphology of polymer nanoparticles serve as 
critical characteristics for their in vivo fates, such as blood circulation time and organ 
biodistribution.  While spherical nanostructures with hydrodynamic diameters (Dh’s) 





research activities on ultrasmall nanoparticles with Dh at the sub-10 nm scale revealed 
noticeable advantages of enabling effective renal excretion32 and minimizing off-target 
accumulation,33 which are attractive features for developing nanoparticulates for imaging 
applications.  However, the decrease of nanoparticle size can enhance its permeability into 
both healthy and diseased tissues and can also result in rapid clearance from the blood and 
thus reduced accumulation in the targeted tissues, which deceases the benefits from 
nanoparticles in some therapeutic applications, such as in the case of cancer therapy.  
Regardless of the size of nanoparticles, imparting stability that prevents premature 
dissociation and release of the loaded therapeutic/diagnostic cargoes is crucial. 
Premature disassembly of nanoparticles into the polymer constituents and/or 
breakdown into degradation products result in premature release of their loaded cargoes, 
and this is considered one of the main challenges for the effective delivery of nanoparticle-
packaged therapeutics to their target sites.  Not only might the drug release prematurely, 
but the free polymeric chains may also induce cyto/immunotoxicity.  Stereocomplexation, 
noncovalent interactions, and cross-linking of one or more of the polymer’s components 
are some of the most commonly utilized strategies to enhance the stability of 
nanomaterials.34-36  Cross-linking can be performed within either the core or the corona of 
preformed micelles.  Synthesis of unimolecular/hyperbranched structures that are not 
prone to dissociation upon dilution is another way to yield stable nanostructures.  The 
relationship between chemical composition and cross-linking of different block 
copolymers and the relative copolymer block length on the size, core/shell dimensions, 





reviewed by our group and others.37-40  The superior characteristics of the cross-linked 
nanomaterials over their non-cross-linked precursors include allowing unique processing 
opportunities, including overcoming complications of aggregation during lyophilization 
processes; biological advantages, including slower kinetics of release of therapeutic 
guests,23,41 higher kinetic and blood stability,42,43 longer pulmonary retention to provide 
for extended release,41 and lower cyto/immunotoxicities; introducing of 
structural/functional factors that enable stimuli-responsive functions; and affording 
unusual nanoparticle properties and structures, including stabilization of nanocrystals and 
the formation of nanocages. 
1.4. Scope of the Dissertation 
This dissertation is focused on the development of targeted-polymeric 
nanoparticles for the treatment of infectious diseases and the synthesis of functional 
degradable polymers which can be used as a component of drug delivery vehicles.  
Furthermore, the ROP of lactide was investigated using hyperpolarized NMR, which will 
lead further research to improve catalytic activity by not only optimization of reaction 
conditions, but also modification of catalyst.  
Chapter II is focused on the improvement of the conjugation conditions, which is 
crucial for the preparation of targeted polymeric nanostructures.  Amidation between 
carboxylic acids located in the shell of the poly(acrylic acid)-block-polystyrene-based 
polymeric nanoparticles and primary amine groups of lysine residues on bacterial adhesin, 
FimHA, was employed as the conjugation method.  We found that free- and/or physically-
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associated FimHA in the reaction mixture was difficult to remove by common purification 
methods, such as dialysis, centrifugal filtration, and column chromatography.  Therefore, 
we aimed to obtain quantitative conjugation yields under improved amidation conditions, 
which would allow for avoiding demanding purification process.  Amidation conditions 
were improved based on several aspects which could be overlooked, such as extents of 
shell cross-linking, half-lives and reactivity of coupling agents, impurities, etc.   
Nanostructures employed in Chapter II were derived from non-degradable block 
copolymers to avoid potential in situ degradation during and after conjugation reactions, 
which could complicate analysis of results.  In Chapter III, IV, and V, degradable 
polycarbonate-based macromolecular materials were developed in order to replace non-
degradable components of polymeric nanostructures, which will allow for hydrolytic 
degradation and biological clearance of the nanomaterials.  Functionalizable hydrophilic 
polycarbonate were designed and synthesized as a degradable alternative for widely used 
water soluble polymers, PHPMA and PEG in Chapter III.  The resulting polymer was 
highly water-soluble and readily functionalizable by postpolymerization modifications 
with low cyto-/immunotoxicities, which are promising characteristics for a degradable 
alternative to PEG and PHPMA.  In Chapter IV, aldehyde-functional polycarbonates were 
synthesized by ozonolysis and reductive work-up of allyl-functional polycarbonates.  
Resulting aldehyde moieties were readily functionalized with aminooxy compounds under 
mild conditions, which could be a promising conjugation strategy for the preparation of 
ligand-nanoparticle conjugates.  In Chapter V, vinyl ether-functional polycarbonates were 





chemistries including acetalization, thioacetalization, and thiol-ene reaction.  Among them, 
the acetal moiety is a promising functionality for stimuli-responsive drug delivery systems 
due to its acid-labile characteristic.  pH-dependent cleavage kinetics of an acetal linkage 
with a model drug compound demonstrated its potential for biomedical applications.     
In Chapter VI, ring-opening polymerization, which is widely used polymerization 
to synthesize degradable polymers, such as polyesters, polycarbonates, polyphosphoesters, 
polypeptides, etc., was investigated using a specialized NMR spectroscopy technique.  
Real-time NMR spectroscopy enhanced by hyperpolarization of nuclear spins enables to 
detect 13C NMR signal of an intermediate formed during the polymerization.  13C temporal 
correlation experiments and homonuclear selective saturation experiments verified that 




IMPROVEMENT OF THE CONJUGATION CONDITIONS FOR THE SYNTHESIS 
OF BACTERIAL ADHESIN-POLYMERIC NANOPARTICLE CONJUGATES FOR 
THE TREATMENT OF URINARY TRACT INFECTIONS 
2.1. Introduction 
Urinary tract infections (UTIs) are among the most common bacterial infections 
worldwide, the second most common infectious diseases after respiratory infections in the 
United States, and the most common hospital-acquired infection.44-47  Socioeconomic 
burden of UTIs including direct (financial) and indirect (social) costs is estimated more 
than a few billion dollars in the United States and would be much higher since social 
impacts are immeasurable.46,48  In addition, a high tendency of recurrence and emergence 
of antibiotic resistant bacteria make treatments more complicated.  More frequent 
exposure of bacteria to antimicrobials promotes development of resistant strains as well 
as the suppression and alteration of normal microbiota for patients with recurring 
infections.49,50  Therefore, there is an urgent need to develop more effective treatment 
methods in order to exclusively eradicate only UTI-causing pathogens from the human 
body and to prevent recurrent UTIs, while maintaining a healthy microbiome of 
commensal or mutualistic flora.  
UTIs include infections in the urethra, bladder, ureters, and kidneys, which 
constitute the urinary system.  Although several uropathogens including bacteria, viruses, 
and fungi can cause UTIs, bacteria, especially uropathogenic Escherichia coli (UPEC), 
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are the primary source of infections.16  Attachment (adherence, adhesion) of uropathogens 
on the surfaces (epithelial cells) of each urinary system is a key initial step in the 
mechanisms of infection and colonization since it prevents bacteria from elimination from 
the urinary tract.51  Adhesion of UPEC to urothelial cells are mediated by adhesive proteins 
(adhesins) at the tip of various pili, such as F1C pili, P pili, S pili, Type 1 pili, etc.52  Among 
them, Type 1 pili are well-characterized and are known to be responsible for UPEC 
adherence, colonization, and invasion of urothelial cells in mouse model studies.53,54  Tip 
adhesive domain of Type 1 pili (FimHA) interact with mannosyl moieties on uroplakin and 
α3β1 integrin on the surface of bladder epithelial cells, which leads to internalization of 
UPEC into these umbrella cells.55-60  After internalization and escape from endocytic 
vesicles to cytoplasm, UPEC can develop intracellular bacterial communities (IBCs) and 
quiescent intracellular reservoirs (QIRs), which enable UPEC to evade both host defense 
system and antibiotic treatment.  Notably, intraepithelial reservoirs might serve as a source 
of recurrent UTIs.61-63  We hypothesized that bacterial adhesin-conjugated polymeric 
nanoparticles can deliver antimicrobials to reservoir bacteria hiding deep inside the cells 
by mimicking the bacterial mode of cell binding and internalization, thus treating and 
eradicating recurrent UTIs.  
Our group reported the development of FimHA-targeted polymeric nanoparticles 
and their FimHA-specific adherence to the cultured bladder epithelial cells in vitro.64  
Amidation between carboxylic acids located in the shell of the shell cross-linked knedel-
like nanoparticles (SCKs)65,66 and primary amine groups of four lysine residues on FimHA 





internalized SCKs with the conjugates within the bladder epithelial cells, the majority was 
localized on the cell membranes/surfaces.  In this study, we prepared adhesin-SCK 
conjugates with varying amounts of FimHA on the surface of the SCK nanoparticles 
without free- and/or physically-associated protein in order to improve the behavior of 
conjugates.  First, we tried a few purification methods to remove unbound FimHA after 
conjugation, including dialysis, centrifugal filtration, and column chromatography, which 
turned out to be ineffective.  Without a reliable purification method, we cannot increase 
the amount of FimHA in the reaction mixture as an approach to increasing FimHA density 
on the nanoparticle surface, which would have facilitated nanoparticles’ binding and 
invasion into the bladder epithelial cells.  As an alternative approach, therefore, we aimed 
to obtain ca. 100% conjugation yields under improved amidation conditions, which allows 
for the maximum density of targeting protein on the surface of nanoparticles with full 
covalent linkages.  Conjugation conditions were improved by considering several aspects, 
such as extents of shell cross-linking, half-lives and reactivity of coupling agents, 
impurities, etc.  Under the improved conditions, the equivalent ratios of protein to polymer 
chain were altered to compare the amount of FimHA added to aqueous solutions of the 
SCK nanoparticles vs. the conjugation efficiency, by which ca. 100% conjugation yield 
was achieved below 1:2 ratios of FimHA : polymer.  The amount of free protein was 
confirmed by SDS-PAGE with silver staining and Western blot.  We prepared three 
conjugates to study cell internalization efficiency as a function of the amount of FimHA 
on the SCKs.  However, resulting conjugates did not provide better cell attachment and 
internalization results in vitro compared to the previous report. 
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2.2. Results and Discussion 
2.2.1. Challenge I:  Purification of FimHA-SCK conjugates to remove free FimHA 
First of all, we attempted to find an effective method of purification for FimHA-
SCK conjugates to remove free and/or non-covalently-attached proteins.  Removal of free 
FimHA is critical to improve behaviors of FimHA-SCK conjugates, since free targeting 
proteins could hinder the interaction of conjugates with the bladder epithelial cells by 
competitively binding to and reducing the number of available receptors.  Also, a reliable 
purification method should allow for adjustment of the amount of FimHA on the surface 
of nanoparticles to observe the influence of adhesion density on binding and 
internalization of conjugates into the epithelial cells.  FimHA-SCK conjugates were first 
prepared under the same conditions to the previous report64 with maximum amount of 
available FimHA.  The amount of added FimHA was determined by molar ratio of FimHA 
to polymer precursor (PAA-b-PS) of SCKs.  For the purification trials, more than 3 
equivalents (~3.4 equiv to single polymer chain) of FimHA were used for conjugation 
reaction, which is in excess based on previous experiments.  Aliquots of the resulting 
reaction mixture were purified by three different methods: 1) column chromatography 
using Sephadex® G-50 (medium) with nanopure water as an eluent; 2) centrifugal filtration 
using Amicon® Ultra centrifugal filters (Millipore, 100 kDa MWCO, Ultracel®-100K) 
with 1X PBS or 1X PBS with 0.05% Tween 20; 3) dialysis against 1X PBS using dialysis 
tubings (Spectra/Por® Biotech Cellulose Ester (CE) dialysis membranes MWCO 100 kDa 
and 300 kDa).  However, all three methods were unsuccessful in the removal of unbound 





at similar rates.  Extensive washing of reaction mixture using centrifugal filter unit with 
1X PBS (final dilution factor = ca. 1/1010) did not work even though we selected a 
membrane with large enough molecular weight cut-off (MWCO = 100 kDa) compared to 
FimHA (ca. 17.7 kDa).  Application of surfactant (0.05% Tween 20 in 1X PBS) to hinder 
the electrostatic interaction between the protein (pI = 8.55, positively charged in 1X PBS 
at pH 7.4) and the anionic SCKs did not improve the outcome either.  After a few cycles 
of filtration, the color of FITC dye conjugated to the SCKs became fainter in the 
nanoparticle solution and was observed on the membrane of centrifugal filter unit, which 
indicated the undesirable adsorption of dye-labeled polymeric nanoparticles on the 
membrane.  Dialysis against 1X PBS (final dilution factor = ca. 1/1014) did not yield more 
favorable results, even when we used dialysis tubing with larger MWCO (300 kDa).  
Incubation of reaction mixture in 1X PBS with 0.1% Tween 20 for 3 h before dialysis or 
centrifugal filtration67 was also unsuccessful.  After failures of the above purification 
attempts, we aimed to achieve ca. 100% conjugation yields, which would allow for the 
removal of only small molecular byproducts without the need of the problematic 
separation step.  After improving conjugation conditions to ensure maximum yields, the 
amount of added FimHA was reduced until ca. 100% yield was achieved.  
2.2.2. Challenge II:  Precipitation during preparation 
Precipitation of polymer and/or polymeric nanoparticles from solution was an 
occasional problem during the shell crosslinking reaction, dialysis, and/or centrifugal 
filtration for unknown reasons.  One of our concerns about precipitation during shell-





precipitation.  Size distributions measured by DLS showed little difference between 
normally prepared SCK solution and re-suspended SCK solution after precipitation 
occurred.  This result indicated that reduced electrostatic repulsion during SCK formation 
might be attributed to precipitation problems.  Since SCKs were prepared from 
poly(acrylic acid)-block-poly(styrene) (PAA-b-PS) for this study, formation of 
carboxylate salts in the shell domain would improve water solubility of SCKs as well as 
increase the repulsive force between the polymeric nanoparticles to prevent aggregation 
and precipitation.  We found that precipitates were readily re-suspended under slightly 
basic conditions, which were prepared by dialysis against buffers (1X PBS (pH 7.4), 
phosphate buffer (pH 7.4), MES buffer (pH 6.0), etc) or by addition of NaHCO3 solution.  
Based on these results, we used buffer solutions to provide a more reproducible 
environment compared to nanopure water in order to prevent pH gradient-induced 
aggregation of nanostructures.  For the carbodiimide-involved reactions, usage of 
phosphate-containing buffers was avoided, since phosphate functionalities can also react 
with carbodiimide reagents and reduce coupling efficiency.68  MES (4-
morpholinoethanesulfonic acid) buffer (pH 6.0) is known to be a suitable reaction medium 
for water-soluble carbodiimide coupling reactions.69,70  The slight acidity of MES buffer 
at pH 6 allows for the formation of sufficient carboxylate salts in the shell layer to stabilize 
PAA-b-PS-based polymeric nanoparticles in aqueous solution since pKa of PAA is 4.5.71  
When shell crosslinking reactions were performed in MES buffer, well-defined SCKs 
ranging from 10% to 50% shell-crosslinking density were prepared without any 
precipitation problems (Figure 2.1).  In addition, we compared two water-soluble 
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carbodiimide coupling reagents, EDC·HCl and EDC·MeI.  This study revealed that 
EDC·HCl was better for SCK formation than EDC·MeI.  More than 1 equivalent of 
EDC·HCl to the available acrylic acid units was applicable for SCK formation in nanopure 
water without precipitation problems, but 1 equivalent of EDC·MeI to the diamine cross-
linker frequently caused precipitation under similar conditions.  More detailed 
comparisons between two carbodiimides will be discussed in the later section.   
Precipitates or floating debris are possible residual impurities inside the dialysis 
tubing created during the production process by the manufacturer.  When nanopure water 
was added to the presoaked dialysis tubing and was transferred to a vial, some debris were 
observed even with the naked eye.  Also, the DLS measurement of the solution showed 
multimodal size distributions.  Although the amount of debris varied from batch to batch, 
careful washing of dialysis tubing is critical to avoid complications during characterization 
and potential interference for further experiments by undesirable impurities, which might 
be fragments of regenerated cellulose or other impurities during manufacturing process.  
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Figure 2.1.  Preparation of SCKs. 
2.2.3. Improvement of amidation conditions 
Reliable and efficient conjugation chemistries are imperative to study behaviors of 
synthetic nanobiomaterials in the biological systems.72  In this section, we will discuss a 
few critical aspects to improve the efficiency of amidation-based coupling chemistry.  Our 
group previously reported the amidation of DOTA chelators to the SCKs prepared from 
PAA-b-PS.72  We found that the coupling efficiency is influenced by physicochemical 
properties of polymeric nanoparticles including surface charge, permeability, extents of 
shell cross-linking, etc. as well as those of conjugated ligands.  In this study, we 





Extents of shell cross-linking.  We examined the influence of shell cross-linking 
percentage on the stability of the SCKs and the coupling efficiencies of FimHA-SCK 
conjugates via sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
and Western blot to estimate the ratio of conjugated and unconjugated adhesin.  FimHA-
conjugated SCKs with lower than 30% crosslinking showed smeared bands between 20 
kDa and 100 kDa in Western blot results (Figure 2.2).  It is hypothesized that those 
unidentified bands are originated from FimHA-conjugated polymers that were 
disassembled from the SCK nanostructures under SDS-PAGE conditions, in which 
noncovalent interactions were interfered.73  Smeared bands were not observed when 50%-
crosslinked SCKs were used for conjugation.  Therefore, more robust SCKs with 50% 
crosslinking were used for further studies to avoid disintegration of conjugates in extreme 
conditions, such as the environment inside the bladder.  Higher extents of cross-linking 
will also reduce permeability of the shell domain,74 which will promote the conjugation 
of adhesion onto the surface of SCKs.  It is desirable for this study since binding sites of 







Figure 2.2.  Western blot results of FimHA-SCK conjugates with different extents of shell cross-linking.  (1) 
FimHA, (2) FimHA-SCKs (10% cross-linked), FimHA : PAA-b-PS = 1 : 4, (3) FimHA-SCKs (10% cross-
linked), FimHA : PAA-b-PS = 1 : 3, (4) FimHA-SCKs (10% cross-linked), FimHA : PAA-b-PS = 1 : 2, (5) 
FimHA-SCKs (20% cross-linked), FimHA : PAA-b-PS = 1 : 1, (6) FimHA-SCKs (50% cross-linked), FimHA 




Unreacted amino groups after shell cross-linking reactions.  After shell cross-
linking reactions, there could be unreacted primary amines within the shell domain of 
SCKs.  The residual amino groups would either be coordinated within the shell domain by 
electrostatic interaction or dangling on the surface of SCKs.  Electrostatically-attached 
amino groups could further cross-link shell domain of SCKs during amidation of FimHA 
with SCKs.  However, amine functionalities dangling on the SCKs could cause inter-SCK-
coupling upon the addition of carbodiimide coupling reagent, which might lead to 
precipitation and/or multimodal size distributions in DLS.  Our group recently reported 
that an addition of EDC·MeI to SCK solution caused inter-SCK cross-linking.75  In 
addition, the FimHA variant used in the current experiments has four lysine residues, 
which could participate in inter-SCK conjugations.  Therefore, further conjugation 
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reactions were performed under diluted concentrations (< 0.15 mg/mL, amount of PAA-
b-PS in solution) in order to minimize inter-particle amidation reaction.76  Another 
potential deteriorative effect of unreacted amino groups are their interaction with 
negatively-charged mannose binding pocket of FimHA, which could interfere with 
essential hydrogen bonding interaction between FimHA and mannose.77   
Half-lives and reactivity of coupling agents.  Stabilities and reactivity of coupling 
agents are one of the most important aspects to improve conjugation efficiency.  In this 
study, amidations were employed for both shell-crosslinking and adhesion conjugation 
reactions.  In order to activate carboxylic acid functionalities within the shell of SCKs, 
water-soluble carbodiimides were used to form better electrophiles for primary amine 
groups of cross-linker or FimHA.  There have been a lot of studies and discussions about 
stability of carbodiimide coupling reagents in different conditions, including pH, buffer, 
and additives, etc.78  Our group has been used either EDC·HCl or EDC·MeI for amidation 
reactions, such as shell crosslinking reactions, conjugation of dye or targeting ligand, etc.  
EDC·MeI is known to be more reactive than EDC·HCl since intramolecular cyclization 
of EDC·HCl is under equilibrium in solution, which might reduce the reactivity compared 
to non-cyclizable EDC·MeI.68,79,80  However, EDC·MeI is less stable than EDC·HCl in 
aqueous solution.  We examined and compared both water-soluble carbodiimides for shell 
cross-linking reactions.  Applications of EDC·HCl did not cause any precipitation.  
However, cloudiness of micellar solution was often induced right after the addition of 
EDC·MeI during shell crosslinking process.  When the excess amount of EDC was used 





the micellar solutions.  O-acylisourea intermediate derived from EDC·MeI and carboxylic 
acid functionality within the shell of micelles might decrease the solubility of polymeric 
nanostructures more than that derived from EDC·HCl might do.  Therefore, slightly excess 
amount of EDC·MeI (2.3 equiv. to diamine cross-linker) had to be used to prevent 
precipitation.  On the other hand, large excess of EDC·HCl (>1.0 equiv to carboxylic 
acids) was able to be applied without precipitation problems to activate all available 
carboxylic acid functionalities within the shell domain.  So, EDC·HCl was selected for 
further reactions due to its longer half-life in aqueous solution and stability of nanoparticle 
solution during reactions.  Since our conjugation experiments were performed under 
diluted conditions in order to prevent inter-particle crosslinking, longer half-life is 
desirable to increase conjugation yield and efficiency.  In addition, use of EDC·HCl for 
SCK formation is more economical since buffer solutions were not required to prepare 
stable SCKs, while those were required when EDC·MeI was used.  
Another key reagent is sulfonated N-hydroxysuccinimide (sulfo-NHS), which is 
often added to carbodiimide coupling reactions to enhance coupling efficiency.  Reaction 
between carboxylic acid and carbodiimide reagent produces highly reactive O-acylisourea 
intermediate, which can readily react with primary amines.  However, hydrolysis is a 
competing side reaction in aqueous solutions due to the high reactivity of the O-
acylisourea intermediate.  For conjugation of larger protein to polymeric nanoparticles 
under dilute conditions, there is a lower chance for nanoparticles to meet one of amino 
groups of proteins.  Moreover, protein conjugations are usually conducted under slightly 





of the intermediate.  Therefore, the unstable O-acylisourea intermediate was trapped by 
sulfo-NHS to form more stable activated ester in order to improve coupling efficiency.  
On the other hand, the shell cross-linking reactions were performed under slightly 
different conditions.  Before adding carbodiimides, micelles and diamine cross-linkers 
were mixed, which promotes an attachment of cross-linkers to the micelles by electrostatic 
interactions between carboxylic acids and primary amines.  Therefore, we were less 
concerned about hydrolysis since both functionalities are already in vicinity with excess 
amount of carbodiimides.   
Another commonly used alternative to sulfo-NHS is sulfonated tetrafluorophenyl 
(sulfo-TFP), which is also included in the carbodiinmide coupling reaction to form 
activated ester by trapping unstable O-acylisourea intermediate.81  Reactivity of TFP ester 
to primary amines is comparable to NHS ester.  However, it is more resistant to hydrolysis 
under basic conditions.82  The half-life of TFP ester is known to be at least two times 
longer than that of NHS ester at pH ~8.70  In order to compare coupling efficiency between 
sulfo-NHS ester- and sulfo-TFP ester-mediated conjugations, FimHA conjugation 
reactions were conducted under the same conditions, except for swapping the two 
sulfonated reagents (Scheme 2.1).  We did not perform conjugation reactions under more 
basic conditions to check relative stability and reactivity of each activated ester due to the 
potential stability issue of FimHA.  SDS-PAGE of resulting conjugates visualized by silver 
staining showed no free FimHA, which indicated comparable conjugation yields (ca. 





provide similar conjugation results, sulfo-TFP was selected for further reactions since its 









Trifluoroacetic acid (TFA).  Carbodiimide coupling reagents, such as EDC, can 
react with the carboxylic acid functionality of residual TFA in PAA-b-PS after acidolysis 
of PtBA-b-PS, which could compromise coupling yields.  Also, during shell cross-linking 
reactions, diamine cross-linker, 2,2′-(ethylenedioxy)bis(ethylamine) (EDDA) can form 
salts with TFA, which could reduce cross-linking efficiency.  Above all, toxicity of 
residual TFA is undesirable for the materials intended for biomedical applications.  After 
acidolysis of PtBA-b-PS in TFA, excess TFA was evaporated with gentle N2 flow.  
Resulting solid was dissolved in nanopure water and dialyzed against nanopure water for 
at least 4 days with frequent changes of water (2 to 3 times per day).  After lyophilization, 
19F NMR showed weak resonances, which indicated residual TFA or TFA salts.  Since 
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free TFA is easier to remove than TFA salts, it is more preferable to purify it at this stage.  
However, we decided not to do further purification of polymer since excess EDC could 
mitigate influence of residual TFA for the conjugation experiments.  Reactions of 
polymeric nanoparticles with proper coupling reagents in suitable aqueous solutions allow 
the use of excess coupling reagents without concern for nanoparticle destabilization by 
alteration of functionalities on the surface of nanostructures.  If residual TFA is determined 
to be problematic, it can be removed by several methods, such as anion exchange, stirring 
with basic resins, dialysis against basic or acidic solutions, etc.  Reliable purification and 
characterization methods are critical to achieve reproducible results.  
2.2.4. Preparation of FimHA-targeted SCKs under the improved conjugation conditions 
The bacterial adhesion-conjugates were synthesized under deliberately-selected 
conditions based on experiments and literature search to ensure maximum conjugation 
efficiency.  First, the stoichiometry of protein to polymer chain was altered until 
quantitative conjugation yield was achieved in order to exclude troublesome removal 
process of free protein.  The amount of free protein in the crude reaction mixtures was 
confirmed by SDS-PAGE with silver staining and Western blot.  As a result, free FimHA 
was not detected when the amount of added adhesin was less than ratio of one FimHA to 
two polymer chains.   
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Every conjugate would have different ratios of ligand to nanoparticle for optimum 
function.  Also, optimum ratios need to be carefully characterized for their translation to 
clinical application.83  Hence, we prepared three conjugates with different ratios of ligand 
to polymer chain, 1 to 3, 1 to 6, and 1 to 9 in order to study cell internalization efficiency 
as a function of the amount of FimHA on the SCKs (Figure 2.3).  SDS-PAGE results with 
silver staining and Western blot results showed strong bands of FimHA-SCK conjugates 
in the sample wells and the stacking gels, which were detected at the same positions with 
FITC signals on the SCKs.  Also, there were very weak free FimHA bands.  Both results 
indicated that covalently-conjugated FimHA-SCKs were prepared under the improved 
amidation conditions.  Dynamic light scattering (DLS) results showed distinct increase of 
hydrodynamic diameters after FimHA conjugations [Dh (DLS, number) of SCKs = 16 ± 5 
nm, Dh (DLS, number) = 80 ± 22 nm of FimHA-SCKs when FimHA : polymer = 1 : 3].  






Figure 2.3.  Schematic representation of FimHA conjugation to the shell of SCK nanoparticles via amidation 
coupling chemistry.  a) SDS-PAGE visualized with UV, b) SDS-PAGE stained with silver stain, c) Western 
blot, (Lane 1) Free FimHA, (Lane 2) FimHA-SCKs (FimHA : PAA-b-PS = 1 : 3), (Lane 3) FimHA-SCKs 
(FimHA : PAA-b-PS = 1 : 6), (Lane 4) FimHA-SCKs (FimHA : PAA-b-PS = 1 : 9), (Lane 5) FITC-SCKs, 
Note) Each SCKs is comprised of ca. 100 poly(acrylic acid)-b-polystyrene block copolymer chains, and 
each block copolymer contains ca. 100 acrylic acid residues, although only a single carboxylic acid and 




Mannose-BSA ELISA results showed growth of signal with increasing FimHA 
concentrations, which indicated FimHA of the resulting conjugates are either in a favorable 
orientation or completely conjugated to SCKs with few free FimHA (Figure 2.4).  When 
resulting reaction mixtures contained free and/or physically-associated FimHA, mannose-
BSA ELISA results showed no FimHA signal in the undiluted samples and higher signals 
in more diluted samples.  Those results suggested that physically-associated FimHA has 
limited extent of conjugation into the shell or is in an unfavorable orientation, which did 





that unconjugated FimHA was dissociated from the SCKs and was bound to mannose.  The 
results in Figure 2.4 were promising for cell binding and internalization experiments in 








2.3. Experimental Section 
2.3.1. Materials 
PAA100-b-PS50 (MnNMR = 13000 Da) and PtBA100-b-PS50 (MnGPC THF = 17800 Da, 
PDI = 1.08, MnNMR = 18800 Da, as a precursor to PAA100-b-PS50) were synthesized as 
reported using RAFT polymerization.84  Sodium 2,3,5,6-tetrafluoro-4-
hydroxybenzenesulfonate was purchased from TCI America.  N-hydroxysulfosuccinimide 





















(FimHA : PAA-b-PS = 1 : 3)
FimHA-SCKs
(FimHA : PAA-b-PS = 1 : 6)
FimHA-SCKs
(FimHA : PAA-b-PS = 1 : 9)
FITC-SCKs
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and 4-morpholineethanesulfonic acid (MES) monohydrate were obtained from Sigma-
Aldrich.  1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC·HCl) 
was purchased from Alfa Aesar.  5-((5-aminopentyl)thioureidyl)fluorescein, 
dihydrobromide salt (5-FITC cadaverine) was purchased from Invitrogen, Carlsbad, CA.  
Dimethylformamide (DMF) was purified by passage through solvent purification systm 
(JC Meyer Solvent Systems) and used as pure solvent.  Spectra/Por membrane tubes were 
purchased from Spectrum Laboratory Inc. (Rancho Dominguez, CA).  Amicon® ultra 
centrifugal filter devices (100 kDa MWCO) were purchased from Millipore (Bedford, 
MA).  All other solvents and chemicals were obtained from Sigma-Aldrich, TCI America, 
or Fisher Scientific and used as received.  
2.3.2. Characterization 
Dynamic light scattering (DLS) measurements were conducted using Delsa Nano 
C (Beckman Coulter, Inc., Fullerton, CA) equipped with a laser diode operating at 658 
nm.  Size measurements were made in nanopure water (n = 1.3329, η = 0.890 cP at 25 ± 
1 °C).  Scattered light was detected at 165° angle and analyzed using a log correlator over 
70 accumulations for a 3.0 mL sample in a glass sizing cell (4.0 mL capacity).  The 
samples in a glass sizing cell were equilibrated for 30 minutes before measurements were 
made.  The photomultiplier aperture and the attenuator were automatically adjusted to 
obtain a photon counting rate of ca. 10 kcps.  The calculations of the particle size 
distributions and distribution averages were performed using CONTIN particle size 
distribution analysis routines.  Transmission electron microscopy (TEM) images were 
collected on a JEOL 1200EX operating at 100 kV and micrographs were recorded at 
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calibrated magnifications using a SIA-15C CCD camera.  The samples as aqueous 
solutions (5 µL) were deposited onto formvar/carbon-coated copper grids.  After 5 min, 
the excess sample was wicked off using filter paper and the grids were allowed to air-dry 
for 2 min.  Following that, the grids were negatively stained with 5 µL of a 1% 
phosphotungstic acid (PTA) or 1% uranyl acetate (UA) aqueous solution.  After 1 min (for 
PTA staining) or 15 sec (for UA staining), the excess stain was wicked off using filter 
paper.  The sample grids were left to dry under ambient conditions overnight before 
analyses. 
2.3.3. Preparation of micelles 
1) Nanoprecipitation (solvent displacement method): PAA100-b-PS50 block
copolymer precursor (ca. 15.5 mg) was dissolved in DMF (15.5 mL) and allowed to stir 
overnight at room temperature.  To this solution, an equal volume of nanopure water (15.5 
mL) was added dropwise via a syringe pump (10 mL/h).  The resulting mixture was 
allowed to stir overnight at room temperature and dialyzed against nanopure water for 4 
days in presoaked dialysis tubing (MWCO ca. 6 – 8 kDa) to afford a micelle solution (final 
volume = ca. 56.9 mL) with a final polymer concentration of ca. 0.27 mg/mL.  Dav (TEM) 
= 17 ± 2 nm, Dh (DLS, number) = 14 ± 4 nm, Dh (DLS, volume) = 21 ± 14 nm, Dh (DLS, 
intensity) = 160 ± 160 nm.  2) Direct dissolution method:  PAA100-b-PS50 block copolymer 
precursor (ca. 12.8 mg) was directly dissolved in 42.6 mL of 0.1 M MES buffer (0.5 M 
NaCl, pH 6.0).  The final polymer concentration was ca. 0.30 mg/mL  Dav (TEM) = 18 ± 
2 nm, Dh (DLS, number) = 14 ± 4 nm, Dh (DLS, volume) = 20 ± 11 nm, Dh (DLS, intensity) 





2.3.4. Representative procedure for the preparation of SCKs 
A solution of 2,2′-(ethylenedioxy)bis(ethylamine) (EDDA) in nanopure water (ca. 
10 mg/mL, 1.0 eq, nominal 10, 20, 30, 40, and 50% crosslinking) was added dropwise to 
the micelle solution (4.5 mg, 0.30 mg/mL polymer concentration, in nanopure water or 
0.1 M MES buffer, 0.5 M NaCl, pH 6.0).  After 30 min, 1-(3-dimethylaminopropyl)-3-
ethylcarbodiimide hydrochloride (EDC·HCl) in nanopure water (ca. 10 mg/mL, 1.0 eq. to 
the available acrylic acids) or 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide 
methiodide (EDC·MeI) (ca. 10 mg/mL, 2.5 eq to EDDA) was added dropwise to this 
solution, and the resulting mixture was allowed to stir overnight before dialysis against 
nanopure water for 4 days in presoaked dialysis tubing (MWCO ca. 6 – 8 kDa) to afford 
SCK solutions with a final polymer concentration of ca. 0.21 mg/mL.  SCKs (50% cross-
linked): Dav (TEM) = 17 ± 2 nm, Dh (DLS, number) = 16 ± 5 nm; Dh (DLS, volume) = 24 
± 16 nm; Dh (DLS, intensity) = 140 ± 140 nm. 
2.3.5. Preparation of 5-FITC cadaverine-labeled SCKs 
A solution of EDC·HCl in nanopure water (4.7 mg, 10 mg/mL, 1 eq. relative to 
the acrylic acids, 24 μmol) and sulfo-NHS in nanopure water (5.3 mg, 10 mg/mL, 1 eq. 
relative to the acrylic acids, 24 μmol) were added dropwise to a solution of SCK (15 mL, 
0.21 mg/mL polymer concentration) in nanopure water.  After stirring for 30 min at room 
temperature, a solution of 5-FITC cadaverine in nanopure water (1.6 mg, 1 mg/mL, 0.1 
eq. to the acrylic acids, 2.4 μmol) was added dropwise.  The reaction was allowed to 
proceed overnight at room temperature before being transferred to presoaked dialysis 





impurities, yielding a 5-FITC cadaverine-labeled SCK solution with a final concentration 
of ca. 0.20 mg/mL.  Dav (TEM) = 15 ± 2 nm, Dh (DLS, number) = 82 ± 23 nm; Dh (DLS, 
volume) = 110 ± 50 nm; Dh (DLS, intensity) = 220 ± 120 nm. 
2.3.6. Conjugation of FimHA to 5-FITC cadaverine-labeled SCKs 
Solutions of sulfo-TFP (0.93 mg, 10 mg/mL, 3.46 μmol, 1.0 eq.) and EDC·HCl (0.66 mg, 
10 mg/mL, 3.46 μmol, 1.0 eq.) in nanopure water was added to the solution of 5-FITC 
cadaverine-labeled SCKs (3.0 mL, 0.15 mg/mL polymer concentration) in nanopure water 
at 4 °C (in a cold room).  After stirring for 30 min, the pH of solution was adjusted to ca. 
7.4 by dropwise addition of sodium phosphate solution, followed by the addition of FimHA 
in 1X PBS (0.50 mg/mL, 0.20 mg when FimHA : polymer = 1 : 3, 0.10 mg when FimHA : 
polymer = 1 : 6, 0.065 mg when FimHA : polymer = 1 : 9).  The reaction was allowed to 
proceed at 4 °C overnight.  The reaction mixture was purified by washing using a 
centrifugal filtration device (MWCO 100 kDa) with 1X PBS (pH 7.4) or dialysis against 
1X PBS (pH 7.4), and the final volume was reconstituted to 3.0 mL with 1X PBS to yield 
FimHA-conjugated, 5-FITC cadaverine-labeled SCKs (final polymer concentration = ca. 
0.15 mg/mL).  When FimHA : polymer = 1 : 3, Dav (TEM) = 17 ± 2 nm, Dh (DLS, number) 
= 80 ± 22 nm; Dh (DLS, volume) = 120 ± 82 nm; Dh (DLS, intensity) = 880 ± 900 nm.  
When FimHA : polymer = 1 : 6, Dav (TEM) = 17 ± 2 nm, Dh (DLS, number) = 76 ± 19 nm; 
Dh (DLS, volume) = 110 ± 88 nm; Dh (DLS, intensity) = 2400 ± 2800 nm.  When FimHA 
: polymer = 1 : 9, Dav (TEM) = 17 ± 2 nm, Dh (DLS, number) = 87 ± 19 nm; Dh (DLS, 






The amidation-based conjugation conditions of FimHA to SCKs were improved in 
consideration of a few factors that might be overlooked, including extents of shell cross-
linking, half-lives and reactivity of coupling agents, impurities, etc.  Under these improved 
conditions, the equivalent ratios of protein to polymer chain were altered to compare the 
amount of FimHA added to aqueous solutions of the SCK nanoparticles vs. the conjugation 
efficiency, by which ca. 100% conjugation yield was achieved below 1:2 ratios of FimHA 
: polymer.  The amount of free protein was confirmed by SDS-PAGE with silver staining 
and Western blot.  We prepared three conjugates to study cell internalization efficiency as 
a function of the amount of FimHA on the SCKs.  However, resulting conjugates did not 
provide better cell attachment and internalization results in vitro compared to the previous 
report.  One potential problem with this synthetic strategy is difficulty in ensuring 
favorable orientation of protein on SCKs since native FimHA has four lysine residues 
which can participate in the amidation-based conjugation to the SCKs.  Therefore, we are 
planning to evaluate a few FimHA variants that have less lysine residues and/or an 
additional lysine tail with or without a flexible linker in order to improve the orientation 
of conjugated-FimHA.  In addition, it would be more important to investigate the influence 
of nanoparticle size and shape on cell adherence and internalization.  Polyvalent 
interactions between Type 1 pili of UPEC and mannose receptors on the surface of 
epithelial cells are believed to be critical for cell binding and internalization of UPEC.  
Since mannose moieties for FimHA are arrayed on the surface of bladder epithelial cells 
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at intervals of ca. 16 nm, cylindrical nanostructures could enhance cell internalization 
efficiency via binding to multiple receptors.   
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CHAPTER III 
FUNCTIONALIZABLE HYDROPHILIC POLYCARBONATE, POLY(5-METHYL-5-
(2-HYDROXYPROPYL)AMINOCARBONYL-1,3-DIOXAN-2-ONE), DESIGNED AS 
A DEGRADABLE ALTERNATIVE FOR PHPMA AND PEG* 
3.1. Introduction 
Hydrophilic, water-soluble polymers have been employed in a wide range of 
products, including, pharmaceuticals, foods, adhesives, coatings, paints, textiles, etc.85 
Among these applications, hydrophilic polymers are one of the essential components of 
nanomedicines in order to enhance water solubility and stability of materials, such as drugs 
and drug carriers.  Up to now, poly(ethylene glycol) (PEG), also known as poly(ethylene 
oxide) (PEO), has been the most widely used water-soluble polymer in the biomedical 
field, especially for drug delivery systems, due to its high hydrophilicity, biocompatibility, 
commercial availability, and stealth character in its ability to reduce opsonization and 
clearance of nanoparticles upon in vivo administration, which improve biodistribution and 
pharmacokinetics of nanocarriers.86-88  However, its potential drawbacks have been 
gradually reported: nonbiodegradability along with undesirable degradation under 
mechanical, thermal, and chemical stress, accumulation in the body, PEG-induced 
*Reprinted with permission from “Functionalizable Hydrophilic Polycarbonate, Poly(5-
methyl-5-(2-hydroxypropyl)aminocarbonyl-1,3-dioxan-2-one), Designed as a Degradable 
Alternative for PHPMA and PEG” by Sangho Cho, Gyu Seong Heo, Sarosh Khan, Amelia 
M. Gonzalez, Mahmoud Elsabahy, and Karen L. Wooley, Macromolecules 2015, 48(24), 
8797-8805.  Copyright © 2015 American Chemical Society. 
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hypersensitivity by the immune system, rapid clearance after repeated injection, etc.88,89  
Moreover, the polyether backbone of PEG limits the functionalizable sites to the chain 
ends, which is an inherent structural limitation.  Such drawbacks of PEG have encouraged 
the exploration of PEG analogues that contain degradable90 and/or side chain reactive 
functionalities91,92 within repeat units along the backbone, and the development of other 
water-soluble polymers for biomedical applications.87-89   Although several natural and 
synthetic hydrophilic polymers have been reported,85,88,93 such as polyglycerol, 
polyvinylpyrrolidone (PVP), poly(vinyl alcohol) (PVA), poly(acrylic acid) (PAA), 
polyacrylamide, polyoxazolines, polyphosphates, poly(amino acid)s, etc., few have 
achieved similar levels of success as PEG.  Of the alternatives, poly(N-(2-
hydroxypropyl)methacrylamide) (PHPMA) is a hydrophilic polymer that can be modified 
with several functionalities via pendant secondary hydroxyl groups and shows minimal 
toxicity.94,95  Well-defined PHPMA can be prepared by controlled radical 
polymerizations;96 however, the low toxicity and biocompatibility of PHPMA can be 
affected negatively by residual copper from atom transfer radical polymerization (ATRP) 
or the presence of a thiocarbonyl-based chain end group from reversible 
addition−fragmentation chain transfer (RAFT) polymerization, which require careful 
removal of the copper catalyst or RAFT end groups before their applications.97,98  
Furthermore, the lack of biodegradability could limit the use of PHPMA conjugates.95 
As an alternative to a nondegradable backbone, metal-free organocatalytic ring-
opening polymerization (ROP) of bis-MPA-derived cyclic carbonate monomers has been 
reported to lead to degradable analogues to polymethacrylate-based polymers with precise 
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control over size, dispersity, and functionalities incorporated.99,100  In addition, 
biocompatibility, biodegradability, and low in vivo toxicity of aliphatic polycarbonates 
(PCs) make them an excellent candidate for biomedical applications.101,102  We, therefore, 
hypothesized that the incorporation of N-(2-hydroxypropyl) amide functionalities on the 
bis-MPA-based PC backbone would afford a degradable and water-soluble polymer that 
has comparable properties to PHPMA.  To confirm this hypothesis, we introduced N-(2-
hydroxypropyl) amide functionalities via amidation of carboxylic acid-functional PCs as 
postpolymerization modification, since controlled ROP of acidic monomers, which 
contain carboxylic acid, amide, or other acidic functionalities, is challenging with common 
organobase catalysts.103  While this work was in progress, Engler, Yang, Hedrick, and co-
workers reported the synthesis of hydrophilic PCs by amidation of pentafluorophenyl 
ester-functional PC with various alkanolamines.104  In this case, the activated ester-
functional PC was synthesized by acid-catalyzed ROP of corresponding monomer 
(MTC−OC6F5)105 and, following amidation with amino alcohols, yielded corresponding 
amide-functional PCs, including our PHPMA analogue.  They demonstrated that their PCs 
were water-soluble and of low toxicity in vitro, and, moreover, the PCs exhibited the 
capability to resist aggregation in serum, which is a characteristic of stealth polymers.  
Here, we report complementary results, which include an alternative synthetic route of 
polycarbonate-based PHPMA analogue, poly(5-methyl-5-(2-
hydroxypropyl)aminocarbonyl-1,3-dioxan-2-one) (PMHPAC), which requires three 
simple steps:  metal-free organobase-catalyzed ROP of benzyl ester-functionalized cyclic 
carbonate monomers, removal of the benzyl esters by catalytic hydrogenolysis, and 
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subsequent amidation of the resulting carboxylic acid-functional PCs with the 
corresponding amine.  This synthetic method also allows the introduction of pendant 
functionalities onto the degradable PC backbone through amide linkages.  The resulting 
polymer was highly soluble in water and showed minimal cyto-/immuno-toxicities.  In 
addition, the pendant hydroxyl groups were readily functionalizable.  Furthermore, 
amphiphilic block copolymers were synthesized to demonstrate synthetic versatility and 
formation of nanostructures in aqueous solution for biomedical applications.  Our results 
suggest that PMHPAC could be utilized as an alternative hydrophilic polymer in clinical 
nanomedicines. 
3.2. Results and Discussion 
Although a similar final polymer structure to PMHPAC was reported recently,104 
this current work extends to an alternate synthetic strategy, postpolymerization 
modification of the reactive hydroxyl side chain moieties, and full characterization of the 
polymer compositions, structures and properties, including evaluation of immunotoxicity 
and demonstration of degradability. 
3.2.1. Synthesis of the polycarbonate-based PHPMA analogue, PMHPAC 
The preparation of the PMHPAC relied upon construction of a PC containing one 
reactive side chain carboxylic acid functionality at each repeat unit.  Benzyl ester-
functional PCs [poly(5-methyl-5-benzyloxycarbonyl-1,3-dioxan-2-one), PMBC, 1] were 
synthesized by organobase-catalyzed ROP of the functionalized cyclic carbonate 
monomer, 5-methyl-5-benzyloxycarbonyl-1,3-dioxan-2-one (MBC) by a previously 
reported procedure with a slight modification (Scheme 3.1 and Figure 3.1, 3.2).99,106,107  
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The benzyl ester groups of the PMBCs were removed by Pd/C-catalyzed hydrogenolysis 
yielding PCs with carboxylic acid functionalities, [poly(5-methyl-5-carboxyl-1,3-dioxan-
2-one), PMC, 2] (Scheme 3.2).108  The selective cleavage of the benzyl ester groups 
without reduction of the polycarbonate backbone was confirmed by 1H and 13C NMR 
spectroscopy (Figure 3.3), IR spectroscopy (Figure 3.4), and GPC analysis (Figure 3.5), 
before and after hydrogenolysis.  1H NMR spectra showed the disappearance of the 
benzylic protons (labeled as a and c in Figure 3.2) and the appearance of a carboxylic acid 
proton (labeled as a in Figure 3.3), as well as intact proton resonances of the polycarbonate 
backbone (labeled as b in Figure 3.3).  Comparing the C=O stretching vibration bands of 
1 and 2 (Figure 3.4), the (C=O) at ~1740 cm-1 of the carbonates remained after 
hydrogenolysis with a new peak at ~1710 cm-1 for the carbonyl stretch along with a broad 
OH absorbance resulting from the carboxylic acids.  By 13C NMR spectroscopy, 
maintenance of the carbonate carbonyl resonance at ca. 154 ppm was observed, while the 
ester carbonyl resonance at 172.0 ppm was replaced by the carboxylic acid carbonyl 
resonance at 173.6 ppm.  In order to confirm that the degree of polymerization and 
dispersity were maintained upon transformation of 1 to 2, the carboxylic acid 
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functionalities of 2 were protected by methylation using (trimethylsilyl)diazomethane 
(TMSCH2N2) under mild conditions,109 to allow for GPC analyses.  The GPC profiles of 
1 showed similar peak shape and PDI (1.09) with those (1.09) of methylated PMC, 
[poly(5-methyl-5-methyloxycarbonyl-1,3-dioxan-2-one), PMMC, 3], which indicates the 
minimal influence of hydrogenolysis on the polycarbonate backbone (Figure 3.5).  As 
expected, the benzyl carbonate chain-end group was also eliminated by hydrogenolysis, 
which was verified by monitoring the aromatic proton resonances.  Although remaining 
toluene interfered with the accurate interpretation immediately following hydrogenolysis, 
there were no aromatic proton signals remaining after the next stage of amidation and 
purification (Figures 3.6, 3.3, and 3.7).  Should retention of the α-chain end be of interest, 
it would be necessary to use an alternate initiator, which would contain functionalities that 
are tolerable for catalytic hydrogenation. 
Scheme 3.1.  Synthesis and ring-opening polymerization (ROP) of 5-methyl-5-benzyloxycarbonyl-1,3-
dioxan-2-one, MBC.  Conditions:  (i) benzyl bromide, TEA, THF, 70 C, overnight; (ii) ethyl chloroformate, 
TEA, THF, 0 C to RT, overnight; (iii) ROH, DBU, DCM, 29 C in the glovebox. 
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Figure 3.1.  (a) GPC profiles (THF as an eluent, 1 mL/min) as a function of polymerization time, for the 
ROP of MBC; (b) Plot of ln([M]0/[M]) against time, obtained from 1H NMR spectroscopy data; (c) Plot of 
number-average molecular weight (Mn) and polydipersity (Mw/Mn) against % monomer conversion in the 
ROP of MBC.  Conditions:  [MBC]0 = 0.5 M in DCM at 29 C in the glovebox, [MBC] : [BnOH] : [DBU] 
= 40 : 1 : 1. 
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Figure 3.2.  1H and 13C NMR spectra (CDCl3) of PMBC27 (1) initiated from benzyl alcohol using DBU. 
Conditions:  [MAC]0 = 0.5 M in DCM at 29 C in the glovebox, [MBC]0 : [BnOH] : [DBU] = 40 : 1 : 1. 
Scheme 3.2.  Synthesis of hydrophilic polycarbonate, PMHPAC, and its functionalization.  Conditions:  (i) 
Pd/C, H2, ethyl acetate, RT, overnight; (ii) TMSCHN2; toluene:methanol (3:2), RT, 30 min; (iii) 
HOBt/HBTU, 1-amino-2-propanol, DIPEA, DMSO, RT, overnight; (iv) 4-pentenoic acid, DCC, DMAP, 
DMSO, RT, 24 h.  0 ≤ a ≤ 1.
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Figure 3.3.  1H and 13C NMR spectra (DMSO-d6) of PMC27 (2).  EA = ethyl acetate. 






Figure 3.5.  GPC profiles (THF as eluent, 1 mL/min) of before (PMBC, 1) and after hydrogenolysis, 
followed by methylation (PMMC, 3).  The carboxylic acids of intermediate PMC (2) after hydrogenolysis 





Figure 3.6.  (a) 1H NMR spectra of PMHPAC27 (4) in DMSO-d6 and D2O. (b) 13C spectrum of PMHPAC27 
(4) in DMSO-d6. (c) 1H NMR spectra of functionalized PMHPAC27 with 4-pentenoic acid, 7, in DMSO-d6. 
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Figure 3.7.  1H NMR spectra of PMAC20-b-PMBC70 (8), PMPC20-b-PMBC70 (9), PMPC20-b-PMHPAC70 (10) 
and 11.  EA = ethyl acetate. 
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Pendant 2-hydroxypropyl amide groups were introduced via amidation between 
the carboxylic acids of PMC and 1-amino-2-propanol using HBTU/HOBt, yielding 
poly(5-methyl-5-(2-hydroxypropyl)aminocarbonyl-1,3-dioxan-2-one (PMHPAC, 4) 
(Scheme 3.2).  The proton resonances of the resulting amide (a) at 7.75 ppm, hydroxyl (b) 
at 4.60 ppm, methine (d) at 3.62 ppm, methylene (f) at 3.0 ppm, and methyl (h) at 0.96 
ppm were observed by 1H NMR spectroscopy, and the integral ratio of each signal 
indicated quantitative grafting density (Figure 3.6a).  The amino group in 1-amino-2-
propanol reacts selectively with the carboxylic acid on the PC backbone since the amino 
group is more nucleophilic than is the hydroxyl group,110 as supported by 1H NMR 
spectroscopy with no sign of esterification or cross-linking reactions.  To further confirm 
the chemoselective coupling and intactness of the polycarbonate backbone during the 
amidation reaction, GPC analyses were performed.  The GPC profile of PMHPAC shows 
slightly broadened molecular weight distribution, with a peak shift to longer retention time 
(Figure 3.8).  Although a broadening of dispersity might be attributed to degradation, 
transesterification, or transamidation of the PC backbone, 13C NMR spectroscopy 
observed only two carbonyl resonances—the carbonate signal maintained at 154.1 ppm 
and an amide carbonyl signal at 171.2 ppm (Figure 3.6b).  In addition, PCs having different 
amide functionalities, as control polymers, were synthesized by coupling the carboxylic 
acids of PMC with two other amines, allylamine (5) and ethylamine (6) (Scheme 3.3).  
The GPC profiles of 5 and 6 showed almost no change of retention time compared to that 
of the precursor polymer, PMBC, with minimal increase of polydispersity (Figure 3.8).  
These results suggest that minimal transesterification or degradation of the polymer 
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backbone occurred during the amidation reactions, and the amide functionality itself did 
not contribute to the broadening of dispersity.  Rather, the pendant hydroxyl groups of 
PMHPAC along the polycarbonate backbone were assumed to undergo interaction with 
the stationary phase of the GPC columns, and lead to changes in peak shape and position 
for PMHPAC, 4.  The resulting PMHPAC is highly soluble in water (>300 mg/mL), 
highlighting that the structural similarity with PHPMA provides for similar water 
solubilities (Table 3.1). 







Scheme 3.3.  Synthesis of polycarbonates having different amide functionalities by amidations between 






Table 3.1.  Comparison of the physicochemical properties of PMHPAC, PEG, PHPMA, and their block 
copolymers. 
  Mn (kDa) Tg (°C) Tdb (°C) Sc (g/mL) Degradability 
4 PMHPAC27 5.8 59.5 182 >0.3 Fulld 
12 PEG135 6.0 −12.5 320 >1 None 
13 PHPMA40 6.1 157.0 220 >0.3 None 
10 PMPC20-b-
PMHPAC70  
4.0−15.2a −13.2, 65.6 180 n/a Full 
14 PEG226-b-PMAC19 10.0−4.0a −18.5 200 n/a Partial 
15 PMMA28-b-
PHPMA90 
3.2−12.9a 105.5, 162.0 250 n/a None 
aMolecular weight of block copolymers, A-b-B, are expressed as [Mn of A block]− [Mn of B block].  bInitial 







3.2.2. Functionalization of PMHPAC 
In contrast to PEG, which is only functionalizable at the chain end, and similar to 
PHPMA, PMHPAC can be readily functionalized along the polymer backbone via pendant 
secondary hydroxyl groups.  The availability of pendant hydroxyl groups for further 
functionalization was demonstrated by esterification with a model compound, 4-pentenoic 
acid using N,N’-dicyclohexylcarbodiimide (DCC) as a coupling agent and 4-
dimethylaminopyridine (DMAP) as a catalyst (Scheme 3.2).  The formation of ester bonds 
was confirmed by a shift of the methine peak from 3.62 ppm in PMHPAC (d) to 4.82 ppm 
in 7 (f), as well as the appearance of peaks at 5.87−4.92 and 2.40−2.20 from the 4-
pentenoate group (Figure 3.6c).  Consumption of the hydroxyl groups of PMHPAC was 
further confirmed by GPC, which demonstrated that the  pentenoic acid-functionalized 
PMHPAC (7, Figure 3.8) had a narrow molecular weight distribution and retention time 
that was similar to those of 1, 3, 5, and 6, each of which lacked the hydroxyl groups of 
PMHPAC (4).  This result supported our assumption that the pendant hydroxyl 
functionalities of 4 are ascribed to the lengthened retention time and broadened 








3.2.3. Synthesis of PMHPAC-based amphiphilic block copolymer 
An amphiphilic block copolymer containing PMHPAC as a hydrophilic segment 
was synthesized to demonstrate synthetic versatility and formation of nanostructures in 
aqueous solution.  Diblock copolymer, PMAC-b-PMBC (8), was synthesized by one-pot 
sequential ROPs of MAC (5-methyl-5-allyloxycarbonyl-1,3-dioxan-2-one) and MBC.  
Subsequent hydrogenolysis and amidation afforded the amphiphilic diblock copolymer, 
10 (Scheme 3.4).  The conditions for catalytic hydrogenolysis of PMAC-b-PMBC not only 
removed the benzyl ester groups but also resulted in hydrogenation of the allyl 
functionalities to propyl groups yielding poly(5-methyl-5-propyloxycarboxyl-1,3-dioxan-
2-one) (PMPC)-b-PMC, 9, as expected, which was verified by 1H NMR spectroscopy 
(Figure 3.7).  In order to utilize the allyl functionalities of 8, various thiol compounds can 
be conjugated via thiol−ene “click” reaction before the hydrogenolysis procedure.  A 
model compound, 2-mercaptoacetate was successfully incorporated onto the PMAC block 
through thioether linkages (11), and was selected for its ability to allow for further 
introduction of new functionalities onto the polymer block segment or into the core of 
micelles or other supramolecular assemblies.  Other cyclic monomers for ROP such as 
cyclic carbonates, lactide, and -caprolactone, etc., could also be polymerized with MBC 






Scheme 3.4.  Synthesis of amphiphilic block copolymer, PMPC-b-PMHPAC (10).  Conditions:  (i) MAC, 
DBU, DCM; (ii) MBC, DCM, 29 C in the glovebox; (iii) DMPA, ethyl 2-mercaptoacetate, DMF, UV 365 





3.2.4. Polymer toxicity 
The cytotoxicities of PMHPAC, PHPMA, and PEG homopolymers, as well as, 
micelles assembled from the corresponding block copolymers, were tested against RAW 
264.7 mouse macrophages and OVCAR-3 cells as a function of concentration (Figures 3.9 
and 3.10).  Minimal cytotoxicity was observed for all polymers over the concentrations 
tested (5 to 3000 g/mL after 24 h incubation), except for PHPMA (13) above 1 mg/mL.  
PHPMA showed higher toxicity, as compared to the polycarbonate-based analogue, 
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PMHPAC (4), and PEG.  In addition, immunotoxicity studies performed for PMHPAC 
(4), PEG and PHPMA homopolymers demonstrated minimal immunotoxicity, with only 
a slight induction of the expression of G-CSF and TNF-α of the 23 measured cytokines, 
as compared to the control untreated cells.  Low cyto-/immuno-toxicities are partial 
indicators for the biocompatibility of these highly hydrophilic polymers for potential 
biomedical applications  Our group has recently established numerical descriptive values 
(i.e., immunotoxicity indices) to compare the induction of cytokines by various types of 
nanoparticles, which provides a useful strategy for direct comparisons between 
immunotoxicities of nanoparticles.111  The immunotoxicity indices calculated for the 
polymers tested in the current study were found to be low (< 4 for each), which highlights 
the high biocompatibility of the tested polymers. 
Figure 3.9.  Cytotoxicity of PMHPAC (4), PEG (12), and PHPMA (13) in (a) RAW 264.7 mouse 






Figure 3.10.  Cytotoxicity of PMHPAC-b-PMPC (10), PEG-b-PMAC (14), and PHPMA-b-PMMA (15) 




3.2.5. Comparison of physicochemical properties of PMHPAC, PHPMA, and PEG 
The properties of PMHPAC and its block copolymer were compared with those 
of PHPMA, PEG, and their corresponding block polymers (Table 3.1).  Homopolymers 
having similar molecular weights (Mn = ~6000 Da) were synthesized or purchased for 
direct comparison.  Similar to PEG and PHPMA, which are known for their high water 
solubility, PMHPAC was highly water-soluble at the tested concentration (~300 mg/mL) 










amount of material available.  Glass transition temperature (Tg) values of the 
homopolymers varied, as measured by differential scanning calorimetry (DSC).  The 
higher Tg values for PMHPAC (59.5 °C) and PHPMA (157 °C) compared to PEG (−
12.5 °C) can be ascribed to inter- and intramolecular hydrogen bonding.  The thermal 
stabilities of the homopolymers were also compared, using thermogravimetric analysis 
(TGA).  As expected, the degradable polycarbonate-based PMHPAC showed lower initial 
decomposition temperature (Td) compared to nondegradable PHPMA and PEG.   
In addition, although PMHPAC was observed to be stable under neutral aqueous 
conditions, its, theoretical, ability to undergo hydrolytic degradation was verified under 
challenging, highly basic conditions to facilitate accelerated, base-promoted hydrolysis.  
After incubation of PMHPAC in 0.1 M NaOD/D2O at 60 °C, degradation was monitored 
by 1H NMR spectroscopy.  PMHPAC was degraded into the MHPAC repeating unit and 
further broken down into bis-MPA as time progressed (Figure 3.11 and 3.12).  The 
degradation products were also confirmed by ESI-MS (Figure 3.13). 
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Figure 3.11.  1H NMR spectra of (a) PMHPAC27 in 0.1 M NaOD/D2O at 60 °C at various time points, (b) a 
mixture of bis-MPA and amino-2-propanol co-dissolved in 0.1 M NaOD/D2O, (c) the lyophilized products 
of PMHPAC27 after incubation in 1.0 M NaOH(aq) overnight at 100 °C and dissolved in D2O, and (d) 






Figure 3.12.  Relative molar ratios of bis-MPA vs MHPAC by the time interval in the solution of PMHPAC 






Figure 3.13.  ESI MS spectra of (a) a mixture of bis-MPA and amino-2-propanol in 0.1 M NaOD/D2O, (b) 
the lyophilized products of PMHPAC27 after incubation in 1.0 M NaOH(aq) overnight at 100 °C and dissolved 
in D2O, and (c) PMHPAC27 in 0.1 M NaOD/D2O at 60 °C for 9 days in negative mode; m/z range of 50–
300. 
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3.2.6. Self assembly of PMHPAC-based amphiphilic block copolymer 10 
A potentially fully degradable polymeric nanostructure was prepared from the 
amphiphilic diblock copolymer containing PMHPAC as a hydrophilic segment.  PMPC20-
b-PMHPAC70 (10) was self-assembled into spherical micelles by direct dissolution in 
water (1 mg/mL).  The formation and morphology of polymeric nanostructures were 
confirmed by dynamic light scattering (DLS), transmission electron microscopy (TEM), 
and atomic force microscopy (AFM) (Figure 3).  The number-averaged hydrodynamic 
diameter of the micelles in water was 16 ± 4 nm.  The diameter in the substrate-adsorbed 
dried state increased to 24 ± 6 nm and 32 ± 6 nm as measured by TEM and AFM, 
respectively, which might be due to the flattening effect of the viscous polymeric core 
having a Tg of −13.2 °C and the hygroscopic property of the PMHPAC shell.  Unlike the 
previous report,104 this PMHPAC-based amphiphilic block copolymer formed smaller 
micelles, which are suitable for biomedical applications.  The ζ-potential, based on surface 
charge density of the resulting micelles, was −14.4 ± 4.7 mV in nanopure water.  It is 
common that polymeric nanoparticles having neutral polymer-based corona or shells have 






Figure 3.14.  Self-assembly of block copolymer, PMPC20-b-PMHPAC70 (10), into spherical micelles.  (a) 
Schematic diagram of micellization. (b) DLS histograms of intensity-averaged (Dh(int)), volume-averaged 
(Dh(vol)), number-averaged (Dh(num)) hydrodynamic diameters. (c) Bright field TEM image, scale bar = 
200 nm, collected for the block copolymer micelle sample drop deposited from water onto a carbon-coated 
copper grid, diameter = 24 ± 6 nm. (d, e) AFM height (d) and phase (e) images, scale bar = 500 nm, collected 
for the block copolymer micelle sample spin coated from water onto freshly cleaved mica, diameter = 32 ± 




3.3. Experimental Section 
3.3.1. Materials 
Benzyl alcohol and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) were dried over 
CaH2, distilled, and stored under inert atmosphere.  Methyl methacrylate (MMA) was 
passed through alumina plug to remove inhibitor before use.  A radical initiator, 2,2’-
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azobis(2-methylpropionitrile) (AIBN) was recrystallized in methanol and stored in the 
freezer until use.  ɑ-Methoxy-ω-hydroxy poly(ethylene glycol)s (mPEG, 6 and 10 kDa) 
were purchased from Rapp Polymere GmbH and dried over P2O5 prior to use.  
Tetrahydrofuran (THF), N,N-dimethylformamide (DMF), and dichloromethane (DCM) 
were purified by passage through solvent purification system (JC Meyer Solvent Systems) 
and used as dried solvents.  The monomers, 5-methyl-5-benzyloxycarbonyl-1,3-dioxan-2-
one (MBC)99 and 5-methyl-5-allyloxycarbonyl-1,3-dioxan-2-one (MAC)114 were 
synthesized as reported, recrystallized, and dried over P2O5 before use.  N-(2-
Hydroxypropyl)methacrylamide (HPMA) was synthesized as reported.115  All other 
solvents and chemicals were purchased from Sigma-Aldrich, TCI America, or Fisher 
Scientific and were used as received. 
3.3.2.  Instruments 
1H and 13C NMR spectra were recorded on Varian Inova 300 spectrometers.  
Chemical shifts were referenced to the solvent resonance signals.  IR spectra were 
recorded on an IR Prestige 21 system (Shimadzu Corp., Japan), equipped with an ATR 
accessory, and analyzed using IRsolution v.1.40 software.  Gel permeation 
chromatography (GPC) eluted with THF or DMF was conducted on a system equipped 
with an isocratic pump model 1515, a differential refractometer model 2414, and a three-
column set of Polymer Laboratories, Inc. (Amherst, MA) Styragel columns (PLgel 5 m 
S3Mixed C, 500 Å, and 104 Å, 300  7.5 mm columns) and a guard column (PLgel 5 m, 
50  7.5 mm) ) using THF as the eluent (1.00 mL/min) at 40 °C or a four-column set of 5 





m DMF (300 × 7.5 mm), and Styragel HR 2, 5 μm DMF (300 × 7.5 mm) using DMF 
(0.05 M LiBr) as the eluent (1.00 mL/min) at 70 °C.  The differential refractometers were 
calibrated with Polymer Laboratories, Inc., polystyrene standards (300−467000 Da) for 
the THF system and poly(ethylene oxide) standards (106−174000 Da) for the DMF system.  
Polymer solutions were prepared at a concentration of ca. 5 mg/mL with toluene (0.05% 
v/v) as a flow rate marker and an injection volume of 200 L was used.  Data were 
analyzed using Empower Pro software from Waters Chromatography, Inc.  Glass 
transition temperatures (Tg) were measured by differential scanning calorimetry (DSC) on 
a Mettler-Toledo DSC822 (Mettler-Toledo, Inc., Columbus, OH) under N2.  
Measurements of Tg were taken with a heating rate of 10 °C/min.  The measurements were 
analyzed using Mettler-Toledo STARe v.10.00 software.  The Tg was taken as the midpoint 
of the inflection tangent and Tm was taken as the onset point, upon the third scan.  
Thermogravimetric analysis (TGA) was performed under Ar atmosphere using a Mettler-
Toledo model TGA/DSC 1, with a heating rate of 10 °C/min.  Dynamic light scattering 
(DLS) measurements were conducted using DelsaNano C (Beckman Coulter, Inc., 
Fullerton, CA) equipped with a laser diode operating at 658 nm.  Size measurements were 
made in nanopure water (n = 1.3329, η = 0.890 cP at 25 ± 1 °C).  Scattered light was 
detected at 165° angle and analyzed using a log correlator over 70 accumulations for a 3.0 
mL sample in a glass sizing cell (4.0 mL capacity).  The samples in a glass sizing cell were 
equilibrated for 30 min before measurements were made.  The photomultiplier aperture 
and the attenuator were automatically adjusted to obtain a photon counting rate of ca. 10 
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kcps.  The calculations of the particle size distributions and distribution averages were 
performed using CONTIN particle size distribution analysis routines.  The ζ-potential of 
the particles in suspension was obtained by measuring the electrophoretic movement of 
charged particles under an applied electric field.  Scattered light was detected at a 30° 
angle at 25 °C.  The ζ-potential was measured at five regions in the flow cell and a 
weighted mean was calculated.  These five measurements were used to correct for 
electroosmotic flow that was induced in the cell due to the surface charge of the cell wall.  
Transmission electron microscopy (TEM) images were collected on a JEOL 1200EX 
operating at 100 kV and micrographs were recorded at calibrated magnifications using a 
SIA-15C CCD camera.  The samples as aqueous solutions (4 L) were deposited onto 
Formvar/carbon-coated copper grids.  Excess sample was wicked off using filter paper 
and the grids were allowed to air-dry for 2 min.  Following that, the grids were stained 
with 4 L of a 1% phosphotungstic acid aqueous solution.  Excess stain was wicked off 
using filter paper after 1 min.  The sample grids were air-dried overnight before analyses.  
The atomic force microscopy (AFM) imaging was performed on MFP-3D system 
(Asylum Research) in tapping mode using standard silicon tips (VISTAprobes, CSR-25, 
resonance constant = 30 kHz, tip radius < 10 nm, spring constant = 0.1 N/m).  For AFM 
sample preparation, nanoparticles were dissolved in nanopure water at 0.025 mg/mL, and 





3.3.3. Organocatalytic ROP of 5-methyl-5-benzyloxycarbonyl-1,3-dioxan-2-one (MBC) 
In a glovebox, MBC and benzyl alcohol initiator were dissolved in dry DCM 
([MBC] = 0.5 M).  DBU (1 equiv to initiator) was added to the monomer/initiator solution.  
After the desired time, the polymerization was quenched by addition of benzoic acid in 
DCM and precipitated into methanol.  For example, MBC (2.0 g, 8.0 mmol), benzyl 
alcohol (21 L, 0.20 mmol), DBU (30 L, 0.20 mmol), DCM (16 mL), and benzoic acid 
solution (37 mg, 0.30 mmol in 300 L DCM) were used to yield PMBC27. 
BnO-PMBC27-OH (1).  Yield = 1.26 g, 90% based upon monomer conversion 
(69%).  Mn,NMR = 6900 g/mol; Mn,GPCTHF = 7100 g/mol; Mn,GPCDMF = 4000 g/mol; PDITHF 
= 1.09 and PDIDMF = 1.10.  1H NMR (300 MHz, CDCl3): δ 7.38−7.24 (br, −OCH2C6H5), 
5.13 (s, −OCH2C6H5), 4.39−4.18 (br, −OC(O)OCH2-), 3.70 (m, −CH2OH), 2.45 (br, −
CH2OH), 1.22 (s, −C(CH3)(CH2O−)2), 1.20 (s, −C(CH3)CH2OH).  13C NMR (75 MHz, 
CDCl3): δ 172.0, 154.4, 135.5, 128.7, 128.4, 128.1, 68.7, 67.2, 46.6, 17.5.  IR (neat, cm−
1): 3125−2825, 1743, 1458, 1381, 1234, 1142, 964, 910, 787, 733, 694.  Tg = 17.2 °C.  
TGA in Ar: 240−390 °C, 96% mass loss; 4% mass remaining above 500 °C. 
3.3.5. Preparation of diblock copolymer, PMAC-b-PMBC  
The monomer for the first block (MAC) and benzyl alcohol initiator were 
dissolved in dry DCM ([MAC] = 0.5 M).  DBU (1 equiv to initiator) was added to the 
monomer/initiator solution.  After the desired time (~80% conversion), the monomer for 
the second block (MBC) in DCM was quickly added to the macroinitiator solution.  After 





and precipitated into cold methanol.  For example, MAC (100 mg, 0.50 mmol) and benzyl 
alcohol (2.0 L, 0.020 mmol) in DCM (1 mL, [MAC] = 0.5 M), DBU (3.0 L, 0.020 
mmol), MBC solution in DCM (500 mg, 2.0 mmol in 3 mL) were used to yield PMAC20-
b-PMBC70. 
PMAC20-b-PMBC70 (8).  Yield = 408 mg, 94%.  Mn,NMR = 21600 g/mol; Mn,GPCDMF 
= 12200 g/mol; PDI = 1.09.  1H NMR (300 MHz, CDCl3): δ 7.39−7.23 (br, −OCH2C6H5), 
5.96−5.77 (m, −CH2CHCH2), 5.36−5.20 (m, −CH2CHCH2), 5.13 (s, −OCH2C6H5), 4.65−
4.57 (m, −OCH2CHCH2), 4.39−4.18 (br, −OC(O)OCH2-), 3.70 (m, −CH2OH), 1.27 (s, −
C(CH3)(CH2O−)2 from PMAC block), 1.22 (s, −C(CH3)(CH2O−)2 from PMBC block).  
13C NMR (75 MHz, CDCl3): δ 172.0, 154.5, 135.5, 131.7, 128.8, 128.5, 128.1, 118.6, 68.7, 
67.2, 66.0, 46.7, 17.6, 17.5.  IR (neat, cm−1): 3100−2800, 1744, 1458, 1381, 1227, 1142, 
964, 910, 787, 733, 694. Tg = 11.5 °C; Tm = 129.5 °C.  TGA in Ar: 215−310 °C, 71% mass 
loss; 310−410 °C, 27% mass loss; 2% mass remaining above 500 °C. 
3.3.6. Representative procedure for catalytic hydrogenolysis 
To the flask containing Pd/C (10 wt%), solution of polymers containing PMBC 
block in ethyl acetate was added.  After the flask was flushed and filled with H2 using 
balloons of H2, the reaction mixture was stirred overnight.  Pd/C was centrifuged and 
filtered out and solvent was removed in vacuo to yield crude product, which was used in 
the next reaction without further purification.  For example, PMBC (770 mg), ethyl acetate 
(30 mL), and Pd/C (~10 wt%, 80 mg) were used to yield PMC27. 
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PMC27 (2).  Yield = 522 mg, ~99%.  Mn, NMR = 4300 g/mol.  1H NMR (300 MHz, 
DMSO-d6): δ 13.04 (br, −C(O)OH), 4.14 (br, −OC(O)OCH2−), 3.51 (d, J = 10.6 Hz, -
CHH’OH), 3.41 (d, J = 10.6 Hz, −CHH’OH), 1.13 (s, −C(CH3)(CH2O−)2), 1.05 (s, −
C(CH3)CH2OH).  13C NMR (75 MHz, DMSO-d6): δ 173.6, 154.0, 68.9, 45.7, 17.0.  IR 
(neat, cm−1): 3675−2400, 1713, 1466, 1396, 1234, 1150, 964, 880, 779, 633.  Tg = 72.5 °C.  
TGA in Ar: 180−265 °C, 31% mass loss; 265−401 °C, 65% mass loss; 4% mass remaining 
above 500 °C. 
PMPC20-b-PMC70 (9).  Yield = 270 mg, ~99%.  Mn, NMR = 15200 g/mol.  1H NMR 
(300 MHz, DMSO-d6): δ 13.06 (br, −C(O)OH), 4.28−4.13 (br, −OC(O)OCH2−), 4.01 (t, J 
= 7.1 Hz, −OCH2CH2CH3), 3.53-3.39 (m, −CH2OH), 1.55 (m, −OCH2CH2CH3), 1.16 (s, 
−C(CH3)(CH2O−)2 from PMPC block), 1.13 (s, −C(CH3)(CH2O−)2 from PMC block), 
1.08 (s, −C(CH3)CH2OH, PMPC end), 1.05 (s, −C(CH3)CH2OH, PMC end), 0.85 (t, J = 
7.4 Hz, −OCH2CH2CH3).  13C NMR (75 MHz, DMSO-d6): δ 173.5, 154.0, 153.8, 68.9, 
66.3, 46.1, 45.7, 21.4, 16.9, 16.8, 10.0.  IR (neat, cm−1): 3750−2400, 1713, 1466, 1389, 
1227, 1165, 964, 719, 640. Tg = −7.0 and 69.0 °C.  TGA in Ar: 200−275 °C, 30% mass 
loss; 275−400 °C, 67% mass loss; 3% mass remaining above 500 °C. 
3.3.7. Representative procedure for amidation between polymers containing PMC and 
amine compounds 
To a stirred solution of PMC (or PMC containing block copolymers) in DMSO, 1-





N,N,N’,N’-tetramethyluronium hexafluorophosphate (HBTU, 1.1 equiv to carboxylic 
acids) in DMSO were added and stirred for 30 min at room temperature.  Then, amine (1.5 
equiv to carboxylic acids) and N,N-diisopropylethylamine (DIPEA, 1.5 equiv to 
carboxylic acids) in DMSO were added and stirred overnight at room temperature.  The 
resulting solution was dialyzed against nanopure water for 3 days and lyophilized.  For 
example, PMC (100 mg, 0.63 mmol for repeat units) in DMSO (2 mL), HOBt (105 mg, 
0.78 mmol) and HBTU (296 mg, 0.78 mmol) in DMSO (1 mL), and amino 2-propanol (72 
L, 0.94 mmol) and DIPEA (162 L, 0.94 mmol) in DMSO (1 mL) were used to yield 
PMHPAC27. 
PMHPAC27 [Poly(5-methyl-5-(2-hydroxypropyl)aminocarbonyl-1,3-dioxan-2-
one)] (4).  Yield = 105 mg, 77%.  Mn,NMR = 5800 g/mol; Mn,GPCDMF = 740 g/mol; PDI = 
1.20.  1H NMR (300 MHz, DMSO-d6): δ 7.85−7.70 (br, −C(O)NH-), 7.61−7.52 (br, −
C(O)NH − , end group), 4.66 − 4.56 (m, − NHCH2CH(OH)CH3), 4.28 − 4.06 (br, −
OC(O)OCH2−), 3.69−3.55 (m, −NHCH2CH(OH)CH3), 3.49−3.44 (br, −CH2OH), 3.10−
2.90 (m, −NHCH2CH(OH)CH3), 1.13 (s, −C(CH3)(CH2O−)2), 1.04 (s, −C(CH3)CH2OH), 
0.95 (d, J = 6.2 Hz, −NHCH2CH(OH)CH3).  1H NMR (300 MHz, D2O): δ 7.92−7.80 (br, 
−C(O)NH−), 4.42−4.20 (br, −OC(O)OCH2−), 3.97−3.84 (m, −NHCH2CH(OH)CH3), 3.76 
(d, J = 11.7 Hz, −CHH’OH), 3.66 (d, J = 11.3 Hz, -CHH’OH), 3.34−3.18 (m, −
NHCH2CH(OH)CH3), 1.30 (s, −C(CH3)(CH2O−)2), 1.24 (s, −C(CH3)CH2OH), 1.15 (d, J 
= 6.5 Hz, −NHCH2CH(OH)CH3).  13C NMR (75 MHz, DMSO-d6): δ 171.2, 154.1, 69.3, 
65.0, 46.6, 45.6, 20.8, 17.1.  IR (neat, cm−1): 3750−3150, 3050–2800, 1744, 1643, 1535, 
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1458, 1389, 1234, 1103, 957, 787.  Tg = 59.5 °C.  TGA in Ar: 182−325 °C, 89% mass loss; 
11% mass remaining above 500 °C.  Solubility in water: >300 mg/mL. 
N-Allyl Amide Functional PC (5).  Yield = 62 mg, ~99%.  Mn,NMR = 5000 g/mol; 
Mn,GPCDMF = 3800 g/mol; PDI = 1.13.  1H NMR (300 MHz, DMSO-d6): δ 8.12−8.00 (br, −
C(O)NH−), 7.82−7.74 (br, −C(O)NH−, end group), 5.81−64 (m, −NHCH2CHCH2), 5.14-
4.96 (m, − NHCH2CHCH2), 4.32 − 4.10 (br, − OC(O)OCH2-), 3.76 − 3.62 (br, −
NHCH2CHCH2), 1.15 (s, −C(CH3)(CH2O-)2), 1.07 (s, −C(CH3)CH2OH).  13C NMR (75 
MHz, DMSO-d6): δ 171.0, 154.1, 135.1, 114.5, 69.3, 45.6, 40.9, 17.1.  IR (neat, cm−1): 
3500−3200, 3100−2800, 1748, 1640, 1535, 1475, 1386, 1233, 961, 844, 787. 
N-Ethyl Amide Functional PC (6).  Yield = 58 mg, ~99%.  Mn,NMR = 4700 g/mol; 
Mn,GPCDMF = 4200 g/mol; PDI = 1.12.  1H NMR (300 MHz, DMSO-d6): δ 7.88−7.78 (br, −
C(O)NH−), 7.60−7.53 (br, −C(O)NH−, end group), 4.95 (t, J = 5.2 Hz, −OH), 4.28−4.08 
(br, −OC(O)OCH2−), 3.12−3.00 (m, −NHCH2CH3), 1.11 (s, −C(CH3)(CH2O−)2), 1.03 (s, 
−C(CH3)CH2OH), 0.96 (d, −NHCH2CH3).  13C NMR (75 MHz, DMSO-d6): δ 170.7, 154.1, 
69.3, 45.5, 33.7, 17.1, 14.5.  IR (neat, cm−1): 3500−3200, 3100−2800, 1746, 1640, 1535, 
1460, 1380, 1231, 962, 845, 786.  
PMPC20-b-PMHPAC70 (10).  Yield = 218 mg, 75%.  Mn,NMR = 19200 g/mol; 
Mn,GPCDMF = 1230 g/mol; PDI = 1.23.  1H NMR (300 MHz, DMSO-d6): δ 7.85−7.55 (br, −
C(O)NH−), 4.70−4.50 (br, −NHCH2CH(OH)CH3), 4.28−4.05 (br, −OC(O)OCH2−), 4.01 





NHCH2CH(OH)CH3), 1.55 (m, −OCH2CH2CH3), 1.16 (s, −C(CH3)(CH2O−)2 from PMPC 
block), 1.13 (s, −C(CH3)(CH2O−)2 from PMHPAC block), 1.04 (s, −C(CH3)CH2OH), 0.95 
(d, J = 6.2 Hz, -NHCH2CH(OH)CH3), 0.85 (t, J = 7.3 Hz, −OCH2CH2CH3).  13C NMR 
(75 MHz, DMSO-d6): δ 171.7, 171.2, 154.1, 153.8, 69.3, 68.8, 66.3, 64.9, 46.5, 46.1, 45.5, 
21.4, 20.8, 17.0, 16.8, 10.0.  IR (neat, cm−1): 3650−3150, 3030−2800, 1744, 1643, 1543, 
1466, 1389, 1234, 1134, 964, 787.  Tg = −13.2 and 65.6 °C.  TGA in Ar: 180−260 °C, 64% 
mass loss; 260−320 °C, 27% mass loss; 8% mass remaining above 500 °C. 
3.3.8. Functionalization of PMHPAC 
To a stirred solution of PMHPAC27 (50 mg, 0.23 mmol for repeat units), 4-
pentenoic acid (26 L, 0.25 mmol), and 4-dimethylaminopyridine (DMAP, 2.8 mg, 0.023 
mmol) in DMF (2 mL), N,N’-dicyclohexylcarbodiimide (DCC, 52 mg, 0.25 mmol) in 
DMF (minimum amount to dissolve) was added dropwise at 0°C.  After stirring 20 h at 
room temperature, the resulting solution was dialyzed against DMF for a day and nanopure 
water for 2 days and lyophilized to yield white solid (7).  Yield = 64 mg, 96% based on 
81% conversion.  Mn,NMR = 7700 g/mol; Mn,GPCDMF = 4200 g/mol; PDI = 1.25.  1H NMR 
(300 MHz, DMSO-d6): δ 8.00−7.90 (br, −C(O)NH−), 7.80−7.72 (br, −C(O)NH−, end 
group), 5.87−5.70 (m, −C(O)CH2CH2CHCH2), 5.07−4.92 (m, −C(O)CH2CH2CHCH2), 
4.89−4.76 (m, −C(O)NHCH2CH(CH3)O−), 4.62−4.56 (m, −NHCH2CH(OH)CH3), 4.34−
4.02 (br, −OC(O)OCH2− ), 3.68−3.54 (m, −NHCH2CH(OH)CH3), 3.29−3.06 (m, −





C(O)CH2CH2CHCH2), 2.29 − 2.19 (m, − C(O)CH2CH2CHCH2), 1.22 and 1.11 (s, −
C(CH3)(CH2O−)2), 1.06 (d, J = 6.0 Hz, −C(O)NHCH2CH(CH3)O−), 0.95 (d, J = 6.0 Hz, −
NHCH2CH(OH)CH3).  13C NMR (75 MHz, DMSO-d6): δ 171.7, 171.4, 171.1, 154.1, 
137.0, 115.4, 69.2, 68.7, 64.9, 46.5, 45.5, 42.8, 32.9, 28.4, 20.8, 17.2, 17.0.  IR (neat, cm−
1): 3500−3225, 3050−2800, 1732, 1643, 1537, 1454, 1383, 1234, 1177, 1096, 962, 918, 
787, 644.  Tg = 34.0 °C.  TGA in Ar: 180−380 C, 94% mass loss; 4% mass remaining 
above 500 C. 
3.3.9. Thiol-ene “click” reaction of pendant allyl functionality of PMAC-b-PMBC with 
ethyl mercaptoacetate 
PMAC-b-PMBC (8) (260 mg, 0.24 mmol for alkene functionalities), 2,2-
dimethoxy-2-phenylacetophenone (DMPA, 12 mg, 0.050 mmol), and ethyl 2-
mercaptoacetate (260 L, 2.4 mmol) were dissolved in 15 mL of DMF.  The solution were 
bubbled with N2 for 10 min and irradiated by UV (365 nm, 6 W) for 2 h.  The reaction 
mixture was precipitate into methanol and dried in vacuo to yield colorless sticky liquid 
(11).  Yield = 245 mg, 85%.  Mn,NMR = 24000 g/mol. 1H NMR (300 MHz, CDCl3): 
−(br, −OCH2C6H5), 5.13 (s, −OCH2C6H5), 4.26−4.10 (m, −OC(O)OCH2−  and −
C(O)OCH2CH2CH2−), 3.70 (m, −CH2OH), 3.24−3.16 (m, −SCH2C(O)O−), 2.74−2.63 (m, 
−C(O)OCH2CH2CH2S − ), 2.02 − 1.86 (m, −C(O)OCH2CH2CH2S − ), 1.32 − 1.18 (m, −
C(CH3)(CH2O−)2 and −C(O)OCH2CH3). 13C NMR (75 MHz, CDCl3):  172.0, 154.5, 35.5, 
128.7, 128.5, 128.1, 68.7, 67.2, 63.9, 61.5, 46.7, 33.6, 29.0, 28.0, 17.5, 14.3.  IR (neat, cm
−1): 3150−2800, 1744, 1458, 1381, 1234, 1142, 972, 787, 740, 702. 
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3.3.10. Self-assembly of diblock copolymer, PMPC20-b-PMHPAC70 
PMPC20-b-PMHPAC70 (2 mg) was dissolved in nanopure water (2 mL) and the 
solution was allowed to stir overnight.  Hydrodynamic diameter by DLS: Dh (intensity) = 
43 ± 26 nm, Dh (volume) = 21 ± 9 nm, Dh (number) = 16 ± 4 nm.  DTEM = 24 ± 6 nm 
(measured for more than 300 nanoparticles).  DAFM = 32 ± 6 nm (measured for more than 
100 nanoparticles from phase images).  HeightAFM = ca. 1.3 nm (measured from height 
image).  ζ-potential in nanopure water: − 14.4 ± 4.7 mV (averaged from three 
measurements: −9.54 mV, −14.81 mV, −18.90 mV). 
3.3.11. Cytotoxicity assays 
RAW 264.7 mouse macrophages (2  104 cells/well) and OVCAR-3 cells (5  103 
cells/well) were plated in 96-well plate in DMEM and RPMI-1640 medium (10% and 20% 
fetal bovine serum, for the RAW 264.7 and OVCAR-3, respectively and 1% 
penicillin/streptomycin).  Cells were incubated at 37 C in a humidified atmosphere 
containing 5% CO2 for 24 h to adhere.  Then, the medium was replaced with a fresh 
medium 1 h prior to the addition of 20 L of polymer stock solutions to 100 L of the 
medium (final concentrations ranged from 1 to 3000 g/mL).  The cells were incubated 
with the various formulations for 72 h and then the medium was replaced with 100 L of 
fresh medium prior to the addition of 20 L MTS combined reagent to each well (Cell 
Titer 96 Aqueous Non-Radioactive Cell Proliferation Assay, Promega Co., Madison, WI).  
The cells were incubated with the reagent for 2 h at 37 C in a humidified atmosphere 





SpectraMax M5 (Molecular Devices Co., Sunnyvale, CA).  The cell viability was 
calculated based on the relative absorbance to the control-untreated cells. 
3.3.12. Multiplex assay 
RAW 264.7 mouse macrophages (2  104 cells/well) were plated in 96-well plate 
in DMEM (10% fetal bovine serum, and 1% penicillin/streptomycin).  The RAW 264.7 
cells were treated with medium (control) and polymers (500 g/mL) for 24 h.  The 
supernatants were then collected and centrifuged for 10 min at 13000 rpm.  Serial dilutions 
of standards of cytokines were also prepared in the same diluent utilized for the samples 
(i.e. cell-culture medium).  Control, standards and polymer-treated samples (50 L) were 
incubated with antibody-conjugated magnetic beads for 30 min in the dark.  After 
washing, the detection antibody was added to the wells and incubated in the dark for 30 
min under continuous shaking (300 rpm).  After washing, streptavidin-phycoerythrin was 
added to every well and incubated while protected from light for 10 min under the same 
shaking conditions.  Finally, after several washings and resuspension in the assay buffer 
and shaking, the expression of the mouse cytokines, interleukin (IL)-1α, IL-1β, IL-2, IL-
3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (P40), IL-12 (P70), IL-13, IL-17, eotaxin, 
granulocyte-colony-stimulating factor (G-CSF), granulocyte macrophage-colony-
stimulating factor (GM-CSF), interferon- (IFN-), keratinocyte-derived chemokine 
(KC), monocyte chemotactic protein (MCP)-1, macrophage inflammatory protein (MIP)-
1, MIP-1, regulated upon activation normal T-cell expressed and presumably secreted 
(RANTES) and tumor necrosis factor- (TNF-) was measured immediately using the 
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Bioplex 200 system with HTF and Pro II Wash station (Bio-Rad Laboratories, Inc., 
Hercules, CA), and the data were analyzed using the Bioplex Data Pro software. 
3.3.13. Methylation of carboxylic acid functionalities109 in PMC (synthesis of PMMC, 3) 
To a stirred solution of PMC27 (50 mg, 0.012 mmol) in 1 mL of toluene:MeOH 
(3:2), an etheric solution (2 M in diethyl ether) of (trimethylsilyl)diazomethane 
(TMSCHN2) was added dropwise until the yellow color persisted (~250 L).  The mixture 
was stirred for 30 min at RT and concentrated in vacuo to give poly(5-methyl-5-
methyloxycarbonyl-1,3-dioxan-2-one), PMMC27 (3).  Mn,NMR = 4700 g/mol; Mn,GPCTHF = 
6700 g/mol; PDI = 1.09.  1H NMR (300 MHz, CDCl3):  4.35−4.23 (m, −OC(O)OCH2−), 
3.73 (s, −OCH3), 1.25 (s, −C(CH3)(CH2O−)2), 1.20 (s, −C(CH3)CH2OH).  13C NMR (75 
MHz, CDCl3):  172.7, 154.5, 69.0, 52.7, 48.4, 46.6, 17.6.  IR (neat, cm−1): 3100−2800, 
1736, 1458, 1389, 1227, 1142, 972, 872, 787, 733. 
4.3.14. PEG 6kDa (12) 
Tg = −12.5 °C (−17 °C, as reported116), Tm = 57.8 °C. TGA in Ar:  320−430 C, 
92% mass loss; 8% mass remaining above 500 C. 
3.3.15. Synthesis of PEG-b-PMAC (14)  
mPEG (10 kDa, 100 mg, 0.010 mmol) and MAC (160 mg, 0.80 mmol) were 
dissolved in dry DCM (1.6 mL, [MAC] = 0.5 M).  DBU (1.5 L, 0.010 mmol) was added 
to the monomer/initiator solution.  After the desired time, the polymerizations were 
quenched by addition of a DCM solution of benzoic acid (1.8 mg, 0.015 mmol in 200 L 
DCM) and precipitated directly into cold diethyl ether to yield PEG-b-PMAC (14) as a 
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white powder.  Yield = 130 mg, 95% based upon 25% conversion.  Mn,NMR = 13800 g/mol; 
Mn,GPCDMF = 12000 g/mol; PDI = 1.05.  1H NMR (300 MHz, CDCl3):  5.86 (m, −
CH2CHCH2), 5.33−5.18 (m, −CH2CHCH2), 4.61 (d, J = 5.6 Hz, −OCH2CHCH2), 4.33−
4.24 (m, −OC(O)OCH2−), 3.80−3.46 (br, −OCH2CH2−), 3.36 (s, CH3O−), 2.50 (t, J = 6.8 
Hz, −CH2OH), 1.25 (s, −C(CH3)(CH2O−)2), 1.21 (s, −C(CH3)CH2OH).  13C NMR (75 
MHz, CDCl3):  171.8, 154.5, 131.7, 118.6, 70.7, 68.7, 66.0, 46.6, 17.6.  IR (neat, cm−1): 
3100−2700, 1751, 1466, 1342, 1234, 1096, 957, 841, 787.  Tg = −18.5 °C; Tm = 48.5 °C. 
TGA in Ar:  200−300 C, 24% mass loss; 300−420 C, 65% mass loss; 7% mass remaining 
above 500 C. 
3.3.16. Synthesis of PHPMA40 (13) 
To a flame-dried Schlenk flask (10 mL) equipped with a magnetic stir bar under 
N2 atmosphere was added 4-cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl]pentanoic 
acid (CTA, 8.5 mg, 0.020 mmol), HPMA (300 mg, 2.1 mmol), AIBN (1.0 mg, 6.3 mol) 
and 2.5 mL of dimethylacetamide (DMAc).  The mixture was stirred for 10 min at RT, 
deoxygenated through three cycles of freeze-pump-thaw and back-filled with N2.  After 
the last cycle, the reaction mixture was stirred for 15 min at RT and immersed into a pre-
heated oil bath at 70 °C to start the polymerization.  After 5 h, the polymerization was 
quenched by cooling the reaction flask with liquid N2.  The polymer was purified by 
precipitation into cold diethyl ether twice.  The yellow precipitate was collected through 
centrifugation and kept under vacuum overnight to remove residual solvents.  Yield 110 
mg of product, 92% yield based upon ~40% conversion.  Mn,NMR = 6100 g/mol; Mn,GPCDMF 
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= 2100 g/mol; PDI = 1.30.  1H NMR (300 MHz, DMSO-d6): 7.40−7.04 (br, −C(O)NH
−), 4.80−4.64 (br, −CH2CH(CH3)(OH)), 3.74−3.60 (br, −CH2CH(CH3)(OH)), 3.28−3.20 
(br, −SCH2−), 3.04−3.28 (br, −CH2CH(CH3)(OH)), 2.35−2.26 (m, −CH2CH2C(O)OH), 
2.02−1.37 (m, −CH2C(CH3)(C(O)−)−), 1.37−1.20 (m, −SCH2CH2(CH2)9CH3), 1.20−0.60 
(m, −CH2C(CH3)(C(O)−)−, −CH2CH(CH3)(OH) and S(CH2)11CH3).  13C NMR (75 MHz, 
DMSO-d6):  177.1, 65.0, 64.9, 64.8, 54.6, 47.6, 45.1, 44.6, 31.3, 29.0, 21.6, 21.4, 17.8, 
16.5, 15.2, 14.02.  IR (neat, cm−1): 3650−3100, 3050−2700, 1751, 1636, 1528, 1466, 1342, 
1242, 1103, 957, 841, 787.  Tg = 157.0 °C.  TGA in Ar: 220−475 C, 92% mass loss; 6% 
mass remaining above 500 C. 
3.3.17. Synthesis of PMMA28  
To a flame-dried Schlenk flask (10 mL) equipped with a magnetic stir bar under 
N2 atmosphere was added CTA (202 mg, 0.50 mmol), MMA (3.00 g, 30 mmol), AIBN 
(8.2 mg, 0.050 mmol) and 1.5 mL of anisole.  The mixture was stirred for 10 min at RT, 
deoxygenated through three cycles of freeze-pump-thaw and back-filled with N2.  After 
the last cycle, the reaction mixture was stirred for 15 min at RT and immersed into a pre-
heated oil bath at 65 °C to start the polymerization.  After 4 h, the polymerization was 
quenched by cooling the reaction flask with liquid N2.  The polymer was purified by 
precipitation into a methanol:water (4/1) mixture twice.  The yellow precipitate was 
collected through centrifugation and kept under vacuum overnight to remove residual 
solvents.  Yield 1.3 g of product, 87% yield based upon ~47% conversion.  Mn,NMR = 3200 





(br, −OCH3), 3.21 (t, J = 7.3 Hz, −SCH2CH2−), 2.61−2.46 (m, −CH2C(O)OH), 2.38−2.06 
(m, −CH2CH2C(O)OH), 2.06−1.74 (br, −CH2C(CH3)(C(O)O−)−), 1.68 (s, −C(CN)(CH3)
− ), 1.62 (m, −SCH2CH2− ), 1.48−1.10 (m, −SCH2CH2(CH2)9CH3), 1.09−0.70 (m, −
CH2C(CH3)(C(O)O−)− and −S(CH2)11CH3).  13C NMR (75 MHz, CDCl3):  178.2, 177.9, 
177.1, 105.1, 60.1, 59.8, 54.5, 53.0, 51.9, 45.6, 45.1, 45.0, 44.6, 37.0, 34.2, 32.0, 29.7, 
29.6, 29.5, 29.4, 29.2, 29.0, 27.1, 22.8, 18.8, 16.5, 14.2.  IR (neat, cm−1): 3100−2800, 1728, 
1443, 1389, 1242, 1150, 988, 841, 810, 748.  Tg = 96.0 °C.  TGA in Ar: 160−210 C, 34% 
mass loss; 210−300 C, 9% mass loss; 300−370 C, 19% mass loss; 370−430 C, 29% 
mass loss; 8% mass remaining above 500 C. 
3.3.18. Synthesis of PMMA28-b-PHPMA90 (15) 
To a flame-dried Schlenk flask (10 mL) equipped with a magnetic stir bar under 
N2 atmosphere was added PMMA28 (45 mg, 14 mol), HPMA (300 mg, 2.1 mmol), AIBN 
(1.0 mg, 6.3 mol) and 2.5 mL of DMAc.  The mixture was stirred for 10 min at RT, 
deoxygenated through three cycles of freeze-pump-thaw and back-filled with N2.  After 
the last cycle, the reaction mixture was stirred for 15 min at RT and immersed into a pre-
heated oil bath at 70 °C to start the polymerization.  After 7 h, the polymerization was 
quenched by cooling the reaction flask with liquid N2.  The copolymer was purified by 
precipitation into cold diethyl ether twice.  The yellow precipitate was collected through 
centrifugation and kept under vacuum overnight to remove residual solvents.  Yield 210 
mg of product, 93% yield based upon ~60% conversion.  Mn,NMR = 16100 g/mol; 
Mn,GPCDMF = 3400 g/mol; PDI = 1.56.  1H NMR (300 MHz, DMSO-d6): 7.40−7.04 (br, 
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−C(O)NH−), 4.80−4.64 (br, −CH2CH(CH3)(OH)), 3.74−3.61 (br, −CH2CH(CH3)(OH)), 
3.61−3.48 (br, −C(O)OCH3), 3.04−3.28 (br, −CH2CH(CH3)(OH)), 2.37−2.26 (m, −
CH2CH2C(O)OH), 2.02 − 1.37 (m, − CH2C(CH3)(C(O) − ) − ), 1.37 − 1.20 (m, −
SCH2CH2(CH2)9CH3), 1.20−0.60 (m, −CH2C(CH3)(C(O)−)−, −CH2CH(CH3)(OH) and 
S(CH2)11CH3).  13C NMR (75 MHz, DMSO-d6):  177.4, 177.1, 177.0, 104.5, 64.9, 64.8, 
64.7, 54.4, 53.7, 51.8, 47.6, 47.4, 45.0, 44.5, 44.3, 43.9, 21.5, 21.4, 18.5, 17.9, 16.5, 15.2.  
IR (neat, cm−1): 3650−3050, 3050−2700, 2361, 1728, 1636, 1520, 1458, 1250, 1196, 1134, 
949, 841.  Tg = 105.5 and 162.0 °C.  TGA in Ar: 250−390 C, 37% mass loss; 390−480 
C, 49% mass loss; 12% mass remaining above 500 C. 
3.4. Conclusions 
A polycarbonate-based degradable analogue of hydrophilic PHPMA was prepared 
via amidation of carboxylic acid-functional PCs with 1-amino-2-propanol, and found to 
exhibit similarly high water solubility and low cyto-/immunotoxicity, while having 
differences of lower glass transition temperature and, importantly, possessing hydrolytic 
degradability.  Metal-free organocatalytic ROP of a bis-MPA-derived benzyl ester-
functional cyclic carbonate monomer and subsequent hydrogenolysis afforded the well-
defined polycarbonate precursor for postpolymerization amidation to yield the degradable 
PHPMA analogue.  This method could be utilized as a general procedure to prepare 
diverse functional PCs.  High water solubility and low cyto-/immuno-toxicities as well as 





PMHPAC as a degradable alternative to PEG and PHPMA.  In addition, a potentially fully 
degradable polymeric nanostructure was formed by self-assembly of a PMHPAC-based 
amphiphilic block copolymer, which has spherical morphology and suitable size for 
biomedical applications.  We believe that degradable PMHPAC may increase the diversity 





ALDEHYDE-FUNCTIONAL POLYCARBONATES AS REACTIVE PLATFORMS* 
4.1. Introduction 
Aldehydes are among the most reactive functional groups under mild reaction 
conditions, which can allow for entry to the construction of a diverse range of functional 
dynamic and/or static polymer materials.  Aldehydes undergo a wide variety of chemical 
reactions with nucleophiles, resulting in both reversible and irreversible bonds.117,118 
Among them, condensation reactions with nitrogen-containing nucleophiles such as 
hydrazines or alkoxyamines are classified as “click” reactions, due to the facile formation 
of stable hydrazones or oximes.119,120  Also, the condensation of aldehyde with primary 
amines yields imine derivatives (Schiff bases) and imine reduction provides stable amino 
bonds.  Efforts to develop polymers bearing pendant aldehyde functionalities have been 
made since the 1950s.  Conventional radical polymerization of aldehyde-bearing 
monomers yielded polymers with uncontrolled molecular weight and dispersity.121,122 
Anionic polymerization was employed to produce well-defined aldehyde-functional 
polymers.123,124  However, the rigorous polymerization conditions required for controlled 
anionic polymerization limited their applications.  Since the development of controlled 
radical polymerizations (CRPs), a few research groups have studied the synthesis and 
* Reprinted with permission from “Aldehyde-functional polycarbonates as reactive
platforms” by Gyu Seong Heo, Sangho Cho, and Karen L. Wooley, Polym. Chem. 2014, 
5, 3555-3558.  Copyright © 2014 The Royal Society of Chemistry 
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application of aldehyde-functional polymers.  Maynard and coworkers prepared poly(3,3’-
diethoxypropyl methacrylate) (pDEPMA) by atom transfer radical polymerization 
(ATRP) and reversible addition–fragmentation chain transfer (RAFT) polymerization.125-
127  Aldehydes were produced by hydrolysis of the acetals and were then conjugated with 
aminooxy- or hydrazine-functionalized compounds including peptides and dyes via oxime 
or hydrazone linkages, respectively.  Aldehyde-functional polymers were also synthesized 
from unprotected monomers by RAFT polymerization128,129  and ring-opening metathesis 
polymerization (ROMP).130 
Although several examples of polymers having aldehyde side chain groups have 
been reported, most are comprised of nondegradable backbones.  While this work was in 
progress, Hedrick, Yang and coworkers reported the synthesis of poly(ethylene oxide)-b-
polycarbonates (PEO-b-PCs) with pendant aldehyde groups via organocatalytic ring-
opening polymerization (ROP) of aldehyde-functional cyclic carbonate monomers using 
PEO as a macroinitiator.131  Aliphatic PCs are remarkable candidates for biomedical 
applications on account of their biodegradability, biocompatibility, and low toxicity in 
vivo.100,101  In particular, various pendant functionalities can be introduced on the PC 
backbones by ROP of functionalized cyclic carbonate monomers.100,132  These well-
established synthetic methods for functional PCs expand potential applications of these 
types of materials. 
We built a different strategy to prepare aldehyde-functional PCs.  Our strategy 
involved the introduction of aldehyde functionalities via post-polymerization modification 





is one of the most intriguing methods to attempt, due to: (1) aldehyde groups can be readily 
introduced by selective cleavage of alkenyl groups using ozone together with a reducing 
agent; (2) the initial alkenes can instead be utilized for other post-polymerization 
modifications, such as by thiol–ene reaction, epoxidation, halogenation, hydroboration, 
etc.; (3) the alkene precursors and resulting aldehydes are orthogonal functional groups 
for further conjugation reactions.  In this study, we prepared allyl-functional PCs by ROP 
of a functionalized cyclic carbonate monomer using 1,8-diazabicyclo [5.4.0]- undec-7-ene 
(DBU) in order to develop a readily accessible synthetic method for versatile allyl-
functional PCs.  Aldehydefunctionalities were introduced by ozonolysis of the pendant 
alkene groups.  The resulting aldehydes were conveniently functionalized with aminooxy-
containing compounds via aldehyde–aminooxy “click” reactions.  Furthermore, PC-based 
statistical copolymers bearing alkene and aldehyde functionalities were synthesized by 
partial ozonolysis and functionalized by stepwise aldehyde–aminooxy and thiol–ene 
“click” reactions in an orthogonal fashion. 
4.2. Results and Discussion 
Allyl-functional PCs [poly(5-methyl-5-allyloxycarbonyl-1,3-dioxan-2-one), 
PMAC] were synthesized by organocatalytic ROP of the functionalized cyclic carbonate 
monomer, 5-methyl-5-allyloxycarbonyl-1,3-dioxan-2-one (MAC).  MAC was 
synthesized by a simple two-step procedure, as reported previously.114  Dove reported the 
ROP of MAC using the dual catalyst system of (˗)-sparteine in combination with a 
thiourea.133  However, the limited availability of (˗)-sparteine could hinder the further 





In Dove's report, polymerizations using DBU as a catalyst were retarded beyond ca. 70% 
monomer conversion, and led to isolated polymers having broad molecular weight 
distributions and bimodal GPC traces.  In this study, polymerizations were carried out 
under more dilute conditions ([MAC]0 = 0.5 M in this study vs. 2 M as reported), in order 
to provide enhanced control, which was expected to occur by maintaining uniform 
solubility throughout the polymerization while also inhibiting transesterification reactions.  
Investigation of the living characteristics of the polymerization was performed in 
dichloromethane (DCM) at ambient temperature in a glovebox (29 ˚C) with [M]0/[I]0 = 
50.  Application of DBU revealed a linear correlation between the number-average 
molecular weight (Mn) against monomer conversion until ca. 80% monomer conversion, 
at which point the ROPs became sluggish.  However, minimal transesterification was 
observed until 2 h after polymerization was suspended (Figure 4.1).  After the 
polymerizations were quenched by addition of benzoic acid in DCM, residual monomer 
and catalyst were removed by column chromatography using silica gel to yield the purified 
polymers (Figure 4.2).  Both the molecular weight and molecular weight distribution could 
be manipulated by polymer fractionation using column chromatography (Figure 4.3).  
Furthermore, chain extension experiments after complete monomer conversion or 
retardation of polymerization showed that the catalyst and chain end remained active for 








Scheme 4.1.  Ring-opening polymerization (ROP) of 5-methyl-5-allyloxycarbonyl-1,3-dioxan- 2-one, 






Figure 4.1.  (a) GPC profiles (THF as eluent, 1 mL/min) as a function of polymerization time, for the ROP 
of MAC; (b) Plot of ln([M]0/[M]) against time, obtained from 1H NMR spectroscopy data; (c) Plot of 
number-average molecular weight (Mn) and polydispersity (Mw/Mn) against % monomer conversion in the 
ROP of MAC.  Conditions: [MAC]0 = 0.5 M in DCM at 29 C in the glovebox, [MAC] : [BnOH] : [DBU] 






Figure 4.2.  1H NMR spectrum of BnO-PMAC15-OH initiated from benzyl alcohol using DBU.  Conditions: 





Figure 4.3.  GPC profiles (THF as eluent, 1 mL/min) of BnO-PMAC15-OH before and after purification 
using column chromatography.  Conditions: [MAC]0 = 0.5 M in DCM at 29 C in the glovebox, [MAC] : 





Table 4.1.  Block copolymers of MAC.  
Polymer Mn (NMR) (g/mol)  Mn (GPC) (g/mol)  PDI 
N3-PEG68-b-PMAC10-OH 5 000 5 100 1.09 
BnO-PMAC37-b-PLLA20-OH 10 400 4 300a) 1.09 
BnO-PLLA20-b-PMAC15-OH 6 000 5 600 1.12 




one), PMOC] were prepared by ozonolysis of allyl-functional polymer precursors and 
their reductive work-up (Scheme 4.2).  Ozone serves as “molecular scissors”, cutting 
double bonds in molecules,134 at specific sites to produce new functional groups.  We 
hypothesized that the PC backbones would remain intact under ozonolysis conditions.  
Initial ozonolysis studies were conducted in CD2Cl2 (20 mg of PMAC15 in 2 mL of 
CD2Cl2) at 78 ˚C.  Ozone was delivered at a rate of 100 mg h-1 as a mixture of column-
dried compressed air (2 L min-1) from a Red Sea AquaZone 100 ozone generator.  For 
unknown reasons, the characteristic blue color of the unreacted ozone in both DCM and 
methanol (MeOH) was difficult to be recognized, even in the solvents themselves.  In 
order to determine the time to halt the exposure to ozone, aliquots of the reaction mixture 
were collected, dried in vacuo, and analyzed by 1H NMR spectroscopy to monitor the 
disappearance of alkene proton resonances (a and b in Figure 4.4) after the allotted period 





9 min (Figure 4.5) and reductive workup provided aldehyde groups (d in Figure 4.4).  The 
resulting polymer was isolated by precipitation into cold diethyl ether.  Unfortunately, 
after full conversion to PMOC, the isolated polymers had limited solubility in common 
organic solvents, except trifluoroacetic acid (TFA).  Inter- and intra-molecular hydrogen 
bonding and dipole–dipole interactions of pendant aldehydes might contribute to the 
observed solubility challenges.126,130  As a result, further reactions with polymers bearing 
aldehyde groups were performed by the in situ generation of the aldehyde functionalities 
and reaction directly without an initial purification.  Under ideal conditions, ozonolysis 
and reductive work-up with dimethyl sulfide (Me2S) give only dimethyl sulfoxide 
(DMSO) and volatile formaldehyde as the by-products, neither of which would interfere 




Scheme 4.2.  Ozonolysis of PMAC and functionalization by aldehyde–aminooxy “click” reaction. 






Figure 4.4.  1H NMR spectra (300 MHz) of PMAC (in DCM), PMOC (generated in situ, in DCM), and 
conjugates after functionalization via aldehyde–aminooxy “click” reactions with O-benzylhydroxylamine 







Figure 4.5.  Ozonolysis kinetics of PMAC15 Conditions: PMAC (20 mg) in DCM (2 mL), (i) O3, DCM, -78 






The availability of in situ-generated aldehyde groups for further functionalization 
was confirmed by aldehyde–aminooxy “click” reactions.  We chose two model 
compounds to study formation of oxime bonds: O-benzylhydroxylamine as a model 
hydrophobic compound and O-(carboxymethyl)hydroxylamine as a model hydrophilic 
compound (Scheme 4.2).  In particular, the latter can be useful for applications, in terms 
of conjugation with various compounds having alcohol or amine functionalities, such as 
peptides, drugs, etc.  The desired aminooxy compound and sodium acetate (NaOAc) in 
MeOH were added to the in situ-generated PMOC in DCM and stirred at 45 ˚C for 1.5 h.  
The resulting polymers were purified by precipitation into water for hydrophobic 
conjugate 1 and dialysis against water (or centrifugal filtration) for hydrophilic conjugate 
2.  Formation of conjugates was verified by monitoring disappearance of aldehyde 
resonances (d) of PMOC and appearance of the trans and cis protons (f and j) of the oxime 
bonds using 1H NMR spectroscopy (Figure 4.4).  Also, the chemical shifts of the 
methylene proton resonances of the side chain (c, e, i, and k) were changed.  The 1H NMR 
integrations indicated that conjugation yields were quantitative.  GPC profiles verified that 
transesterification and/or degradation of the PC backbone linkages by ozonolysis and/or 
over-oxidation were not significant up to the time of completion of the reaction (Figure 
4.6).  Moreover, we found that insoluble PMOCs became soluble during conjugation 
reactions.  Therefore, isolated PMOCs, despite their limited solubility, are applicable to 








Figure 4.6.  GPC profiles (THF as eluent, 1 mL min−1) of BnO-PMAC15-OH and isolated products of 
aldehyde–aminooxy “click” reactions with O-benzylhydroxylamine after ozonolysis of PMAC, with 




The properties of the resulting polymer conjugates were readily modified by 
varying the aminooxy compounds (Table 4.2).  Introduction of aldehydes to the PMAC, 
which was a viscous liquid with a low Tg of 16.0 ̊ C, led to an obvious morphology change, 
as PMOC was a white solid (Tg = 49.0 ˚C).  After aldehyde–aminooxy “click” reactions, 
conjugate 1 was a viscous liquid (Tg = 0.0 C), while 2 was a white solid (Tg = 76.0 ˚C).  
Thus, the polymer bulk properties could be readily modified by alteration of the aminooxy 
compounds.  Also, as expected, the solubilities of the conjugates were distinctive. 









Table 4.2.  Thermal properties and solubility of synthesized polymers.  
 Thermal properties (ºC) Solubility 
Polymer Tga) Td, 5%b) Td, 50%b) Organic solvent Aqueous solvent 
PMAC15 -16.0 277 333 most none 
PMOC15 49.0 245 305 limitedc) none 
1 0.0 235 262 most none 
2 76.0 183 265 limitedd) soluble 
a)Glass transition temperature, measured by DSC analysis at the third scan.; b)Temperatures at 5 and 50% 




Orthogonal functional groups, alkenes and aldehydes, were easily introduced into 
the well-defined polymer scaffold.  Partial conversions of alkenes to aldehydes were 
controlled simply by adjusting the times of exposure to ozone.  After 3 and 5 min of 
bubbling ozone and reductive work-up, ca. 33% and 60% of alkenes were converted to 
aldehydes, respectively.  The kinetics of ozonolysis made conversions predictable (Figure 
4.5).  Aldehyde–aminooxy “click” reaction of the resulting alkeneand aldehyde-functional 
PC (PMAC-co-PMOC) with O-benzylhydroxylamine and consecutive thiol–ene reaction 
with ethyl 2-mercaptoacetate demonstrated orthogonal functionalization of the resulting 








Scheme 4.3.  Synthesis of PMAC-co-PMOC by partial ozonolysis of PMAC (i and ii), followed by in situ 
functionalization via consecutive aldehyde–aminooxy (iii) and thiol–ene “click” (iv) reactions. Conditions: 
(i) O3, DCM, −78 °C, 3 min; (ii) Me2S, −78 °C to RT; (iii) O-benzylhydroxylamine, NaOAc, MeOH, 45 






Figure 4.7.  1H NMR spectra of polymer 3 (partial ozonolysis of PMAC15 and consecutive functionalization 
by aldehyde-aminooxy “click” reaction with O-benzylhydroxylamine and polymer 4 (thiol-ene reaction of 





4.3. Experimental Section 
4.3.1. Materials 
α-Hydroxy-ω-azido poly(ethylene glycol) 3,000 Da (HO-PEG68-N3) was 
purchased from Rapp Polymere, dried in a desiccator over P2O5 and stored under inert 
atmosphere.  Benzyl alcohol and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) were dried 
over CaH2, distilled, and stored under inert atmosphere.  Tetrahydrofuran (THF), N,N-
dimethylformamide (DMF), and dichloromethane (DCM) were purified by passage 
through solvent purification system (JC Meyer Solvent Systems) and used as dried 
solvents.  The monomer, 5-methyl-5-allyloxycarbonyl-1,3-dioxan-2-one (MAC) was 
synthesized as reported,114 recrystallized several times before use, and dried over P2O5.  
All other solvents and chemicals were obtained from Sigma-Aldrich, TCI America, or 
Fisher Scientific and used as received. 
4.3.2.  Instruments 
All polymerizations were performed under inert atmosphere in a glovebox.  1H and 
13C NMR spectra were recorded on Varian Mercury 300 spectrometers.  Chemical shifts 
were referenced to the solvent resonance signals. 
IR spectra were recorded on an IR Prestige 21 system (Shimadzu Corp., Japan), 
equipped with an ATR accessory, and analyzed using IRsolution v.1.40 software. 
Gel permeation chromatography (GPC) eluted with THF was conducted on a 
system equipped with Waters chromatography, Inc. (Milford, MA) model 1515 isocratic 
pump and a model 2414 differential refractometer with a three-column set of Polymer 





104 Å, 300  7.5 mm columns) and a guard column (PLgel 5 μm, 50  7.5 mm).  The 
system was equilibrated at 40 °C in THF, which served as the polymer solvent and eluent 
(flow rate set to 1.00 mL/min).  The differential refractometer was calibrated with Polymer 
Laboratories, Inc., polystyrene standards (300–467,000 Da).  Polymer solutions were 
prepared at a concentration of ca. 3 mg/mL with 0.05% vol toluene as flow rate marker 
and an injection volume of 200 μL was used.  Data were analyzed using Empower Pro 
software from Waters Chromatography, Inc. 
Glass transition temperatures (Tg) were measured by differential scanning 
calorimetry (DSC) on a Mettler-Toledo DSC822 (Mettler-Toledo, Inc., Columbus, OH) 
under N2.  Measurements of Tg were taken with a heating rate of 10 °C/min.  The 
measurements were analyzed using Mettler-Toledo Stare v. 10.00 software.  The Tg was 
taken as the midpoint of the inflection tangent, upon the third scan.  Thermogravimetric 
analysis (TGA) was performed under Ar atmosphere using a Mettler-Toledo model 
TGA/DSC 1, with a heating rate of 10 °C/min. 
Column chromatography was performed on CombiFlash Rf4x (Teledyne ISCO) 
with RediSepRf Column (Teledyne ISCO). 
4.3.3. Organocatalytic ROP of 5-methyl-5-allyloxycarbonyl-1,3-dioxan-2-one (MAC) 
In a typical experiment, MAC and benzyl alcohol initiator were dissolved in dry 
DCM ([MAC]0 = 0.5 M). DBU (1 equiv to initiator) was added to the monomer/initiator 
solution.  After the desired time, the polymerizations were quenched by benzoic acid 
solution in DCM and precipitated directly into hexanes.  Impurities were removed by 





containing fractions were concentrated then dissolved in a minimal amount of DCM and 
precipitated into hexanes.  For example, MAC (1.0 g, 5.0 mmol), benzyl alcohol (26 L, 
27 mg, 0.25 mmol), DBU (37 L, 38 mg, 0.25 mmol), DCM (10 mL), benzoic acid 
solution (36 mL, 46 mg, 0.38 mmol in 200 L DCM) were used to yield BnO-PMAC15-
OH. 
BnO-PMAC15-OH. Yield = 670 mg, 87% based upon monomer conversion (75%).  Crude: 
Mn, GPC = 3,000 g/mol. PDI = 1.13. Mn, NMR = 3,100 g/mol.  After fractionation, fractions 
11–12: Mn, GPC = 1,200 g/mol. PDI = 1.08, fractions 14–16: Mn, GPC = 2,800 g/mol. PDI 
= 1.03. 1H NMR (300 MHz, CDCl3, 7.26 ppm): δ 7.35 (m, OBn–ArH), 5.86 (m, CHvinyl), 
5.33–5.20 (m, CH2-vinyl), 5.13 (s, OBn–CH2), 4.61 (d, OCH2CHCH2), 4.43–4.24 (m, 
OC(O)OCH2), 3.70 (m, CH2OH), 2.50 (t, OH), 1.25 (s, CH3), 1.21 (s, C(CH3)CH2OH). 
13C NMR (75 MHz, CDCl3, 77.16 ppm): δ 171.8, 154.5, 135.1, 131.6, 128.6, 118.5, 68.6, 
66.0, 46.6, 17.6. IR (neat, cm-1 ): 3150–2800 (br), 1736 (s), 1649 (w), 1470 (m), 1402 (m), 
1379 (m), 1231 (s), 1138 (s), 968 (s), 785 (m), 739 (w), 698 (w). Tg = -16.0 C (-17.5 C, 
onset). TGA in N2: 255280 C, 7% mass loss; 280415 C, 74% mass loss; 415450 C, 
10% mass loss; 9% mass remaining above 500 C. 
4.3.4. Synthesis of diblock copolymer, α-azido poly(ethylene glycol)68-block-poly(5-
methyl-5- allyloxycarbonyl-1,3-dioxan-2-one)n, N3-PEG68-b-PMACn 
N3-PEG-b-PMAC block copolymer was synthesized using the above-mentioned 
method with commercially available α-hydroxy-ω-azido poly(ethylene glycol) 3,000 Da 





For the synthesis of PMAC-b-PLLA block copolymers, MAC (or L-lactide) and 
benzyl alcohol initiator were dissolved in dry DCM. DBU was added to the 
monomer/initiator solution.  After the desired time (~80% conversion for MAC and >90% 
conversion for L-lactide), L-lactide (or MAC) was dissolved separately in DCM and added 
to the reaction mixture.  After the desired time, the polymerizations were quenched by 
benzoic acid solution in DCM and precipitated directly into cold diethyl ether.  Otherwise, 
the mixture was purified by column chromatography on silica gel in hexanes/ethyl acetate 
(4:1 to 1:1).  The polymer containing fractions were concentrated and then dissolved in a 
minimal amount of DCM and precipitated into hexanes. 
N3-PEG68-b-PMAC10-OH. Yield = 234 mg, 90% based upon monomer conversion. Mn, 
GPC = 5,100 g/mol. PDI = 1.09. Mn, NMR = 5,000 g/mol. 1H NMR (300 MHz, CDCl3, 5.32 
ppm): δ 5.89 (CHvinyl), 5.34–5.20 (CH2-vinyl), 4.61 (OCH2CHCH2), 4.39–4.23 
(OC(O)OCH2), 3.59 (OCH2CH2), 3.36 (N3CH2CH2O), 1.25 (s, CH3), 1.20 (s, 
C(CH3)CH2OH).  
BnO-PMAC37-b-PLLA20-OH. Yield = 162 mg, 74% based upon monomer conversion. Mn, 
GPC = 4,300 g/mol (flow marker was shifted). PDI = 1.09. Mn, NMR = 10,400 g/mol. 1H 
NMR (300 MHz, CDCl3, 7.26 ppm): δ 7.34 (OBn-ArH), 5.86 (CHvinyl), 5.32–5.10 (CH2-
vinyl, PLLA-CH and OBn-CH2), 4.60 (OCH2CHCH2), 4.32–4.24 (OC(O)OCH2 and 
CHOH), 1.55 (PLLA-CH3), 1.25 (s, PMAC-CH3).  
BnO-PLLA20-b-PMAC15-OH. Yield = 197 mg, 71% based upon monomer conversion. Mn, 
GPC = 5,600 g/mol. PDI = 1.12. Mn, NMR = 6,000 g/mol. 1H NMR (300 MHz, CDCl3, 5.32 





4.61 (OCH2CHCH2), 4.40–4.25 (OC(O)OCH2 and CHOH), 3.69 (CH2OH), 1.55 (PLLA-
CH3), 1.26 (s, PMAC-CH3). 
4.3.5. Ozonolysis of PMAC [synthesis of poly(5-methyl-5-oxoethyloxycarbonyl-1,3-
dioxan-2- one, PMOC] 
PMAC15 (20 mg, 0.10 mmol repeat unit, 1 equiv) was dissolved in DCM (2.0 mL), 
and the solution was cooled to –78 ºC (dry ice/acetone cooling bath).  Ozone was bubbled 
through the cooled solution until a slight blue color was obtained (10 min).  When a slight 
blue color was not recognizable, an aliquot was collected, dried in vacuo, and analyzed by 
1H NMR to determine conversion.  N2 was then bubbled through for 10 min., and then 
dimethyl sulfide (37 µL, 31 mg, 0.50 mmol, 5 equiv) was added.  The reaction was slowly 
allowed to warm to room temperature and stir overnight.  The resulting solution was used 
without further purification or was precipitated in diethyl ether to yield PMOC as a white 
solid (quantitative).  For kinetic study of ozonolysis, aliquots were collected, dried in 
vacuo, and analyzed by 1H NMR at the allotted period of time (1, 3, 5, 7, 9, or 11 min). 
Mn, NMR = 3,100 g/mol. 1H NMR (300 MHz, CD2Cl2, 5.32 ppm): δ 9.52 (br, CHO), 7.36 
(br, OBn– ArH), 4.74 (m, OCH2CHO), 4.34 (m, OC(O)OCH2), 1.33 and 1.27 (br s, CH3). 
1H NMR (300 MHz, TFA-d, 11.5 ppm) δ 9.63 (br, CHO), 7.37 (br, OBn–ArH), 5.07 (br 
s, OCH2CHO), 4.56 (br s, OC(O)OCH2), 1.47 (br s, CH3). 13C NMR (75 MHz, TFA-d, 
164.2 ppm): δ 201.7, 176.2, 158.2, 88.1, 72.0, 49.5, 18.4. IR (neat, cm-1 ): 3675–3075 (br), 
3075–2775 (br), 2843 (w), 2725 (w), 1736 (s), 1468 (m), 1402 (m), 1383 (m), 1233 (s), 





in N2: 210355 C, 76% mass loss; 355420 C, 9% mass loss; 15% mass remaining 
above 500 C 
4.3.6. Functionalization of aldehyde-functional polycarbonates (PMOC) 
Isolated or in situgenerated PMOC (50 mg, 0.25 mmol for repeat unit) in DCM 
(5.0 mL) was mixed with aminooxy compound [O-benzylhydroxylamine hydrochloride 
(80 mg, 0.50 mmol) for 6 conjugate 1, O-(carboxymethyl)hydroxylamine (55 mg, 0.50 
mmol) for conjugate 2] and NaOAc (136 mg, 1.0 mmol) in MeOH (5.0 mL).  The mixture 
was stirred for 1.5 h at 45 ºC.  The conjugate 1 was purified by precipitation into water.  
The conjugate 2 was concentrated and diluted with nanopure water.  The resulting solution 
was purified by dialysis against nanopure water for 2 days and lyophilized. 
Conjugate 1. Yield = 61 mg, 80%. Mn, GPC = 2,400 g/mol (flow marker was shifted). 
PDI = 1.10. Mn, NMR = 4,700 g/mol. 1H NMR (300 MHz, CDCl3, 7.26 ppm): δ 7.43 (br, 
HC=NO), 7.30 (br, OBn–ArH), 6.72 (br, HC=NO), 5.07 and 5.04 (s, OBn–CH2), 4.98 (m, 
OCH2CHNO), 4.64 (m, OCH2CHNO), 4.25 (m, OC(O)OCH2), 1.22 (s, CH3). 13C NMR 
(75 MHz, CDCl3, 77.16 ppm): δ 171.9, 165.2, 154.5, 147.0, 144.7, 137.4, 137.2, 128.8, 
128.6, 128.5, 128.3, 76.7, 76.5, 68.7, 62.0, 60.0, 46.8, 46.7, 17.6. IR (neat, cm-1): 3100–
2800 (br), 1746 (s), 1497 (w), 1470 (m), 1454 (m), 1400 (m), 1377 (m), 1236 (s), 1140 
(s), 974 (s), 909 (s), 864 (w), 785 (m), 729 (s), 698 (s). Tg = 0.0 C (-0.2 C, onset). TGA 
in N2: 200320 C, 85% mass loss; 320500 C, 5% mass loss; 10% mass remaining 





Conjugate 2. Yield = 52 mg, 76%. Mn, NMR = 4,200 g/mol. 1H NMR (300 MHz, 
CD3OD, 4.78)  7.45 (br, HC=NO), 7.26 (br, OBn–ArH), 6.71 (br, HC=NO), 5.05 (s, 
OBn–CH2), 4.92 (m, OCH2CHNO), 4.62 (m, OCH2CHNO), 4.37 (m, CH2COOH), 4.22 
(m, OC(O)OCH2), 4.34 (m, CCH2OH), 1.18 (s, CH3). 13C NMR (75 MHz, D2O): δ 174.2, 
155.7, 150.0, 148.2, 130.0, 72.8, 69.9, 62.8, 61.0, 47.6, 17.9. IR (neat, cm-1): 3700–3100 
(br), 3020–2840 (br), 1738 (s), 1601 (s), 1458 (m), 1406 (m), 1236 (s), 1142 (s), 1059 (m), 
1024 (m), 968 (m), 922 (w), 883 (w), 866 (w), 785 (m), 698 (w). Tg = 76.0 C (-71.0 C, 
onset). TGA in N2: 155220 C, 28% mass loss; 220330 C, 36% mass loss; 320500 
C, 9% mass loss; 27% mass remaining above 500 C. 
4.3.7. Synthesis of alkene- and aldehyde-functional polycarbonates (PMAC-co-PMOC) 
and functionalization by consecutive aldehyde-aminooxy and thiol-ene “click” reactions 
PMAC15 (20 mg, 0.10 mmol for repeat units, 1 equiv) was dissolved in DCM (2.0 
mL), and the solution was cooled to -78 ºC (dry ice/acetone cooling bath).  Ozone was 
bubbled through 7 the cooled solution.  After the allotted period of time (3 and 5 min), N2 
was then bubbled through for 10 min., and then dimethyl sulfide (37 µL, 31 mg, 0.50 
mmol, 5 equiv) was added.  The reaction was slowly allowed to warm to room temperature 
and stir overnight.  The resulting PMAC-co-PMOC solution in DCM was mixed with 
aminooxy compound (O-benzylhydroxylamine, 0.20 mmol) and NaOAc (0.40 mmol) in 
MeOH (5.0 mL).  The mixture was stirred for 1.5 h at 45 ºC.  The conjugate 3 was purified 





A solution of conjugate 3 (20 mg, 5.5 mol, 55 mol for alkene functionalities), 
ethyl 2-mercaptoacetate (61 L, 66 mg, 550 mol), and DMPA (3.0 mg, 11 mol) in 0.70 
mL of DMSO was irradiated under UV irradiation (365 nm, 6 W) for 2 h.  The reaction 
mixture was purified by dialysis (MWCO 6–8 kDa) in THF overnight.  A viscous liquid 
was collected after the removal of solvent in vacuo. 
Conjugate 3. Yield = 20 mg, 85%. Mn, NMR = 3,600g/mol. 1H NMR (300 MHz, 
DMSO-d6, 7.26 ppm): δ 7.49 (br, HC=NO), 7.32 (br, OBn–ArH), 6.86 (m, HC=NO), 5.84 
(m, CHvinyl), 5.29–5.13 (m, CH2-vinyl), 5.08 and 5.02 (s, OBn–CH2), 4.85 and 4.66 (s, 
OCH2CHNO), 4.57 (s, OCH2CHCH2), 4.23 (m, OC(O)OCH2), 1.17 (s, CH3). 
Conjugate 4. Yield = 19 mg, 76%. Mn, NMR = 4,600 g/mol. 1H NMR (300 MHz, 
CDCl3, 7.26 ppm)  7.47 (br, HC=NO), 7.34 (br, OBn–ArH), 6.75 (br, HC=NO), 5.86 (m, 
CHvinyl), 5.33–5.33 (m, CH2-vinyl), 5.12 and 5.09 (s, OBn–CH2), 4.94 and 4.69 (s, 
OCH2CHNO), 4.62 (s, OCH2CHCH2), 4.28 (m, OC(O)OCH2), 4.23–4.14 (m, 
OCH2CH2CH2S and OCH2CH3), 3.20 (s, SCH2C(O)O), 2.69 (m, OCH2CH2CH2S), 1.94 













In summary, we have developed aldehyde-functional PCs via ozonolysis and 
reductive work-up of allyl-functional PCs.  Ozone efficiently cleaves the double bonds 
without damage to the PC backbone.  The resulting aldehydes were functionalized with 
aminooxy compounds under mild conditions.  Furthermore, alkene- and aldehyde-bearing 
PCs were prepared by partial ozonolysis and functionalized by consecutive aldehyde–
aminooxy and thiol–ene “click” reactions in an orthogonal fashion.  Although we 
demonstrated a few examples, aldehyde-functional PCs are potentially excellent platforms 
for divergent research directions, due to their capability to form various conjugates via 
combinations of oxime, hydrazone, and/or Schiff base linkages with aldehydes and also 







A VINYL ETHER-FUNCTIONAL POLYCARBONATE AS A TEMPLATE FOR 
MULTIPLE POSTPOLYMERIZATION MODIFICATIONS 
 
5.1. Introduction 
There has been constant interest in development of functional polymers due to their 
lower cost, easier processibility, and diverse properties.  In particular, polymers bearing 
reactive functional groups provide unique opportunity, since modulation of functionalities 
at the molecular level by postpolymerization modification helps tune material properties 
and widens potential range of applications.  Hence, introductions of new functionalities to 
polymers have been widely investigated. 
Vinyl ether is an interesting functional group, as it has an electron-rich double 
bond due to an adjacent electron-donating oxygen, which helps the formation of a stable 
carbocation next to the oxygen.135  Although the majority of applications of vinyl ethers 
are as monomers for cationic polymerizations136 and radical copolymerizations, this 
highly-reactive functional group can also undergo a variety of reactions, including 
acetalization, thioacetalization, thiol-ene reaction, hydrolysis, and so on.  One of the 
advantages of the vinyl ether functionality is its capability to form both stable covalent 
bonds as well as dynamic covalent bonds.  While thiol-ene reactions with various thiols 
yield robust thioether linkages, acetalizations with alcohols can also provide acid-labile 
acetal bonds.  Therefore, this exceptional reactivity enables a variety of applications, 





and stimuli-responsive release of biologically-active molecules via acetal or thioacetal 
linkages. 
To date, there are few studies that have investigated vinyl ether-bearing polymers.  
In 2011, Frey and Wurm et al. developed vinyl ether-functionalized poly(ethylene glycol) 
(PEG) and demonstrated their functionalization via two postpolymerization 
modifications: thiol-ene reaction and acetal formation.92  Meng, Zhong, and coworkers 
reported vinyl ether-functionalized PEG-b-poly(acrylic acid) to conjugate paclitaxel 
(PTX) via its acid-labile acetal linkage and demonstrated pH-dependent release of PTX 
from self-assembled polymeric micelles.137  However, the non-degradable backbone of 
both polymers could limit further utilization for biomedical applications. 
Our group recently developed a vinyl ether-functionalized polyphosphoester 
(PPE) to tackle this degradability issue.138  However, difficulty in purification of the cyclic 
phosphotriester monomer as well as the instability of PPE backbone under acetalization 
conditions with nucleophiles (alcohols or thiols) and an acid catalyst (p-toluenesulfonic 
acid, PTSA) impede further applications.  In this study, we introduced vinyl ether 
moieties, which have been proven to be a versatile functionality for multiple 
postpolymerization modifications on the more stable but still degradable polycarbonate 
(PC) backbones.  Well-defined PCs can be prepared via metal-free organocatalytic ring-
opening polymerization (ROP) of functional cyclic carbonate monomers,100,133,139 and a 
variety of functionalities can also be introduced by postpolymerization 
modifications.107,140  We hypothesized that the stability of the vinyl ether functionality 





which has been previously tested with vinyl ether-functionalized cyclic phosphotriester 
monomer.138  Hence, we designed and synthesized a novel vinyl ether-functionalized 
cyclic carbonate monomer, 5-methyl-5-((2-vinyloxy)ethyl)oxycarbonyl-1,3-dioxan-2-one 
(MVEC).  The organobase, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), successfully 
initiated ROP of this synthesized monomer and yielded well-defined vinyl ether functional 
homo-/co-polymers.  Multiple conjugation chemistries — acetalization, thio-acetalization, 
and thiol-ene reactions — were demonstrated as postpolymerization methods.  In order to 
establish its capability for stimuli-responsive drug delivery, the amphiphilic block 
copolymer, mPEG-b-PMVEC, was synthesized and model hydroxyl-containing drug 
compounds were conjugated via acetal linkages.  After conducting the characterization of 
their self-assembled nanostructures in aqueous solutions, cleavage kinetics of acetal bonds 
were studied using 1H NMR spectroscopy. 
5.2. Results and Discussion 
5.2.1. Monomer design and synthesis 
Six-membered cyclic carbonate monomers, the most commonly used monomers 
for the preparation of PCs by ROP, can be prepared by cyclization of 1,3-diols in various 
ways.100  Among them, 2,2-bis(hydroxymethyl)propionic acid (bis-MPA)-based cyclic 
carbonate monomers have been well-studied due to the facile introduction of 
functionalities to the carboxylic acid through ester or amide linkages, taking advantage of 
different reactivity between acid and alcohol of bis-MPA.  A vinyl ether-functionalized 
cyclic carbonate monomer, 5-methyl-5-((2-vinyloxy)ethyl)oxycarbonyl-1,3-dioxan-2-one 





MPA.99,108  Esterification of bis-MPA with 2-chloroethyl vinyl ether, followed by 
cyclization using ethyl chloroformate, yielded cyclic carbonate monomer with vinyl ether 
functionality, MVEC, 2, in 48% overall yield (Scheme 5.1).  At the beginning, the 
esterification step suffered from low reaction yields (~20%) due to the low reactivity of 
the alkyl chloride.  Sodium iodide was added to compensate for the low reactivity by in 
situ halogen exchange reaction, which improved reaction yields to up to 78%.  Although 
the cyclization step was straightforward in moderate yield (~60%), careful purification 
was necessary since small amounts of impurities hindered crystallization of MVEC.  The 
crude MVEC was yellowish liquid and was not readily crystallized or solidified.  After 
isolation by flash chromatography, the resulting MVEC was slowly crystallized in vacuo.  
Drying MVEC was easier in solid state.  Removal of water is imperative to obtain well-
defined PCs via ROP of cyclic carbonate monomers since hydroxyl chain-end produced 
from decarboxylation of water-initiated chain-end can yield telechelic PCs.  1H and 13C 
NMR spectra (Figure 5.1 and 5.2) and electrospray ionization mass spectrometry (ESI-
MS) results were consistent with the structure of monomer.  
MVEC, 2, is an interesting molecule due to the versatile reactivity due to both its 
vinyl ether as well as its cyclic carbonate functionality.  It can participate in not only ROP 
through cyclic carbonate moiety but also cationic and radical polymerization through vinyl 
ether moiety.  In addition, both functional groups can undergo postpolymerization 
modifications after corresponding polymerizations: crosslinking reaction141 of cyclic 





ethers, etc.138  In this study, we exploit this vinyl ether functionality for postpolymerization 




















5.2.2. Organocatalytic ROP of MVEC, 2 
Vinyl ether-functional PCs [poly(5-methyl-5-((2-vinyloxy)ethyl)oxycarbonyl-1,3-
dioxan-2-one), PMVEC, 3] were synthesized by organobase-catalyzed ROP of the 
functionalized six-membered cyclic carbonate monomer, 2.  The ROP of MVEC was 
conducted in a glovebox under similar conditions as we previously reported.107,140  The 







in dichloromethane (DCM) solution of MVEC using benzyl-protected bis-MPA (Bn-
MPA) as an initiator and DBU as a catalyst ([MVEC]0 = 0.7 M in DCM, [MVEC]0 : [Bn-
MPA] : [DBU] = 75:1:2).  The semi-logarithmic plot of [M]0/[M] vs. time displayed 
pseudo-first-order kinetic behavior of ROP (Figure 5.3b).  Also, a linear relationship 
between number average molecular weight (Mn) and monomer conversion indicated that 
degree of polymerizations (DPs) are pre-determinable (Figure 5.3c).  The consistent low 
dispersities (ĐM ≤ 1.10) up to 83% monomer conversion evidenced minimal degree of 
transesterification of PC backbone during ROP.  After the polymerizations were quenched 
by addition of a DCM solution of benzoic acid, residual monomer, DBU, and benzoic acid 
were removed by repetitive precipitations into methanol.  By 1H NMR spectroscopy, the 
ratios of numbers of vinyl protons (b, f, and g) and those of PC backbone (e and j) to those 
of initiator (a and c) were consistent, which indicates vinyl ethers remained intact during 
ROP and after quenching with benzoic acid (Figure 5.4). 
The chemical availability of vinyl ether functionalities for postpolymerization 
modifications was verified using three types of reactions: thiol-ene “click” reaction, 






Figure 5.3.  (a) GPC profiles (THF as eluent, 1 mL/min) as a function of polymerization time, for the ROP 
of MVEC; (b) Plot of ln([M]0/[M]) against time, obtained from 1H NMR spectroscopy data; (c) Plot of 
number-average molecular weight (Mn) and dispersity (ĐM, Mw/Mn) against % monomer conversion in the 
ROP of MVEC.  Conditions:  [MVEC]0 = 0.7 M in DCM at 29 C in the glovebox, [MVEC]0 : [Bn-MPA] : 







Figure 5.4.  1H NMR spectra of (a) PMVEC, 3 (in CDCl3), (b) after acetalization with 4-methylbenzyl 
alcohol, 4 (in CD2Cl2), (c) after thio-acetalization with 4-methylbenzyl mercaptan, 5 (in CDCl3), (d) after 




5.2.3. Acetalization and thio-acetalization of the vinyl ether side chain moieties of 
PMVEC with 4-methylbenzyl alcohol and 4-methylbenzyl mercaptan 
Conjugation between the electron-rich vinyl ether moiety of PMVEC and 
hydroxyl- or thiol-bearing model compounds via formation of acetal or thioacetal linkages 
were demonstrated as postpolymerization modification methods.  First, initial 






spectroscopy.  1H NMR spectra were collected at a desired time while a mixture of 4-
methylbenzyl alcohol, PMVEC, and PTSA in THF-d8 was spinning in the NMR 
spectrometer at 19 °C (Figure 5.5).  Formation of acetal linkages was monitored by 
disappearance of vinyl resonances (a and b) at 6.49 and 4.02 ppm, respectively, of PMVEC 
and appearance of methine proton (d) at 4.83 ppm and methyl protons (g) at 1.33 ppm of 
acetal group as well as benzyl protons (e) at 4.62 and 4.49 ppm of conjugated 4-
methylbenzyl alcohol using 1H NMR spectroscopy (Figure 5.5).  Also, the chemical shift 
of the methylene proton next to the oxygen of vinyl ether group were changed from 3.85 
to 3.75 ppm (from c to f in Figure 5.5).  In addition, consumption of vinyl ether groups, 
calculated by the integral of the vinyl resonances at 6.52 ppm (a in Figure 5.5) at 
corresponding times divided by that of the initial polymer were plotted against reaction 
time, showed first order kinetics.  With an exponential fit, the half-life of the vinyl ether 
moieties was estimated to ca. 70.6 min at these conditions (Figure 5.6).  Because PMVEC, 
other reagents, and solvent were not dried before the acetalization, water impurities could 
cause hydrolysis of vinyl ether and resulting acetal functionalities competing with 
acetalization reaction.  Therefore, consumption of vinyl ether groups was not directly 
correlated to the conversion of acetal linkages.  Considering the competition of 
acetalization and hydrolysis, the reaction time needs to be monitored to control the desired 
amounts of vinyl, acetalized, and hydrolyzed moieties.  In order to prevent further 
hydrolysis, the reaction was quenched by adding an excess triethylamine (TEA) and 
unreacted alcohol compounds, acid catalyst, and TEA were removed by dialysis against 





methylbenzyl alcohol and purification by dialysis.  Precipitations of resulting polymers 
into organic solvents such as methanol or diethyl ether did not ensure the complete 
removal of acid catalyst, which led to insoluble materials after concentration in vacuo.  
Residual PTSA likely catalyzed cross-linking reactions via trans-acetalization, or 
acetalization of remaining vinyl ethers with hydrolyzed hydroxyl groups on polymer 
backbone.92,138  When vinyl ether moieties of the resulting acetalized polymers were fully 
consumed, we did not encounter unexpected insoluble materials even after long-term 





Figure 5.5.  Reaction of PMVEC with 4-methylbenzyl alcohol in the presence of PTSA in THF-d8.  For 







Figure 5.6.  Consumption of vinyl ether groups versus time for the reaction of PMVEC with 4-methylbenzyl 
alcohol. Conditions: [PMVEC50]0 = 3.8 mM, [4-methylbenzyl alcohol]0 = 1.88 M, [PTSA] = 1.18 mM, 19 °C. 
or Conditions: [PMVEC50]0 = 3.8 mM in THF-d8 at 19 °C. [alkene] : [4-methylbenzyl alcohol]0 : [PTSA] = 




The conversions of vinyl ethers to acetals were calculated by chain-end analysis 
using 1H NMR spectroscopy. The conversion of vinyl ethers to acetal linkages after 2 h 
reaction was 51%, with 16% of intact vinyl ethers and 33% of hydroxyl groups from the 
competing hydrolysis reaction of vinyl ethers and resulting acetals (Figure 5.4b).  It is 
noteworthy that all polymers and reagents were not dried for postpolymerization 
modifications and all conjugations were not conducted in an inert atmosphere to 
demonstrate suitability for practical applications.  The acetal conversion percentages (ca. 
51%) of PC-based polymers, 4, were superior to polyphosphoester-based system (ca. 
18%)138 since the more stable PC backbone allows for prolonged reaction time.  
The thio-acetalization with the model thiol compound, 4-methylbenzyl mercaptan, 
was also conducted under the similar conditions to acetalization.  The conversion of vinyl 





of hydroxyl groups, which were obtained via chain-end analysis of 1H NMR spectrum 
(Figure 5.4c).  Comparing the conversion of vinyl ether groups in the two reactions, 
acetalization (ca. 51%) was more efficient than thioacetalization (ca. 36%), which might 
be due to the better nucleophilicity of oxygen than sulfur in the polar aprotic solvent, THF.  
Although we did not optimize the reaction conditions for thio-acetalization, the conversion 
was already higher than polyphosphoester-based system (ca. 8%).138   
5.2.4. Thiol−ene “click” reaction of the vinyl ether side chain moieties of PMVEC with 
3-mercaptopropionic acid 
The thiol-ene “click” reaction was also employed as a postpolymerization 
modification method to functionalize vinyl ether functionalities of PMVEC to form stable 
and robust thioether linkages.  Previous reports have demonstrated that radical-mediated 
thiol-ene reaction conditions are compatible with PC backbones.107,133,139  Conjugation 
between vinyl ether groups on PMVEC and model thiol, 3-mercaptopropionic acid, was 
initiated by UV irradiation (365 nm, 6 W) in the presence of a photoinitiator, 2,2-
dimethoxy-2-phenylacetophenone (DMPA).  Excess amount (10 equiv relative to the 
vinyl ether functionalities) of thiols was applied to avoid radical-mediated cross-linking 
of polymers.  Formation of conjugate 6 was confirmed by monitoring disappearance of 
vinyl resonances (b, f, and g) at 6.40, 4.18, and 4.02 ppm, respectively, of PMVEC (Figure 
5.4a) and appearance of α proton to the carboxylic acid (w) at 2.57 ppm (Figure 5.4d) and 
protons of the thio-ether bonds (u and v) at 2.77 and 2.68 ppm, respectively, (Figure 5.4d) 
using 1H NMR spectroscopy. Also, the signal for the methylene proton resonances of the 





(s) at 3.62 ppm, respectively (Figure 5.4a and d).  The 1H NMR integration indicated that 
conjugation yield was quantitative.   
5.2.5. Synthesis of block copolymers and their postpolymerization modifications 
The di- and tri-block copolymers containing PMVEC block(s) were synthesized to 
show versatility of PMVEC as a segment for various block copolymers.  First, the 
amphiphilic diblock copolymer, α-methoxy poly(ethylene glycol)-block-PMVEC 
(mPEG-b-PMVEC), 7, was synthesized using mPEG-OH 5 kDa (mPEG5K-OH or 
mPEG113-OH) as a macroinitiator and DBU as an organobase catalyst ([mPEG5K-OH] : 
[DBU] : [MVEC] = 1:1:20, [MVEC]0 = 0.5 M in DCM, Scheme 5.2).  After the desired 
time, the polymerization was quenched by adding a DCM solution of benzoic acid and the 
resulting diblock copolymer was isolated by precipitation into diethyl ether.  1H NMR 
spectrum of mPEG-b-PMVEC showed proton resonances of PMVEC (as in Figure 5.4a) 
as well as those of mPEG (Figure 5.7).  Degrees of polymerization (DPn) calculated by 
chain-end analysis by 1H NMR spectroscopy was in agreement with the monomer 
conversion calculated by 1H NMR spectroscopy.  The distinct peak shift on GPC profiles 
of the macroinitiator and block copolymer verified successful chain extension of PMVEC 
block from mPEG5K-OH (Figure 5.8).  The subsequent acetalization of the resulting block 
copolymer with 4-methylbenzyl alcohol afforded the amphiphilic diblock copolymer with 
pendant acetal functionalities.  After quenching the reaction with TEA, dialysis, and 
precipitation, 1H NMR spectrum of isolated polymer was consistent with that of model 






Scheme 5.2.  Synthesis of mPEG-b-PMVEC and its functionalization via acetal formation with a model 













Figure 5.8.  GPC traces (DMF as eluent, 1 mL/min) of macroinitiator (mPEG113-OH), 7 (mPEG113-b-




In addition, hydroxyl-telechelic triblock copolymers were prepared.  One-pot 
sequential ROP of MBC and then MVEC were conducted with DBU as a catalyst and Bn-
MPA as a diol initiator affording triblock copolymer, HO-PMVEC-b-PMBC-b-PMVEC-
OH.  Reversed order of addition of two monomers yielded HO-PMBC-b-PMVEC-b-
PMBC-OH (Scheme 5.3).  Vinyl ether groups on the triblock copolymers were 
functionalized with various thiol compounds via thiol-ene reaction to introduce new 
functionalities.  We intended to incorporate charged thiols, 3-mercaptopropionic acid, 
cysteamine hydrochloride, and L-cysteine hydrochloride monohydrate, through robust 
thioether linkages to achieve differently charged block copolymers (Scheme 5.4 and 
Figure 5.9).   
Synthesis of di- and tri-block copolymers via chain extension experiments 





cyclic monomers for ROP such as cyclic carbonates, lactide, and -caprolactone, etc.  
Also, postpolymerization modifications of resulting block copolymers will further 









Scheme 5.4.  Preparation of functionalized ABA-type block copolymers by thiol-ene reaction of PMVEC25-






Figure 5.9.  1H NMR spectra of PMVEC25-b-PMBC20-b-PMVEC25 and its functionalized polymers; (a) in 







5.2.6. Self-assembly of amphiphilic block copolymers 
The self-assembled polymeric nanostructures were readily prepared by direct 
dissolution of synthesized amphiphilic block copolymers in suitable buffers.  First, self-
assembly behaviors of mPEG-b-PMVEC (7), acetal-functionalized mPEG-b-PMVEC (8), 
and mPEG-b-poly(5-methyl-5-(2-hydroxyethyloxy)carbonyl-1,3-dioxan-2-one 
(PMHEC) were studied by dynamic light scattering (DLS), ζ-potential measurements, 
transmission electron microscopy (TEM) (Figure 5.10).  PMHEC is the hydrolyzed block 
of PMVEC or acetalized PMVEC.  The number-averaged hydrodynamic diameters of the 
micellar nanostructures of 7, 8, and mPEG-b-PMHEC, in buffer solutions measured by 
DLS were 28 ± 7, 16 ± 5, 9 ± 3 nm, respectively, in acetate buffer (pH 5.0), and 28 ± 8 
nm (micelles of 7) and 16 ± 3 nm (micelles of 8) in 1X PBS (pH 7.4), with narrow and 
monomodal size distribution (Figure 5.10a).  The spherical shapes of micelles were 
confirmed by TEM (Figure 5.10b,c).  Hydrodynamic diameters of micelles gradually 
decreased depending on the amount of hydroxyl functionalities, which might be attributed 
to the increased hydrophilicity of core-forming PC blocks by hydrolysis.  Also, critical 
micelle concentration (CMC) of micelles of mPEG-b-PMHEC was higher than those of 7 
and 8, as expected.  Although we did not measure CMCs of amphiphilic block copolymers, 
DLS measurement of micelles of mPEG-b-PMHEC was not feasible under the 
concentration of 5 mg/mL.  On the other hand, hydrodynamic diameters of micelles of 7 
could be measured at the concentration of 0.25 mg/mL.  The PEG corona of resulting 





respectively, in acetate buffer (pH 5.0), and -9.6 ± 2.3 mV (micelles of 7) and -6.6 ± 2.9 





Figure 5.10.  Self-assembly of amphiphilic diblock copolymers.  (a) Number-averaged (Dh (num)) 
hydrodynamic diameters and ζ–potential values of 7 (mPEG113-b-PMVEC11), 8 (the acetal-functionalized 
mPEG113-b-PMVEC11), and mPEG113-b-PMHEC11.  (b, c) Bright field TEM images of the block copolymer, 




5.2.7. Monitoring cleavage of acetal moieties 
The cleavage of acetal functionalities in acidic conditions were monitored using 
1H NMR spectroscopy for quantitative analysis of cleavage kinetics.  During this process, 
the residual vinyl ether functionalities can undergo further acetalization with hydrolyzed 





conditions, which could complicate the analysis.  Therefore, available vinyl ether groups 
were completely consumed during acetal formation of mPEG113-b-PMVEC13 with 4-
methylbenzyl alcohol, even though it could diminish the final acetal contents via 
competing hydrolysis reaction.  Since the acetal-functional mPEG-b-PMVEC self-
assembles into the micelles in aqueous solution and acetal moieties reside in the core of 
micelles, in situ 1H NMR monitoring of acetal protons is challenging.  Instead, an aliquot 
of micellar solution was collected and purified by dialysis against nanopure water to 
remove small molecular impurities before 1H NMR analysis in CD2Cl2 to observe entire 
blocks.  Two samples were prepared in acetate buffers (pH 4 and 5) and kept in 37 °C 
shaker.  As expected, decrease of acetal content was faster in the more acidic solution.  
Half-lives of acetal cleavage were ca. 10 days at pH 4 and ca. 27 days at pH 5, respectively 
(Figure 5.11).  Interestingly, our systems showed slower cleavage rates compared to 
previously-reported systems.  Although we do not have experimental evidence of these 
phenomena, slower degradation might be attributed to formation of more compactly-
aggregated core, which could provide protection against the surrounding acidic 
environment.  The slow cleavage rates will enable more sustained and controlled release 
of polymeric nanostructure-conjugated therapeutics compared to physically-encapsulated 
ones, which could reduce patient side effects caused by premature release of payload as 
well as decrease frequency of dosage for better patient compliance and lower cost of 
treatment.  In addition, after the release of compounds under acidic conditions, remaining 
hydroxyl groups will further enhance hydrophilicity of resulting polymer, which might 






Figure 5.11.  Cleavage of acetal moieties within the micelles of acetal functionalized mPEG113-b-PMVEC11, 




5.3. Experimental Section 
5.3.1. Materials 
Benzyl alcohol and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) were dried over 
CaH2, distilled, and stored under inert atmosphere.  Tetrahydrofuran (THF), N,N-
dimethylformamide (DMF), and dichloromethane (DCM) were purified by passage 
through solvent purification system (JC Meyer Solvent Systems) and used as dried 
solvents.  Benzyl 2,2-bis(hydroxymethyl)propanoate (Bn-MPA) and 5-methyl-5-
benzyloxycarbonyl-1,3-dioxan-2-one (MBC) were synthesized as reported, recrystallized, 
and dried over P2O5 before use.99  All other solvents and chemicals were purchased from 







5.3.2.  Characterization 
1H and 13C NMR spectra were recorded on Varian NMRS 500 spectrometers.  
Chemical shifts were referenced to the solvent resonance signals.  IR spectra were 
recorded on an IR Prestige 21 system (Shimadzu Corp., Japan), equipped with an ATR 
accessory, and analyzed using IRsolution v.1.40 software. Gel permeation 
chromatography (GPC) eluted with THF was conducted on a system equipped with Waters 
Chromatography, Inc. (Milford, MA) model 1515 isocratic pump and a model 2414 
differential refractometer with a three-column set of Polymer Laboratories, Inc. (Amherst, 
MA)  Styragel columns (PLgel 5 μm Mixed C, 500 Å, and 104Å, 300  7.5 mm columns), 
and a guard column (PLgel 5 μm, 50  7.5 mm).  The system was equilibrated at 40 °C in 
THF, which served as the polymer solvent and eluent (flow rate set to 1.00 mL/min).  The 
differential refractometer was calibrated with Polymer Laboratories, Inc., polystyrene 
standards (300–467,000 Da).  Polymer solutions were prepared at a concentration of ca. 3 
mg/mL with 0.05% vol toluene as flow rate marker and an injection volume of 200 μL 
was used.  Data were analyzed using Empower Pro software from Waters 
Chromatography, Inc.  Glass transition temperatures (Tg) were measured by differential 
scanning calorimetry (DSC) on a Mettler-Toledo DSC822 (Mettler-Toledo, Inc., 
Columbus, OH) under N2.  Measurements of Tg were taken with a heating rate of 
10 °C/min.  The measurements were analyzed using Mettler-Toledo STARe v.10.00 
software.  The Tg was taken as the midpoint of the inflection tangent and Tm was taken as 
the onset point, upon the third scan.  Thermogravimetric analysis (TGA) was performed 





10 °C/min.  Dynamic light scattering (DLS) measurements were conducted using 
DelsaNano C (Beckman Coulter, Inc., Fullerton, CA) equipped with a laser diode 
operating at 658 nm.  Size measurements were made in nanopure water (n = 1.3329, η = 
0.890 cP at 25 ± 1 °C).  Scattered light was detected at 165° angle and analyzed using a 
log correlator over 70 accumulations for a 3.0 mL sample in a glass sizing cell (4.0 mL 
capacity).  The samples in a glass sizing cell were equilibrated for 30 min before 
measurements were made.  The photomultiplier aperture and the attenuator were 
automatically adjusted to obtain a photon counting rate of ca. 10 kcps.  The calculations 
of the particle size distributions and distribution averages were performed using CONTIN 
particle size distribution analysis routines.  The ζ-potential of the particles in suspension 
was obtained by measuring the electrophoretic movement of charged particles under an 
applied electric field.  Scattered light was detected at a 30° angle at 25 °C.  The ζ-potential 
was measured at five regions in the flow cell and a weighted mean was calculated.  These 
five measurements were used to correct for electroosmotic flow that was induced in the 
cell due to the surface charge of the cell wall.  Transmission electron microscopy (TEM) 
images were collected on a JEOL 1200EX operating at 100 kV and micrographs were 
recorded at calibrated magnifications using a SIA-15C CCD camera.  The samples as 
aqueous solutions (4 µL) were deposited onto formvar/carbon-coated copper grids.  
Excess sample was wicked off using filter paper and the grids were allowed to air-dry for 
2 min.  Following that, the grids were stained with 4 µL of a 1% phosphotungstic acid 
aqueous solution.  Excess stain was wicked off using filter paper after 1 min.  The sample 





5.3.3. Synthesis of (2-vinyloxy)ethyl 2,2-bis(hydroxymethyl)propanoate (1) 
A mixture of 2,2-bis(hydroxymethyl)propionic acid (5.0 g, 37 mmol), potassium 
hydroxide (90% assay; 2.6 g, 46 mmol), sodium iodide (1.1g, 7.3 mmol), and DMF (40 
mL) was heated to 100 °C for 1 h at which point a homogenous solution was formed.  2-
Chloroethyl vinyl ether (3.8 mL, 37 mmol) was added to the warm solution, and stirring 
was continued at 100°C for 20 h.  The reaction was cooled and the solvent was removed 
under vacuum.  The residue was extracted with DCM and water twice and the organic 
layer was dried over MgSO4 and evaporated.  The concentrate was further purified by 
column chromatography with ethyl acetate and hexane (1:4) as an eluent to yield yellow 
liquid (5.90 g, 78%).  1H NMR (500 MHz, CDCl3): δ 6.47–6.42 (dd, J = 6.8 and 14.4 Hz, 
–OCHCH2), 4.40–4.37 (m, –C(O)OCH2CH2O–), 4.23–4.18 (dd, J = 2.3 and 14.2 
Hz, -OCHCHH’), 4.06–4.03 (dd, J = 2.3 and 6.8 Hz, –OCHCHH’), 3.92–3.89 (m, –
C(O)OCH2CH2O–), 3.88–3.84 (m, –CH2OH), 3.72–3.68 (m, –CH2OH), 3.01 (t, J = 6.6 
Hz, –CH2OH), 1.08 (s, –C(CH3)(CH2OH)2).  13C NMR (125 MHz, CDCl3): δ 175.8, 
151.5, 87.6, 67.9, 65.8, 63.2, 49.6, 17.3.  ESI MS (m/z): 211.1169 (experimental), 
211.1158 (calculated for C9H16O5Li+). 
5.3.4. Synthesis of 5-methyl-5-((2-vinyloxy)ethyl)oxycarbonyl-1,3-dioxan-2-one 
(MVEC) (2) 
(2-vinyloxy)ethyl 2,2-bis(hydroxylmethyl)propionate (4.2 g, 21 mmol) and ethyl 
chloroformate (6.0 mL, 63 mmol) were dissolved in THF (80 mL), and the solution was 
stirred at 0 °C for 30 min under N2.  Subsequently, triethylamine (TEA, 8.5 mL, 61 mmol) 





bath and stirred at room temperature overnight.  TEA·HCl precipitate was filtered and the 
filtrate was concentrated and purified by column chromatography with ethyl acetate and 
hexane (1:4) as an eluent to yield white solid (2.90 g, 62%).  1H NMR (500 MHz, CDCl3): 
δ 6.44−6.38 (dd, J = 6.7 and 14.4 Hz, −OCHCH2), 4.67 (d, J = 10.8 Hz, 
−OCH2C(CH3)(CH2−)−), 4.41−4.38 (m, −C(O)OCH2CH2O−), 4.21−4.15 (m, 
−OCH2C(CH3)(CH2−)− and −OCHCHH’), 4.04−4.01 (dd, J = 2.3 and 6.7 Hz, 
−OCHCHH’), 3.89−3.86 (m, −C(O)OCH2CH2O−), 1.30 (s, −C(CH3)(CH2−)(CH2−)).  13C 
NMR (125 MHz, CDCl3): δ 171.2, 151.4, 147.6, 87.5, 73.0, 65.4, 64.2, 40.3, 17.5.  ESI 
MS (m/z): 237.0949 (experimental), 237.0950 (calculated for C10H14O6Li+). 
5.3.5. Organocatalytic ROP of MVEC (3) 
In a glovebox, MVEC and Bn-MPA initiator were dissolved in dry DCM 
([MVEC]0 = 0.7 M).  DBU (1 equiv to initiator) was added to the monomer/initiator 
solution.  After the desired time, the polymerization was quenched by addition of a DCM 
solution of benzoic acid and precipitated into methanol.  For example, MVEC (365 mg, 
1.6 mmol), Bn-MPA (5.9 mg, 26 µmol), DBU (7.9 µL, 53 µmol), DCM (2.5 mL), benzoic 
acid solution (9.7 mg, 80 µmol in 300 µL DCM) were used to yield PMVEC50.  PMVEC50.  
Yield = 185 mg, 65% based upon monomer conversion (80%).  Mn,NMR = 11700 g/mol; 
Mn,GPCTHF = 11600 g/mol; PDI = 1.06.  1H NMR (500 MHz, CDCl3): δ 7.40−7.29 (m, 
−OCH2C6H5), 6.48−6.38 (m, −OCHCH2), 5.13 (br, −C(O)OCH2C6H5), 4.39−4.32 (m, 
−C(O)OCH2CH2O−), 4.32−4.21 (br, −OC(O)OCH2−), 4.22−4.14 (m, −OCHCHH’), 
4.05−4.00 (m, −OCHCHH’), 3.91−3.83 (m, −C(O)OCH2CH2O−), 3.74−3.66 (m, 





−C(CH3)(CH2−)(CH2OH)).  13C NMR (125 MHz, CDCl3): δ 174.0, 172.2, 155.0, 154.5, 
151.6, 135.6, 128.8, 128.6, 128.2, 87.4, 68.7, 65.7, 63.7, 63.3, 48.6, 46.7, 17.6.  IR (neat, 
cm-1): 2965, 1740, 1620, 1460, 1385, 1234, 1200, 1145, 964, 825, 783, 733.  Tg = -9.0 °C.  
TGA in Ar: 270−450 °C, 92% mass loss; 8% mass remaining above 500 °C. 
5.3.6. Acetalization of the vinyl ether side chain moieties of PMVEC with 4-methylbenzyl 
alcohol (4) 
To the solution of PMVEC70 (54 mg, 0.23 mmol for alkene functionalities) and 4-
methylbenzyl alcohol (290 mg, 2.4 mmol) in 0.5 mL THF, p-toluenesulfonic acid (PTSA, 
0.40 mg, 2.3 µmol) in 0.5 mL THF was added at 0 °C.  After stirring for 2 h at room 
temperature, excess amount of TEA was added to quench the reaction.  The reaction 
mixture was purified by dialysis against THF for 24 h and dried in vacuo to yield colorless 
sticky liquid.  Yield = 54 mg, 76%.  Mn,NMR = 19700 g/mol.  1H NMR (500 MHz, CD2Cl2): 
δ 7.34−7.30 (br, −OCH2C6H5), 7.24−7.10 (m, −OCH2C6H4CH2), 6.48−6.38 (m, 
−OCHCH2), 5.13 (br, −C(O)OCH2C6H5), 4.80 (m, −OCH(CH3)O−), 4.57 (d, J = 11.5 Hz, 
−OCHH’C6H4CH3), 4.43 (d, J = 11.5 Hz, −OCHH’C6H4CH3), 4.39−4.12 (br, 
−OC(O)OCH2−, −C(O)OCH2CH2O−, and −OCHCHH’), 4.01 (m, −OCHCHH’), 
3.89−3.82 (br, −C(O)OCH2CH2OCHCH2), 3.80−3.69 (br, 
−C(O)OCH2CH2OCH(CH3)O−), 3.69−3.59 (br, −C(O)OCH2CH2OH), 3.40 (s, 
−CH2OH), 2.31 (s, −OCH2C6H4CH3, para), 1.30 (d, J = 5.1 Hz, 
−C(O)OCH2CH2OCH(CH3)O−), 1.28−1.20 (s, −C(CH3)(CH2−)2), 1.17 (s, 
−C(CH3)(CH2−)(CH2OH)).  13C NMR (125 MHz, CD2Cl2): δ 172.4, 154.8, 151.9, 137.7, 





17.6.  IR (neat, cm-1): 3700–3300, 3100–2800, 1744, 1458, 1381, 1234, 1134, 1096, 964, 
795.  Tg = -20.5 °C.  TGA in Ar: 90−240 °C, 21% mass loss; 240−390 °C, 68% mass loss; 
11% mass remaining above 500 °C. 
5.3.7. Kinetic study of acetalization of the vinyl ether side chain moieties of PMVEC 
PMVEC50 (52 mg, 0.23 mmol of vinyl ether moieties) and 4-methylbenzyl alcohol 
(280 mg, 2.3 mmol) were dissolved in 1 mL THF-d8.  After addition of PTSA solution 
(380 µg, 2.3 µmol) in THF-d8 (200 µL), the solution was transferred to a NMR tube and 
the reaction was monitored via 1H NMR while spinning in the spectrometer (19 °C).  Half-
life time for this condition was 70.6 min. 
5.3.8. Thio-acetalization of the vinyl ether side chain moieties of PMVEC with 4-
methylbenzyl mercaptan (5) 
To the solution of PMVEC70 (78 mg, 0.34 mmol for alkene functionalities) and 4-
methylbenzyl mercaptan (0.46 mL, 3.4 mmol) in 1.0 mL THF, PTSA (0.58 mg, 3.4 µmol) 
in 0.50 mL THF was added at 0 °C.  After stirring for 2 h at room temperature, an excess 
amount of TEA was added to quench the reaction.  The reaction mixture was precipitated 
into methanol and collected by centrifugation followed by drying in vacuo to yield 
colorless sticky liquid.  Yield = 61 mg, 67%.  Mn,NMR = 18900 g/mol.  
1H NMR (500 MHz, 
CDCl3): δ 7.37−7.28 (br, −OCH2C6H5), 7.22−7.07 (m, −OCH2C6H4CH2), 6.46−6.39 (m, 
−OCHCH2), 5.15 (br, −C(O)OCH2C6H5), 4.79−4.64 (m, −OCH(CH3)S−), 4.42−4.12 (m, 
−OC(O)OCH2−, −C(O)OCH2CH2O−, and −OCHCHH’), 4.02 (br, −OCHCHH’), 
3.89−3.83 (br, −C(O)OCH2CH2OCHCH2), 3.80−3.73 (br, 





−C(O)OCH2CH2OH), 2.31 (s, −SCH2C6H4CH3, para), 1.49 (br, 
−C(O)OCH2CH2OCH(CH3)S−), 1.30−1.20 (s, −C(CH3)(CH2−)2).  
13C NMR (125 MHz, 
CDCl3): δ 172.1, 154.5, 151.6, 136.7, 135.5, 129.5, 129.3, 128.9, 128.0, 99.7, 87.3, 80.8, 
68.7, 65.7, 64.3, 63.7, 63.6, 62.6, 46.7, 32.4, 29.8, 21.9, 21.2, 19.5, 17.6.  IR (neat, cm-1): 
3700–3300, 3100–2800, 2361, 1744, 1458, 1381, 1234, 1142, 1103, 972, 918, 864, 787, 
733, 648.  Tg = 7.3 °C.  TGA in Ar: 205−410 °C, 95% mass loss; 4% mass remaining 
above 500 °C. 
5.3.9. Thiol-ene “click” reaction of the vinyl ether side chain moieties of PMVEC with 
3-mercaptopropionic acid (6) 
PMVEC70 (50 mg, 217 µmol for alkene functionalities), 2,2-dimethoxy-2-
phenylacetophenone (DMPA, 11 mg, 43 µmol), and 3-mercaptopropionic acid (190 µL, 
2.2 mmol) were dissolved in 5 mL DMF.  The solution were bubbled with N2 for 10 min 
and irradiated by UV (365 nm, 6 W) for 2 h.  The reaction mixture was precipitated into 
ether/pentane (1/4) and dried in vacuo to yield colorless sticky liquid.  Yield = 46 mg, 
63% based on 100% conversion.  Mn,NMR = 23800 g/mol.  
1H NMR (500 MHz, 
CD2Cl2/MeOD): δ 7.36-7.27 (m, −OCH2C6H5), 5.13 (br, −C(O)OCH2C6H5), 4.32−4.25 
(br, −OC(O)OCH2−), 4.25−4.21 (m, −C(O)OCH2CH2O−), 3.65−3.59 (m, 
−C(O)OCH2CH2O− and −OCH2CH2S−), 2.77 (t, J = 7.3 Hz, −SCH2CH2C(O)OH), 2.68 
(t, J = 6.6 Hz, −OCH2CH2S−), 2.57 (t, J = 7.3 Hz, −SCH2CH2C(O)OH), 1.23 (s, 
−C(CH3)(CH2−)2).  
13C NMR (125 MHz, CD2Cl2/MeOD): δ 174.8, 172.8, 155.0, 71.4, 





1389, 1234, 1119, 964, 787, 710, 633.  Tg = -14.8 °C.  TGA in Ar: 220−395 °C, 82% mass 
loss; 18% mass remaining above 500 °C. 
5.3.10. Synthesis of mPEG113-b-PMVEC13 (7) 
MVEC (276 mg, 1.2 mmol) and mPEG (5 kDa, 0.30 mg, 60 µmol) were dissolved 
in DCM (2.4 mL, [MVEC] = 0.5 M).  DBU (9.0 µL, 60 µmol) was added to initiate the 
polymerization.  After 30 min, the polymerizations were quenched by addition of a DCM 
solution of benzoic acid, precipitated into diethyl ether, and collected by centrifugation 
followed by drying in vacuo to yield white powder.  Yield = 487 mg, >98%.  Mn,NMR = 
8000 g/mol.  Mn,GPC = 10500 g/mol.  PDI = 1.06.  
1H NMR (500 MHz, CDCl3): δ 6.46-
6.37 (m, −OCHCH2), 4.36−4.31 (m, −C(O)OCH2CH2O−), 4.31−4.22 (br, 
−OC(O)OCH2−), 4.21−4.13 (m, −OCHCHH’), 4.04−3.99 (m, −OCHCHH’), 3.89−3.83 
(m, −C(O)OCH2CH2O−), 3.62 (s, −OCH2CH2O− for PEG), 3.35 (s, −OCH3), 1.24 (s, 
−C(CH3)(CH2−)2), 1.19 (s, −C(CH3)(CH2−)(CH2OH)).  
13C NMR (125 MHz, CDCl3): δ 
172.04, 154.4, 151.5, 87.3, 71.3, 70.6, 70.0, 69.0, 68.6, 68.3, 65.6, 63.5, 46.6, 17.5. .  IR 
(neat, cm-1): 3050–2700, 1751, 1628, 1466, 1342, 1273, 1242, 1103, 957, 841.  Tg = -20.4 
°C; Tm = 44.5 °C.  TGA in Ar: 190−350 °C, 33% mass loss; 350−430 °C, 62% mass loss; 
5% mass remaining above 500 °C. 
5.3.11. Acetalization of the vinyl ether side chain moieties of mPEG-b-PMVEC with 4-
methylbenzyl alcohol (8) 
To the solution of mPEG113-b-PMVEC13 (0.30 g, 0.49 mmol for alkene 
functionalities) and 4-methylbenzyl alcohol (0.60 g, 4.9 mmol) in 1.0 mL THF, PTSA (1.7 





room temperature, an excess amount of trimethylamine was added to quench the reaction.  
The reaction mixture was precipitate into diethyl ether twice and dried in vacuo to yield 
white powder.  Yield = 296 mg, 93%.  Mn,NMR = 8400 g/mol.  
1H NMR (500 MHz, 
CD2Cl2): δ 7.22−7.09 (m, −OCH2C6H4CH2), 6.46-6.37 (m, −OCHCH2), 4.85−4.76 (m, 
−OCH(CH3)O−), 4.87 (d, J = 11.5 Hz, −OCHH’C6H4CH3), and 4.44 (d, J = 11.5 Hz, 
−OCHH’C6H4CH3), 4.39−4.17 (br, −OC(O)OCH2−, −C(O)OCH2CH2O−), 3.80−3.50 (m, 
−C(O)OCH2CH2O− and −OCH2CH2O− for PEG), 2.31 (s, −OCH2C6H4CH3, para), 1.32 
(d, J = 5.1 Hz, −C(O)OCH2CH2OCH(CH3)O−), 1.25 (s, −C(CH3)(CH2−)2), 1.19 (s, 
−C(CH3)(CH2−)(CH2OH)).  
13C NMR (125 MHz, CD2Cl2): δ 172.4, 154.5, 135.0, 129.1, 
127.7, 99.2, 71.3, 70.6, 69.9, 60.6, 46.7, 19.6, 17.5.  IR (neat, cm-1): 3700–3200, 2882, 
1749, 1466, 1387, 1343, 1277, 1238, 1144, 1103, 1061, 961, 841, 787, 444, 420, 409.  Tg 
= -9.6 °C; Tm = 45.1 °C. 
5.3.12. Self-assembly of functionalized diblock copolymers 
The functionalized diblock copolymers were suspended into nanopure water (5 
mg/mL) and sonicated for 10 min. 
5.3.13. Monitoring cleavage of acetal moieties of 8 
Cleavage of acetal moieties of 8 was monitored by 1H NMR spectroscopy. 8 (100 
mg) was dissolved in 20 mL of acetate buffers (pH 4 and pH 5, final concentrations = 5 
mg/mL).  After incubation of polymer solutions at 37 °C for desired times, an aliquot (2 
mL) of the solution was collected, dialyzed against nanopure water for 1 day, and 
lyophilized.  The resulting polymer powder was dissolved in CDCl3 and 
1H NMR 






A highly-reactive vinyl ether-functionalized aliphatic polycarbonate and its block 
copolymers were developed as a template for multiple post-polymerization conjugation 
chemistries.  The vinyl ether-functional six-membered cyclic carbonate monomer was 
synthesized by a well-established two-step procedure starting from 2,2-
bis(hydroxymethyl)propanoate (bis-MPA).  An organobase-catalyzed ring-opening 
polymerization of the synthesized monomer afforded polycarbonates with the pendant 
vinyl-ether functionalities (PMVEC).  The vinyl ether moieties on the resulting polymers 
were readily conjugated with hydroxyl- or thiol-containing compounds via three different 
post-polymerization modification chemistries — acetalization, thio-acetalization, and 
thiol-ene reaction.  Acetal-functionalized polycarbonates were studied in depth to exploit 
their acid-labile acetal functionality.  The amphiphilic block copolymer of poly(ethylene 
glycol) and PMVEC was functionalized with the model hydroxyl compound and its self-
assembled nanostructure was characterized.  Kinetics of acetal cleavage within the block 
copolymer micelles were examined in acidic buffer solutions (pH 4 and 5) and showed 
relatively slower rates compared to the previous reports.  The results suggested that this 







DETECTION OF AN INTERMEDIATE IN RING-OPENING POLYMERIZATION 
OF L-LACTIDE USING HYPERPOLARIZED NMR 
 
6.1. Introduction 
Hyperpolarization of nuclear spins by dissolution dynamic nuclear polarization 
(D-DNP) has been recognized for its potential to study non-equilibrium chemical 
processes in solution.  Several thousand-folds of signal enhancement provided by D-DNP 
allows for monitoring diverse reactions in real-time that occur on the NMR time scale, 
such as protein-ligand interactions,142-147 enzymatic reaction,148,149 protein folding,50 and 
fast organic reactions,150-152 without need for signal averaging or isotope-labeling.  
This emerging technique can also offer benefits in the field of polymer chemistry, 
including understanding polymerization mechanisms and studying reaction kinetics, 
etc.153,154  Recently, olefin polymerization catalyzed by zirconium-based metallocenes has 
been studied by DNP-NMR to determine tacticity and deactivation mechanisms.154  In 
another study, it has been demonstrated that 13C DNP-NMR measurements of “living” 
anionic polymerization of styrene enables not only observation of the resonances 
associated with anionic chain-end, but also attainment of information on polymerization 
kinetics.153  The previous works supported our hypothesis that “living” characteristics of 
controlled polymerizations allow D-DNP NMR measurements to detect active chain-ends 
or intermediate structures due to their constant concentration during polymerization 





such as reaction intermediates, D-DNP NMR provides significant insight into reaction 
mechanism.  As a follow-up study, we extended the application of D-DNP NMR into the 
mechanism study of a less-studied polymerization system organocatalytic ring-opening 
polymerization (ROP) of L-lactide using 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD). 
Polylactide (PLA) is an aliphatic polyester, which can be degraded into low 
molecular weight oligomers or lactic acid by microorganisms or hydrolysis.  Due to its 
biodegradability and biocompatibility, PLAs have been a valuable substitute for 
petroleum-based products such as polyethylene, polystyrene, etc.155,156  Traditionally, 
PLAs have been synthesized by ROPs using metal catalysts.157  However, metal catalysts 
are not ideal for electronic and medical applications due to the detrimental effects of 
residual metals.  Therefore, organocatalyzed ROPs have been actively investigated.  
Among various organocatalysts, we are especially interested in 1,5,7-
triazabicyclo[4.4.0]dec-5-ene (TBD) due to its high catalytic activity.158  Its ability to 
catalyze both acyl transfer and carbonyl activation by hydrogen bonding enables dual 
activation of monomers, which has been believed to be attributed to its superior catalytic 
efficiency.  Theoretical and experimental studies proposed two possible mechanisms 
(Scheme 6.1): a nucleophilic catalytic mechanism and an acid-base catalytic mechanism 
(hydrogen bonding mechanism).  Computational studies indicated that the hydrogen 
bonding mechanism is energetically favorable,159,160 while experimental studies suggested 
the presence of the nucleophilic catalytic mechanism based on the model systems.158  
Here, we report the observation of intermediate resonance of ROP by hyperpolarized 










6.2. Results and Discussion 
Before the hyperpolarized NMR experiments, the test polymerization was 
performed to check the feasibility of the mechanism study using D-DNP NMR 
spectroscopy.  ROP of L-lactide under similar conditions with DNP experiments yielded 
poly(L-lactide) (Scheme 6.2), which was confirmed by THF gel permeation 
chromatography (GPC) (Figure 6.1) and NMR spectroscopy (Figure 6.2).  Also, spin-
relaxation time of the ester carbon in L-lactide was sufficiently long for monitoring the 
reaction process before the carbon nuclei lost their hyperpolarization significantly (Figure 











Figure 6.1.  GPC trace of PLLA prepared from the test polymerization. 
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Figure 6.2.  13C NMR spectra of L-lactide (black) and PLLA (blue) synthesized from test polymerization. 
Figure 6.3.  Spin-lattice relaxation of the hyperpolarized ester carbon of L-lactide dissolved in toluene.  A 
5 degree pulse was applied to acquire each data point and the time interval between the subsequent scans 
was 2 s.  The small-flip angle effect was considered to determine the spin-lattice relaxation time (T1) from 
the apparent T1 as discussed in the reference.151  The single exponential fit results in T1 = 50 s of the lactide 
ester carbon.   
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The ROP of L-lactide catalyzed by TBD was monitored by 13C NMR spectroscopy 
using the D-DNP technique in real-time.  The broader range of chemical shifts in 13C NMR 
spectrum allows for clearer observations of desired signals with minimal overlap of 
resonances.  The hyperpolarized L-lactide in the solid state was rapidly transferred into the 
NMR spectrometer after dissolution in toluene, which initiates the polymerization in the 
presence of TBD as an organocatalyst and benzyl alcohol as an initiator in the NMR tube, 
generating site-specifically hyperpolarized products, i.e., carbon resonances derived from 
hyperpolarized lactide only have signal enhancement.  For DNP experiments, the optimal 
reaction conditions were found to be the ratio of 10:1:1 ([L-lactide]:[TBD]:[benzyl 
alcohol]), where the reaction rate was compromised to monitor the polymerization process 
before the substantial loss of polarization.  Figure 6.4 shows the time-resolved DNP-NMR 
13C spectra obtained from a single polymerization reaction by a series of small-flip-angle 
pulse excitation.  The consumption of monomer, L-lactide, and the formation of polymer, 
poly(L-lactide), were observed as a signal decrease at ca. 167 ppm (corresponding to the 
ester carbon of the monomer, C1) and, a signal increase at ca. 170 ppm (corresponding to 
the ester carbon of the polymer, C2), respectively.  Both resonances eventually decayed 
by the spin-lattice relaxation.  Interestingly, small signals were additionally observed near 
175 ppm (C3), which did not appear in the reference spectra of L-lactide and poly(L-
lactide).  The earlier appearance of these signals compared to the product signal presents 
a possibility that the additional peaks might be related to reaction intermediates.  In 
addition, when considering the concomitant spin relaxation and short life-time of the 
intermediates, relatively constant intensity of resonances around 175 ppm supports the 
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above hypothesis reflecting “living” characteristics of ROP.  Based on the predicted 
chemical shifts of the proposed intermediates from both mechanisms, we hypothesized 
that the small peaks near 175 ppm could be a resonance of the polymerization 
intermediate. 
Figure 6.4.  Regions of ester carbons from a series of 13C NMR spectra recorded during the course of the 
ROP of L-lactide catalyzed by TBD.  The spectra were acquired by a series of small flip angle pulses with 
the time resolution of 400 ms. (C1: ester carbon of L-lactide, C2: ester carbon of poly(L-lactide), C3: 
additionally observed signals) 
Intermediates in the nucleophilic catalytic mechanism possess an amide carbon.  
In order to identify the rough 13C chemical shift of amide carbon derived from TBD, N-
Acetyl TBD was synthesized as a model intermediate compound, which was confirmed 
by NMR spectroscopy and ESI-MS.  Vinyl acetate can be used for acetylation of TBD 
since it was used to verify acyl transfer reaction via TBD as a bifunctional catalyst in the 
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previous report.158  When one amino group of TBD reacts with vinyl acetate, however, the 
adjacent tertiary amino group will act as a base catalyst, which could make it too unstable 
to characterize.  Therefore, we applied acetyl chloride as an acetylating agent since 
hydrogen chloride byproduct can deactivate the adjacent basic amino group by protonation 
after acetylation (Scheme 6.3).  The resulting compound was stable enough to be detected 
by ESI-MS.  The 13C chemical shift of amide carbon in N-acetyl TBD·HCl salt was ca. 
170.5 ppm in CDCl3, which supports the possibility that the observed peaks could have 
originated from an amide carbon formed during ring-opening of lactide by TBD.  However, 
insolubility of N-acetyl TBD·HCl salt in toluene prevents attainment of the exact chemical 
shift of amide carbon in the solvent we used for dissolution, after which we decided not 
to synthesize more similar model compounds.  However, it is worth mentioning that 13C 
chemical shifts of intermediates in the hydrogen bonding mechanism might appear at 
similar chemical shifts since the ester carbon resonance of lactide could be shifted 
downfield by hydrogen bonding with TBD. 





To identify the origins of the hyperpolarized signals observed aside from that of 
monomer, several 13C temporal correlation experiments were performed.  First, a direct 
temporal correlation between monomer and polymer was established with encoding of the 
spins by a frequency selective-inversion pulse (IBURP2) applied at the resonance of L-
lactide ester carbon, ca. 167 ppm.  The polymer signal produced from the non-inverted 
monomer was removed by employing selective-saturation pulses (EBURP2) before 
acquiring a series of 13C NMR spectra.  The obtained spectra clearly showed the transfer 
of the inverted monomer spins to the signals of the polymer ester carbons at ca. 170 ppm, 
represented by red colored signals (Figure 6.5).  Additionally, the signal at ca. 175 ppm 
appears inverted, indicating that it originates from the ester carbon of monomer.  The 
downfield shift of the peak from the resonance of lactide ester carbon along with the 13C 
chemical shift of amide functionality of the model compound suggested that the inverted 
peak observed could be derived from either amide or ester functionalities of specific 






Figure 6.5.  Time-resolved DNP-NMR 13C spectra of the ROP of L-lactide catalyzed by TBD.  The blue 
and red colored signals represent a positive and a negative signal, respectively.  Top: a full-width spectrum, 




From the previous experiment, the correlations between the monomer and 
polymer, and the monomer and the additional peak at ca. 175 ppm, were found.  In order 
to confirm the flow of NMR spins from the additional peak to the polymer, homonuclear 
selective saturation experiments were designed.  In this experiment, a homonuclear 
decoupling (HD) pulse scheme was used to selectively saturate a spin of interest during 
the entire measurement.  The HD pulse scheme is originally devised for a quick 
identification of correlated protons of a molecule in a 1D 1H NMR experiment, which has 
been largely replaced by the 2D COSY experiment.  Here, we demonstrate the 13C 
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temporal correlation experiment using the HD pulse for a frequency-selective saturation 
during the NMR measurement.  By the irradiation of HD pulse on the frequency of 
potential intermediate species, the polymer signal was expected to be reduced since the 
hyperpolarization that was transferred from the monomer to the intermediate would be 
lost upon the selective-saturation.  The pulse scheme contains a continuous wave that was 
applied before the measurement started to eliminate any polymer signal that was produced 
during the stabilization time after the sample injection, as described in Figure 6.6a.  In the 
experiment, a time-resolved 13C DNP NMR spectra were obtained while the HD pulse was 
irradiated to the frequency of potential intermediate, ca. 175 ppm, which is 8.64 ppm away 
from the monomer ester carbon signal.  For comparison, the off-resonance experiment was 
conducted where the HD pulse was irradiated to the frequency that was the same offset 
away from the monomer to the upfield.  In this experiment, 10% HD duty cycle was 
chosen for an effective saturation without a large signal loss due to the reduced detection 
time.  The peaks of ester carbons from both polymer and monomer are integrated and the 
averaged results from five independent data sets are plotted in Figure 6.6b.  In data 
processing, a signal from THF, a component of glassy matrix used to prepare the sample 
for DNP experiments, was used for calibrating the signal enhancement by DNP in different 
measurements, and the maximum integral value of the monomer ester carbon was used to 
normalize all the other peaks.  The signal of polymer ester carbon was noticeably reduced 
by 42% when the HD pulse was applied on resonance, while that of monomer ester carbon 
showed similar signal decays in the on and off resonance experiments (Figure 6.6b).  This 





the reaction intermediate.  In addition, similar results were obtained using EBURP2 pulses 
instead of the HD pulse as shown in Figure 6.7.  Furthermore, we designed a simple pulse 
sequence that contains EBURP2 pulses to eliminate the resonance near 175 ppm only 
during the first two scans.  Reappearance of the signal at ca. 175 ppm from the third scan 






Figure 6.6.  (a) Pulse sequence used for the homonuclear selective saturation experiment.  The polarized 
monomer was transferred from the polarizer to the home-built sample injector for a transfer time (tt).  A 
continuous wave (CW) was irradiated to the frequency at 175 ppm during an injection time (ti) of 360 ms 
and a stabilization time (ts) of 400 ms to saturate the intermediate peak that was generated before the NMR 
measurement.  A series of 15° pulse (αk) were applied to acquire the time-resolved 13C NMR spectra while 
the HD pulse was irradiated to the desired frequency.  (b) Time evolution of signal integrals of the C2 (left) 
and C1 (right) from hyperpolarized 13C NMR measurements.  The error bars indicate 90 % confidence 
intervals. 
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Figure 6.7.  The temporal correlation of the intermediate and poly L-lactide was observed using a 13C DNP-
NMR selective-saturation experiment. The hyperpolarized monomer was transferred from the polarizer to 
the home-built sample injector for a transfer time (tt).  The sample was injected into a 5 mm NMR tube, 
which was preinstalled in a 400 MHz NMR spectrometer, after dissolution with 4 mL of preheated toluene.  
Benzyl alcohol and TBD were preloaded in the NMR tube in the ratio of 7:1:1 ([L-lactide]:[TBD]:[benzyl 
alcohol]) for the final sample conditions.  The NMR experiment was triggered after an injection time (ti) of 
400 ms and a stabilization time (ts) of 400 ms.  The resonance of ester carbon in the polymer was selectively 
saturated by EBURP2 shaped π/2 pulse applied for a duration of 20 ms in the beginning and it was repeated 
three times, followed by a randomized pulsed field gradient Gx,y,z to remove polymer signal produced before 
the intermediate saturation.  Then, the EBURP2 shaped π/2 pulses with a duration of 20 ms were used four 
times to saturate the resonance of intermediate before the small flip angle pulse of 15.9° for the signal 
detection.  In a control experiment, the EBURP2 pulses were turned off.  A total of 64 transients were 
acquired for XX s, and the time between each transient was 0.34 s.  Time evolution of signal integrals of the 
C2 (left) and C1 (right) from hyperpolarized 13C NMR measurements. 
Figure 6.8.  Regeneration of 13C signal at ca. 175 ppm after removing a selective saturation pulse EBURP2, 
applied to the intermediate frequency (ca. 175 ppm) was observed.  The time-resolved spectra were acquired 
using a pulse sequence, (trigger‒ [(shaped π/2) ‒ Gx,y,z  ‒ αx ‒ acquire FID]2‒ [αx ‒ acquire FID ‒ Gx,y,z]62). 
The duration of EBURP2 shaped π/2 pulse was 20 ms and the flip angle α of the excitation pulse was 15.9° 
with the pulse strength of γB1 = 29.4 kHz applied. A randomized Gx,y,z pulsed field gradients (35.5 /cm, 1 
ms) were used after each scan.  16384 data points were acquired for each scan with the time interval between 
each transient of 400 ms.  
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6.3. Experimental Section 
6.3.1. Materials 
Benzyl alcohol was distilled from calcium hydride and stored over 4 Å molecular 
sieves.  TBD (1,5,7-triazabicyclo[4.4.0]dec-5-ene) was used as received from TCI 
America.  L-lactide (LLA, 98%, Alfa Aesar) was recrystallized twice from ethyl 
acetate/hexanes, dried by azeotropic distillation in dry toluene twice, dried over 4 Å 
molecular sieves in dry DCM twice, concentrated in vacuo, and stored under inert 
atmosphere prior to use.  Tetrahydrofuran (THF), toluene, and dichloromethane (DCM) 
were purified by passage through solvent purification system (JC Meyer Solvent Systems) 
and used as dried solvents.  α,γ-bisdiphenylene-β-phenylallyl (BDPA) was obtained from 
Sigma Aldrich, St. Louis, MO and used as received. 
6.3.2.  NMR spectroscopy 
All hyperpolarized NMR experiments were carried out using a broadband observe 
(BBO) probe on a 400 MHz NMR spectrometer (Bruker Biospin, Billerica) equipped with 
three pulsed field gradients at a temperature of 298 K.  For the experiment shown in Figure 
1, the spectra were acquired using a pulse sequence, (trigger ‒ [Gz ‒ αx ‒ acquire FID]x64). 
The resulting data set consists of 64 transients and 18432 data points were acquired for 
each scan with the time resolution of 0.4 s.  Prior to every scan, a randomized pulsed field 
gradient Gz (35.5 G/cm, 1 ms) was applied to remove unwanted coherences present from 
the previous scan.  The flip angle α of the excitation pulse was 21.2°, and the pulse strength 
γB1 = 29.4 kHz was applied.  During the acquisition, WALTZ-16 1H decoupling was 
applied with field strength γB1 = 2.3 kHz.  In the T1 relaxation measurement of pure L-
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lactide, the same pulse scheme was used with a 5-degree pulse and the time interval of 2 
s. In the selective-inversion experiment shown in Figure 2, the spectra were acquired
using a pulse sequence, (trigger‒ (shaped π) ‒ Gx,y,z ‒ [(shaped π/2) ‒ Gx,y,z]3 ‒ [αx ‒ acquire 
FID ‒ Gx,y,z]64).  An IBURP2 shaped π pulse at the resonance frequency of the ester carbon 
of L-lactide with a duration of 20 ms, three EBURP2 shaped π/2 pulses at the resonance 
frequency of the ester carbon of poly(L-lactide) with a duration of 20 ms, and Gx,y,z pulsed 
field gradients (35.5 /cm, 1 ms) were used.  The flip angle α of the excitation pulse was 
15.9° and the pulse strength γB1 = 29.4 kHz was applied.  16384 data points were acquired 
for each scan with an acquisition time of 341 ms.  In the homonuclear selective saturation 
experiments, the spectra were acquired using a pulse sequence, (CW ‒ trigger ‒ Gx,y,z ‒ [αx 
‒ acquire FID / HD ‒ Gx,y,z]32) (Figure 3a).  An HD pulse was applied during the 
acquisition with 10 % duty cycle and the pulse strength γB1= 1.5 kHz.  The flip angle α of 
the excitation pulse was 15.9°, and 16384 data points were acquired for each scan with an 
acquisition time of 218 ms, followed by a Gx,y,z pulsed field gradients (35.5 /cm, 1 ms).  
During the acquisition, WALTZ-16 1H decoupling was applied with field strength γB1 = 
2.3 kHz. 
6.3.3. Sample preparation for DNP experiments 
L-lactide (87 mg, 0.60 mmol) and free radical BDPA (2.8 mg, 15 mM) were 
dissolved in 400 µL of glass-forming solvent (THF:toluene, 85:15, v/v) and the resulting 
solution was used as a stock solution for DNP experiments.  A DCM solution of initiator 




            L-lactide / BDPA stock solution (40 µL, 1.5 M) was hyperpolarized in a HyperSense DNP 
polarizer (Oxford Instruments, Tubney Woods, UK), with 60 mW power of 93.965 GHz 
microwaves, for 3 hours at T = 1.4 K.  Prior to the dissolution, a stock solution of TBD 
and benzyl alcohol in DCM was prepared and 25 µL of the solution was loaded in the 
NMR tube.  The NMR tube was installed in the NMR instrument, and connected to the 
injection system.  Subsequently, the hyperpolarized sample was dissolved with 4 mL of 
pre-heated toluene, and automatically transferred to a 5 mm NMR tube inside the NMR 
spectrometer  The sample injection was driven by N2 gas and the gas pressure was 
optimized for fast and homogeneous mixing of the hyperpolarized sample and the pre-
loaded initiator and catalyst in the NMR tube.161   NMR experiments were triggered after 
an injection time of 360 ~ 400 ms and a stabilization time of 400 ms. The reaction 
conditions were the equivalent ratio of 10:1:1 ([L-lactide]:[TBD]:[benzyl alcohol]).  Less 
than 2 s was taken for the transfer of the hyperpolarized sample into the measurement 
stage and a total sample volume was 450 µL after mixing. 
6.3.5. Test ROP of L-lactide 
In a 20 mL scintillation vial equipped with a stir bar, benzyl alcohol (3.8 mg, 3.6 
µL, 0.035 mmol) and TBD (4.8 mg, 0.035 mmol) were dissolved in DCM (minimum 
amount to dissolve).  L-lactide (100 mg, 0.69 mmol) in toluene (14.5 mL, [L-lactide] = ca. 
0.05 M, [L-lactide]:[TBD]:[benzyl alcohol] = 20:1:1) was added to initiator/catalyst 
solution.  After 7 sec, the polymerization was quenched by DCM solution of benzoic acid.  
The conversion was determined by 1H NMR spectroscopy.  The polymer was precipitated 





Molecular weight and PDI were determined by THF GPC.  MnGPC(RI) = 2900 Da, Mw/Mn 
= 1.21. 
6.3.6. Synthesis of model intermediate compound, N-acetyl TBD 
In a flame-dried scintillation vial (5 mL) equipped with a stir bar, acetyl chloride 
(113 mg, 103 µL, 1.44 mmol) was added dropwise to TBD (40.0 mg, 0.287 mmol) in 
DCM-d2 (1 mL).  After 30 min, the resulting solution was concentrated in vacuo to remove 
excess acetyl chloride.  Remaining acetic acid was azeotropically removed with dry 
benzene (0.3 mL  2) in vacuo.  13C NMR (100 MHz, CDCl3): δ 170.5 ppm.  HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C9H16N3O 182.1293; Found 182.1295. 
6.4. Conclusions 
An unprecedented 13C signal, which was not observable by conventional NMR 
spectroscopy, was detected by hyperpolarized NMR.  Signal enhancement, which was 
achieved by hyperpolarization of nuclear spins using dynamic nuclear polarization (DNP) 
technique, makes the collection of 13C NMR spectra possible in real time during ROP.  13C 
temporal correlation experiments and homonuclear selective saturation experiments 
verified that the observed 13C NMR signal has characteristics of intermediate species.  
Although further studies will be necessary to gain more advanced understanding for the 
mechanism of ROP with the chemical structure of the intermediate, this study showed a 










The majority of the most common health problems are infectious diseases or 
related complications.  Although a variety of antimicrobials have been developed, the 
efficacy of these interventions to manage infectious diseases is compromised by poor 
bioavailability, side effects, and physical and biological barriers to their efficient delivery 
to target sites, as well as drug-resistant microorganisms.  Moreover, the development of 
new antimicrobials becomes increasingly difficult and expensive.  Therefore, novel 
treatment strategies are required to improve the efficacy of currently available 
antimicrobial agents.   
Nanotechnology can contribute to more effective treatment of infectious diseases 
using available antibiotics.  Nanomaterials can carry and selectively deliver therapeutics 
to the site of the disease with enhanced efficacy and reduced side-effects.  We have a keen 
interest in exploiting the polymeric nanostructures due to their capability to incorporate a 
wide range of therapeutics and targeting ligands as well as their tunability of 
physicochemical properties by synthesis and modification.  This dissertation aims to 
contribute to fundamental chemistry advances toward the development of degradable 
polymer-based nanoparticles for the treatment of infectious diseases. 
In a first project, bacterial adhesin, FimHA-targeted polymeric nanoparticles were 
developed via amidation between carboxylic acids located in the shell of the poly(acrylic 





lysine residues on FimHA.  After improving amidation conditions, we prepared FimHA-
polymeric nanoparticle conjugates with varying amount of adhesin on the surface of 
nanostructures in order to optimize cell binding and internalization efficiency.  Although 
the behaviors of these conjugates were not improved compared to those of the previous 
reports, the improved conjugation conditions in this study can be used for future studies 
with other FimHA variants or polymeric nanostructures with different morphologies.   
In a second direction involving a series of projects, functional degradable polymers 
and their self-assembled nanostructures were developed for the biomedical applications.  
Degradable polycarbonates were synthesized by metal-free organocatalytic ring-opening 
polymerization of functional cyclic carbonate monomers, and postpolymerization 
modifications.  Hydrophilic polycarbonate analogous to non-degradable PHPMA, and 
reactive aldehyde- and vinyl ether-functionalized polycarbonates were synthesized and 
their potential applications were examined.  Polycarbonates have higher stability than 
polyphosphoester analogs that we have previously developed, yet still retaining hydrolytic 
degradability.  These projects contributed an expansion of the type of reactive side chain 
groups available on polycarbonate backbone. 
In a third directon, a mechanistic study of organocatalytic ring-opening 
polymerization (ROP) of lactide was performed by hyperpolarized NMR spectroscopy.  
The collection of 13C NMR data in real time during polymerization was possible due to 
signal enhancement by hyperpolarization of lactide monomer.  We observed an 
unprecedented signal at ca. 175 ppm, which showed characteristics of an intermediate for 





mechanism of the polymerization, this study demonstrated that hyperpolarized NMR 
technique can be a valuable method to investigate “living” polymerizations.  
In summary, a novel strategy to treat recurrent bacterial infections was explored 
by mimicking the bacterial mode of cell invasion, which would enable delivery of 
antimicrobials to reservoir bacteria that evade current/conventional antibiotic treatments 
by hiding inside the cells.  This strategy served as the motivation for several fundamental 
advances that were made to the compositions of polymers to increase functionality while 
adjusting degradability and mechanistic studies of their synthesis.  This work serves as a 
guide for future development of functional polycarbonates and their self-assembled 
nanostructures to be used as degradable nanocarriers for antimicrobial delivery.  Further 
degradation studies of polycarbonates via hydrolysis and/or enzymatic hydrolysis will 
need to be conducted in vitro as well as in vivo.  Furthermore, future studies will need to 
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CFTR-CONJUGATED POLYMERIC NANOPARTICLES FOR THE TARGETED 
DELIVERY OF ANTIMICROBIAL SILVER COMPOUNDS TO TREAT LUNG 
INFECTIONS 
 
Lung infections are one of the major health issues worldwide.  The leading causes 
of death for children under the age of five and adults by curable infections are pneumonia 
and tuberculosis (TB), respectively, according to the World Health Organization.1,2  What 
makes situation worse is the emergence of antibiotic resistant bacteria such as 
Mycobacterium tuberculosis (MTB), which makes treatment of pulmonary diseases more 
challenging.3  In the case of cystic fibrosis (CF), respiratory failure by lung infections of 
multiple bacteria leads to patient death and the most common species to cause these 
infections are Pseudomonas aeruginosa (PA). 
The goal of this project is the development of multi-functional, biodegradable 
polymeric nanoparticles, which are capable of loading antimicrobial silver compounds as 
well as targeting infectious bacteria to localize drugs and/or diagnostic imaging agents 
(Figure A.1).  We envision that directly targeting bacteria at the site of infection may 
increase the efficacy of conventional antibiotics towards chronic lung infections.  In order 
to treat our target disease, cystic fibrosis (CF), degradable polymeric nanoparticles were 
conjugated with a peptide sequence corresponding to the first extracellular domain of 





interaction of this molecule with the disease-causing bacteria, Pseudomonas aeruginosa 










For the preparation of CFTR-targeted SCKs, after introduction of thioester 
functionalities on the shell of SCKs which were prepared from anionic polyphosphester-
b-poly(L-lactide) (aPPE-b-PLLA), native chemical ligation (NCL) with CFTR peptide 
provided the peptide-SCK conjugates (Figure A.2.).  After CFTR conjugation, 
hydrodynamic diameters increased while zeta potentials changed little.  SDS-PAGE with 





small peptides have transfer issues during typical SDS-PAGE/Western blot process.  Also, 
harsh conditions of SDS-PAGE could cause unpredicted problems with degradable SCKs.  
So, we used simple dot blots to bypass those problems and confirmed the existence of 





Figure A.2.  Targeted degradable nanoparticles were prepared by native chemical ligation (NCL) between 




Preliminary confocal studies using CFTR-conjugated SCKs with PA showed 
higher colocalization of targeted-SCKs than that of naked SCKs in vitro, which suggests 
that this approach offers a viable option for targeting the pathogen (Figure A.3).  Overall, 
CFTR-conjugated dSCKs appear to have targeting capability and warrant further 






Figure A.3.  Comparison of the binding affinity of naked SCKs and CFTR peptide-conjugated SCKs, with 
or without 100 µg/mL CFTR peptide or scrambled peptide, as determined by the ratio of red pixels (SCKs) 
to green pixels (PAO1-GFP).  Pixels counted in ImageJ after segmentation using Renyi entropy.  
Significance determined with One-Way ANOVA with Geisser-Greenhouse correction.  * P < 0.05, *** P < 
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DEVELOPMENT OF FULLY DEGRADABLE CYLINDRICAL MICELLES VIA 
CRYSTALLIZATION-DRIVEN SELF-ASSEMBLY 
 
In Chapter II, we studied to improve amidation-based conjugation conditions 
between FimHA and shell crosslinked polymeric nanostructures.  However, resulting 
conjugates did not exhibit better behaviors in vitro.  One of potential approaches to 
enhance cell binding and internalization efficiency is utilization of larger and/or longer 
nanostructures.  UPEC internalizes into bladder epithelial cells via polyvalent interactions 
between FimHA at the tip of Type 1 pili and mannose moieties at interval of ca. 16 nm on 
the surface of bladder epithelial cells.  However, sizes of our spherical SCKs measured by 
TEM are less than 20 nm, which would allow only monovalent interaction.  Therefore, it 
is critical to make a comparative study of the effects of nanoparticle shape on binding one 
or multiple receptors on bladder epithelial cells and the effects on the cell internalization. 
Since 2011, research groups of Andrew Dove and Rachel O’Reilly have developed 
and optimized crystallization-driven self-assembly (CDSA) of amphiphilic block 
copolymers, PAA-b-PLA.  Semi-crystalline PLA segment allows for the growth of 
cylindrical nanostructures via crystallization of PLA which is induced by heating above 
glass transition temperature of PLA block.  Using CDSA, we have attempted to prepare 
cylindrical nanoparticles.  The advantage of this method is both spheres and cylinders 
could be prepared from the same amphiphilic block copolymer precursor, as well as 





We first tried to synthesize fully degradable cylindrical micelles using PPE-b-
PLLA via CDSA.  Both anionic and cationic PPE-b-PLLAs were tested (Figure B.1).  
Although cylinders were produced from cationic polymers, those nanostructures 
precipitated out during CDSA process, which is relatively harsh conditions for readily 
degradable PPE segment.  Therefore, we needed to search other hydrophilic blocks, which 
are stable under CDSA conditions, while still retaining degradability.  As we discussed 
earlier in this dissertation, aliphatic polycarbonates are excellent candidates due to their 
biocompatibility, biodegradability, as well as low in vivo toxicity.  In addition, 





Figure B.1.  Anionic and cationic PPE-b-PLLAs and TEM images of cylindrical micelles prepared from the 






We synthesized PMHPAC-b-PLLA (Scheme B.1).  Unexpectedly, PMHPAC70-b-
PLLA20 formed cylindrical micelles after direct dissolution in water without CDSA.  
However, CDSA of short cylinders allowed the existing cylinders to be elongated.  
Hydrodynamic diameter increased and longer cylinders were observed by TEM (Figure 
B.2).  Conditions for cylinder formation using PMHPAC-b-PLLA need to be optimized 
for further applications.  In addition, other functional hydrophilic polycarbonates could be 












Figure B.2.  Cylindrical micelles produced from PMHPAC-b-PLLA by direct dissolution (left) and their 
elongated cylinders via CDSA (right) 
 
